Benign breast diseases - Breast biopsy, breast pathology - Breast cancer - Breast cancer and pregnancy - Breast cancer biomarkers and genomic tests - Breast cancer diagnosis - Breast cancer epidemiology - Breast cancer prevention - Breast cancer risk - Breast cancer screening, mammography - Breast cancer stem cells - Breast cancer treatment - Breast cancer treatment: surgery, radiotherapy - Breast imaging - Breast plastic surgery - Familial breast cancer, hereditary breast cancer, genetic predisposition - Mastitis - Sentinel lymph node biopsy, axillary management - Triple negative breast cancer

Benign breast diseases

• Australia
  • Australian Journal of General Practice
    • Skin changes of the female breast: A guide to assessment and management [2025]
• Brazil
  • Clinics
    • Management of benign and suspicious breast lesions during the coronavirus disease pandemic: recommendations for triage and treatment [2020]
  • Einstein
    • Brazil's benign breast disease care profile and geospatial analysis [2025]
• Canada
  • Canadian Journal of Surgery
    • A survey of Canadian breast health professionals’ recommendations for high-risk benign breast disease [2019]
  • Ontario Health
    • High-Risk Benign Breast Lesions: An Ontario Health (Cancer Care Ontario) Recommendations Report [2026]
• China
  • Chinese Medical Journal
    • Clinical practice guidelines for intraductal papilloma: Chinese Society of breast surgery (CSBrS) practice guidelines 2021 [2021]
    • Clinical practice guideline for diagnosis and treatment of hyperplasia of the mammary glands: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021 [2021]
    • Clinical practice guideline for breast fibroadenoma: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021 [2021]
  • Pharmaceutical Biology
    • Guidelines for the clinical application of the Xihuang pill for the prevention and treatment of breast hyperplasia diseases [2024]
• France
  • Collège National des Gynécologues et Obstétriciens Français
    • Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF): benign breast tumors [2016]
• Germany
  • Breast Care
    • Benign Breast Tumours - Diagnosis and Management [2018]
• High-income countries
  • npj Breast Cancer
    • A systematic review of determinants of breast cancer risk among women with benign breast disease [2025]
• Spain
  • Breast
    • Differences in breast cancer risk after benign breast disease by type of screening diagnosis [2020]
  • International Journal of Environmental Research and Public Health
    • Long-Term Risk of Breast Cancer after Diagnosis of Benign Breast Disease by Screening Mammography [2022]
• United Kingdom
  • British Journal of General Practice
    • Breast pain: assessment, management, and referral criteria [2020]
  • National Institute for Health and Care Excellence
    • High-intensity focused ultrasound for symptomatic breast fibroadenoma [2017]
• United States
  • American Society of Breast Surgeons
    • Select Choices in Benign Breast Disease: An Initiative of the American Society of Breast Surgeons for the American Board of Internal Medicine Choosing Wisely® Campaign [2018]
  • Breast Cancer Research and Treatment
    • Pathologic Discordance to Clinical Management Decisions Suggests Overtreatment in Pediatric Benign Breast Disease [2019]
  • International Journal of Women's Health
    • Prevalence, Impact, and Diagnostic Challenges of Benign Breast Disease: A Narrative Review [2023]
  • StatPearls
    • Benign Breast Calcifications
• {Related topics}
  • Topic
    • Mastitis
    • Breast plastic surgery
    • Breast imaging
    • Breast cancer
    • Breast biopsy, breast pathology

Breast biopsy, breast pathology

• Australia
  • Cancer Australia
    • The use of fine needle aspiration and core biopsy of the breast
• Australia, New Zealand
  • Royal College of Pathologists of Australasia
    • Breast
• Brazil
  • Value in Health Regional Issues
    • The Negative Impact of the New Coronavirus Pandemic on the Trend of Breast Biopsies and Their Direct Costs: Interrupted Time Series Analysis [2023]
• Bulgaria
  • Clinical Surgical Oncology
    • Nationwide analysis of the breast cancer guidelines adherence in Bulgaria [2024]
• Canada
  • Canadian Association of Radiologists Journal
    • Canadian Recommendations on Optimal Breast Biopsy Practices Developed Using a Modified Delphi Panel [2025]
• Central and Eastern Europe
  • Pathology & Oncology Research
    • Pathological Diagnosis, Work-Up and Reporting of Breast Cancer 1st Central-Eastern European Professional Consensus Statement on Breast Cancer [2022]
• China
  • Breast
    • Clinicopathological characteristics and prognosis of breast cancer with special histological types: A surveillance, epidemiology, and end results database analysis [2020]
  • Chinese Medical Journal
    • Clinical practice guidelines for visualized percutaneous breast tissue clips: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021 [2021]
    • Clinical practice guidelines for ultrasound-guided vacuum-assisted breast biopsy: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
• Egypt
  • JCO Global Oncology
    • Clinicopathologic Features of Breast Cancer in Egypt-Contemporary Profile and Future Needs: A Systematic Review and Meta-Analysis [2023]
• Europe
  • European Lobular Breast Cancer Consortium
    • Pitfalls in the Histological Diagnosis of Morphologic Variants of Invasive Lobular Carcinoma of the Breast [2025]
    • Integration of Pathological Criteria and Immunohistochemical Evaluation for Invasive Lobular Carcinoma Diagnosis: Recommendations From the European Lobular Breast Cancer Consortium [2024]
  • European Society of Breast Imaging
    • Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging [2020]
• India
  • Indian Journal of Medical Research
    • Stereotactic breast biopsy: A review & applicability in the Indian context [2021]
• International
  • Acta Cytologica
    • Systematic Review and Meta-Analysis of the Diagnostic Accuracy of the International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy in Diagnosing Breast Cancer [2023]
  • American Journal of Clinical Pathology
    • The Use of the International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy [2023]
  • Annals of Oncology
    • Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration [2015]
  • Breast Cancer Research and Treatment
    • First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions) [2016]
  • Breast Health Global Initiative
    • Can pathology diagnostic services for cancer be stratified and serve global health? [2020]
  • Histopathology
    • Phyllodes tumours of the breast: a consensus review [2016]
    • Breast lesions of uncertain malignant nature and limited metastatic potential: Proposals to improve their recognition and clinical management [2016]
  • International Academy of Cytology
    • IAC Standardized Reporting of Breast Fine-Needle Aspiration Biopsy Cytology [2017]
  • International Collaboration on Cancer Reporting
    • Dataset for reporting of the invasive carcinoma of the breast: recommendations from the International Collaboration on Cancer Reporting (ICCR) [2024]
    • Invasive Carcinoma of the Breast
    • Ductal Carcinoma In Situ, Variants of Lobular Carcinoma In Situ and Low Grade Lesions
  • International Journal of Molecular Sciences
    • The "Forgotten" Subtypes of Breast Carcinoma: A Systematic Review of Selected Histological Variants Not Included or Not Recognized as Distinct Entities in the Current World Health Organization Classification of Breast Tumors [2024]
  • International Journal of Surgery
    • Artificial Intelligence in digital pathology of breast cancer, new era of practice? [2025]
  • Medical Sciences
    • Radiologic-Pathologic Discordance After Image-Guided Breast Biopsy: A Systematic Review of Prevalence and Outcomes [2026]
  • Modern Pathology
    • Classification of Fibroepithelial Lesions of the Breast in Core Needle Biopsy With Implications for Further Management [2025]
    • Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer [2022]
    • Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group [2015]
  • Translational Breast Cancer Research
    • Breast biopsy techniques in a global setting-clinical practice review [2023]
• Iran
  • World Journal of Surgical Oncology
    • Chronological changes and trend of breast cancer clinics and pathology among Iranian women during 22 years from the largest breast cancer registry in Iran [2019]
• Ireland, United Kingdom
  • Journal of Clinical Pathology
    • Impact of COVID-19 on the practice of breast pathologists: a survey of breast pathologists in the UK and Ireland [2023]
• Italy
  • Pathologica
    • Standardizing the pathologic assessment of HER2-(ultra)low breast cancer: insights from a national Italian project [2026]
    • Consensus document on preoperative diagnostic procedures in breast lesions [2025]
    • Pathological examination of breast cancer samples before and after neoadjuvant therapy: recommendations from the Italian Group for the Study of Breast Pathology - Italian Society of Pathology (GIPaM-SIAPeC) [2022]
• Japan
  • Breast Cancer
    • The Japanese breast cancer society clinical practice guidelines for pathological diagnosis of breast cancer, 2022 edition [2024]
• Netherlands
  • Breast
    • The impact of standardized structured reporting of pathology reports for breast cancer care [2022]
  • Cancer Epidemiology
    • Notification of locoregional breast cancer recurrence based on pathology reports: A nationwide validation study with the Netherlands Cancer Registry [2025]
• Republic of Korea
  • Cancers
    • A Comparison of the Prognostic Effects of Fine Needle Aspiration and Core Needle Biopsy in Patients with Breast Cancer: A Nationwide Multicenter Prospective Registry [2023]
• Sub-Saharan Africa
  • Archives of Pathology & Laboratory Medicine
    • Assessment of Breast Pathology Reporting Needs and Development of Tumor Synoptic Templates in Sub-Saharan Africa [2025]
  • BMC Health Services Research
    • Breast cancer pathology services in sub-Saharan Africa: a survey within population-based cancer registries [2020]
• Switzerland
  • Acta Radiologica
    • Lesions with unclear malignant potential (B3) after minimally invasive breast biopsy: evaluation of vacuum biopsies performed in Switzerland and recommended further management [2015]
• United Kingdom
  • British Journal of Cancer
    • The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion <=1 mm in size)-results from the UK Sloane Project [2022]
  • Modern Pathology
    • Diagnostic Discordance and Error in Breast Pathology: Causes, Classifications, and Medicolegal Implications [2026]
  • National Institute for Health and Care Excellence
    • Image-guided radiofrequency excision biopsy of breast lesions [2009]
  • NHS England
    • NHS Breast Screening Programme Guidance: Biopsy testing guidance
    • Breast screening: quality assurance guidelines for breast pathology services
    • Breast screening: how to record vacuum-assisted excisions
  • Royal College of Pathologists
    • Dataset for histopathological reporting of breast disease in surgical excision specimens of breast cancer [2024]
    • Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening [2021]
• United States
  • Agency for Healthcare Research and Quality
    • Core-Needle Biopsy for Breast Abnormalities [2016]
  • American College of Radiology
    • ACR Practice Parameter for the Performance of Ultrasound-Guided Percutaneous Breast Interventional Procedures
    • ACR Practice Parameter for the Performance of Stereotactic-Tomosynthesis Guided Breast Interventional Procedure
    • ACR Practice Parameter for the Performance of Magnetic Resonance Imaging-Guided Breast Interventional Procedures
  • Annals of Surgical Oncology
    • Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer [2018]
  • BMC Women's Health
    • Development of a diagnostic test set to assess agreement in breast pathology: practical application of the Guidelines for Reporting Reliability and Agreement Studies (GRRAS) [2013]
  • Breast
    • Surgical Margin Reporting in Breast Conserving Surgery: Does compliance with guidelines affect re-excision and mastectomy rates? [2015]
  • Breast Cancer Surveillance Consortium
    • Breast biopsy patterns and findings among older women undergoing screening mammography: The role of age and comorbidity [2022]
    • Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic [2022]
    • Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer [2018]
    • Trends in Breast Tissue Sampling and Pathology Diagnoses among Women Undergoing Mammography in the U.S.: A Report from the Breast Cancer Surveillance Consortium [2015]
  • CA: A Cancer Journal for Clinicians
    • Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual [2017]
  • College of American Pathologists
    • Protocol for the Examination of Resection Specimens from Patients with Invasive Carcinoma of the Breast [2024]
    • Breast Fine-Needle Aspiration Practice in 2019: Results of a College of American Pathologists National Survey [2021]
  • JAMA Oncology
    • Clinicopathologic Characteristics and Prognosis of ERBB2-Low Breast Cancer Among Patients in the National Cancer Database [2023]
  • StatPearls
    • Stereotactic and Needle Breast Biopsy
• {Related topics}
  • Topic
    • Sentinel lymph node biopsy, axillary management
    • Breast cancer diagnosis
    • Breast cancer biomarkers and genomic tests
    • Breast cancer
    • Benign breast diseases

Breast cancer

• Africa
  • BMJ Open
    • Patient journey and timeliness of care for patients with breast cancer in Africa: a scoping review [2025]
  • Breast Care
    • A Review on Breast Cancer Care in Africa [2015]
  • Infectious Agents and Cancer
    • An update on the management of breast cancer in Africa [2017]
  • WHO African Region
    • Assessment of breast cancer control capacities in the WHO African Region in 2022 [2024]
• Americas
  • Pan American Health Organization
    • Breast cancer
• Antigua and Barbuda
  • Frontiers in Public Health
    • Cost analysis of female breast cancer in Antigua and Barbuda: a prevalence based study [2026]
• Argentina
  • Journal of Cancer Education
    • Argentina's National Program for Control of Breast Cancer: Time 1, Patient Navigation, and Patient Cancer Education Experience [2022]
• Asia
  • Asia-Pacific Journal of Oncology Nursing
    • The Effectiveness of Support Groups in Asian Breast Cancer Patients: An Integrative Review [2016]
  • BMC Health Services Research
    • Health system barriers influencing timely breast cancer diagnosis and treatment among women in low and middle-income Asian countries: evidence from a mixed-methods systematic review [2022]
  • European Society for Medical Oncology
    • Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer [2024]
    • Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer [2023]
    • Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS [2020]
• Australia
  • Australian Institute of Health and Welfare
    • Breast cancer in young women: key facts about breast cancer in women in their 20s and 30s [2015]
  • Cancer Australia
    • Breast cancer
  • International Journal for Equity in Health
    • Does breast cancer policy meet the needs of Aboriginal and Torres Strait Islander women in Australia? a review [2023]
• Benin
  • Journal of Cancer Policy
    • Direct and indirect costs of breast cancer management in Sub-Saharan Africa [2025]
• Bosnia and Herzegovina
  • Biomolecules and Biomedicine
    • Guidelines for breast cancer management in Bosnia and Herzegovina [2023]
• Brazil
  • BMC Health Services Research
    • The trend and direct costs of screening and chemotherapy treatment of breast cancer in the new coronavirus pandemic: total and interrupted time series study [2022]
  • Ciência & Saúde Coletiva
    • Temporal trends in social security benefits for female breast cancer in Brazil [2022]
  • JCO Global Oncology
    • Impact of COVID-19 Disease in Early Breast Cancer Management: A Summary of the Current Evidence [2022]
• Canada
  • Alberta Health Services
    • Breast Cancer
  • BC Cancer Agency
    • Breast Cancer
  • BCGuidelines
    • Breast Disease and Cancer: Diagnosis
    • Breast Cancer: Management and Follow-up
  • Canadian Cancer Society
    • Breast cancer
  • Canadian Family Physician
    • Primary care physician use across the breast cancer care continuum. CanIMPACT study using Canadian administrative data [2016]
  • Ontario Health
    • Breast Cancer Pathway Map
  • Public Health Agency of Canada
    • Breast Cancer
• Central and Eastern Europe
  • Radiology and Oncology
    • Advancing HER2-low breast cancer management: enhancing diagnosis and treatment strategies [2024]
• China
  • Annals of Translational Medicine
    • National consensus in China on diagnosis and treatment of patients with advanced breast cancer [2015]
  • Cancer
    • Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018) [2020]
  • Chinese Journal of Cancer Research
    • Breast cancer: Epidemiology, risk factors and screening [2023]
    • National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version) [2022]
  • Chinese Medical Journal
    • Clinical practice guidelines for the diagnosis and treatment of inflammatory breast cancer: Chinese Society of Breast Surgery (CSBrS) Practice Guidelines 2022 [2023]
    • Clinical practice guidelines for ductal carcinoma in situ: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
    • Clinical practice guidelines for diagnosis and treatment of invasive breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
• Colombia
  • Lancet Regional Health – Americas
    • Quality of care in Colombian women with early-onset breast cancer in two time periods: findings from a nationwide administrative registry cohort [2025]
• Costa Rica, Mexico
  • PLoS ONE
    • Cost-Effectiveness of Breast Cancer Control Strategies in Central America: The Cases of Costa Rica and Mexico [2014]
• Denmark
  • Clinical Epidemiology
    • Danish Breast Cancer Cooperative Group [2016]
• Eastern Europe
  • SAGE Open Medicine
    • Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countries [2020]
• Egypt
  • Eastern Mediterranean Health Journal
    • Presentation and management of female breast cancer in Egypt [2022]
• Ethiopia
  • Ministry of Health Ethiopia
    • National Guideline for breast health, early diagnosis and timely breast cancer management in Ethiopia (2024-2028) [2024]
• Europe
  • Breast
    • Why is appropriate healthcare inaccessible for many European breast cancer patients? – The EBCC 12 manifesto [2021]
    • The requirements of a specialist breast centre [2020]
    • Addressing disparities and challenges in underserved patient populations with metastatic breast cancer in Europe [2020]
    • New approaches for improving outcomes in breast cancer in Europe [2015]
  • Breast Cancer Research and Treatment
    • Healthcare providers’ adherence to breast cancer guidelines in Europe: a systematic literature review [2020]
  • European Commission
    • Manual for Breast Cancer Services [2021]
  • European Society for Medical Oncology
    • Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up [2024]
    • ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer [2023]
    • ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5) [2022]
    • ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer [2021]
    • ESO–ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4) [2020]
    • ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer [2020]
    • ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3) [2017]
    • Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [2015]
    • ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) [2014]
    • Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [2012]
  • European Society of Breast Cancer Specialists
    • Multidisciplinary meeting for breast cancer care: EUSOMA recommendations for optimization [2026]
    • European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO [2024]
    • The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer [2012]
  • Journal of Obstetrics and Gynaecology of India
    • Guidance and Standards for Breast Cancer Care in Europe [2020]
• France
  • Breast Cancer
    • French national survey on breast cancer care: caregiver and patient views [2024]
  • Clinical Breast Cancer
    • Ductal Carcinoma in Situ: A French National Survey. Analysis of 2125 Patients [2020]
  • European Journal of Breast Health
    • Breast Cancer Management during the COVID 19 Pandemic: French Guidelines [2020]
  • PLoS ONE
    • Compliance with clinical guidelines for breast cancer management: A population-based study of quality-of-care indicators in France [2019]
• Gambia
  • BMC Health Services Research
    • Geospatial analysis and impact of targeted development of breast cancer care in The Gambia: a cross-sectional study [2021]
• Germany
  • Archives of Gynecology and Obstetrics
    • Multidisciplinary breast centres in Germany: a review and update of quality assurance through benchmarking and certification [2012]
  • Breast Care
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2025 [2025]
    • Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024 [2024]
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023 [2023]
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022 [2022]
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021 [2021]
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021 [2021]
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020 [2020]
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019 [2019]
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019 [2019]
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2016 [2016]
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2016 [2016]
  • Deutsches Ärzteblatt International
    • The Screening, Diagnosis, Treatment, and Follow-Up of Breast Cancer [2018]
  • Geburtshilfe und Frauenheilkunde
    • Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer [2018]
• Ghana
  • BMC Women's Health
    • Socio-cultural beliefs and perceptions influencing diagnosis and treatment of breast cancer among women in Ghana: a systematic review [2024]
• High-income countries
  • International Journal of Environmental Research and Public Health
    • What Is the Evidence Globally for Culturally Safe Strategies to Improve Breast Cancer Outcomes for Indigenous Women in High Income Countries? A Systematic Review [2021]
• India
  • South Asian Journal of Cancer
    • Breast cancer: An overview of published Indian data [2016]
• International
  • Annals of Translational Medicine
    • A quality evaluation of the clinical practice guidelines on breast cancer using the RIGHT checklist [2021]
  • Breast Health Global Initiative
    • The role of dissemination and implementation science in global breast cancer control programs: Frameworks, methods, and examples [2020]
    • The Breast Health Global Initiative 2018 Global Summit on Improving Breast Healthcare Through Resource-Stratified Phased Implementation: Methods and overview [2020]
    • Situational analysis of breast health care systems: Why context matters [2020]
  • Cancers
    • Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review [2021]
  • Critical Reviews in Oncology/Hematology
    • Rare but distinct: A systematic review of primary neuroendocrine tumors of the breast according to WHO 2019 guidelines [2026]
  • Current Oncology
    • Clinical practice guidelines in breast cancer [2018]
  • JAMA Network Open
    • Financial Toxicity Among Patients With Breast Cancer Worldwide: A Systematic Review and Meta-analysis [2023]
  • Oncologist
    • Financial toxicity among patients with breast cancer: a systematic review and meta-analysis [2026]
  • Senologic International Society
    • Current Challenges and Perspectives in Breast Cancer in Elderly Women: The Senologic International Society (SIS) Survey [2023]
    • Breast Cancer Management During the COVID-19 Pandemic: The Senologic International Society Survey [2021]
• Iran
  • Iranian Journal of Public Health
    • Psychological Consequences of Breast Cancer in Iran: A Meta-Analysis [2019]
    • The Economic Burden of Breast Cancer in Iran [2015]
• Ireland
  • Department of Health Ireland
    • Diagnosis, Staging and Treatment of Patients with Breast Cancer
  • Ireland's Health Services
    • Breast Cancer National Clinical Guidelines
• Ireland, United Kingdom
  • British Journal of Cancer
    • Impact of the COVID-19 pandemic on breast cancer patient pathways and outcomes in the United Kingdom and the Republic of Ireland - a scoping review [2024]
• Japan
  • BMC Research Notes
    • Cost of illness of breast cancer in Japan: trends and future projections [2015]
  • Breast Cancer
    • Impact of the COVID-19 pandemic on breast cancer diagnosis and treatment trends in Japan [2025]
    • Annual report of National Clinical Database-Breast Cancer Registry in 2021: characteristics categorized by body mass index and menopause status [2025]
    • Characteristics of female breast cancer in Japan: annual report of the National Clinical Database in 2018 [2023]
    • Recommendations for the management of breast cancer patients during the COVID-19 pandemic from the Japan Breast Cancer Society [2021]
• Latin America
  • Cancer Reports
    • Recommendations for streamlining precision medicine in breast cancer care in Latin America [2021]
  • ecancermedicalscience
    • Management of non-invasive tumours, benign tumours and breast cancer during the COVID-19 pandemic: recommendations based on a Latin American survey [2020]
  • Globalization and Health
    • Breast cancer policy in Latin America: account of achievements and challenges in five countries [2016]
• Lithuania
  • Medicina
    • The cost of newly diagnosed breast cancer in Lithuania, 2011 [2015]
• Low and middle income countries
  • Breast
    • Factors influencing the time to diagnosis and treatment of breast cancer among women in low- and middle-income countries: A systematic review [2024]
  • Oncologist
    • Economic Evaluations of Breast Cancer Care in Low- and Middle-Income Countries: A Scoping Review [2021]
  • Systematic Reviews
    • A systematic review of public health interventions to address breast cancer inequalities in low- and middle-income countries [2024]
    • Economic analyses of breast cancer control in low- and middle-income countries: a systematic review [2013]
  • World Journal of Clinical Oncology
    • Challenges to the early diagnosis and treatment of breast cancer in developing countries [2014]
• Malaysia
  • Ministry of Health Malaysia
    • Management of Breast Cancer (Third Edition) [2019]
• Mexico
  • ecancermedicalscience
    • Costs of breast cancer care in Mexico: analysis of two insurance coverage scenarios [2015]
• Middle East, North Africa
  • ecancermedicalscience
    • Do we need regional guidelines for breast cancer management in the MENA region? MENA Breast Cancer Guidelines project [2017]
• Morocco
  • Asian Pacific Journal of Cancer Prevention
    • Factors Influencing Patient and System Delays in Women with Breast Cancer in Morocco: A Systematic Review [2025]
• Netherlands
  • Breast
    • Patterns of care over 10 years in young breast cancer patients in the Netherlands, a nationwide population-based study [2022]
    • Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis [2021]
  • Journal of Hematology & Oncology
    • Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study [2021]
• New Zealand
  • Health New Zealand
    • New breast cancer diagnoses and treatments 2020 [2023]
  • PLoS ONE
    • Differences in Breast Cancer Survival between Public and Private Care in New Zealand: Which Factors Contribute? [2016]
• Philippines
  • Department of Health Philippines
    • Breast Cancer National Clinical Practice Guidelines [2022]
• Republic of Korea
  • Cancer Research and Treatment
    • The Economic Burden of Breast Cancer in Korea from 2007-2010 [2015]
• Saudi Arabia
  • Saudi Health Council
    • Saudi Breast Cancer Management Guidelines [2019]
• Serbia
  • Frontiers in Public Health
    • Medical cost of breast cancer services in Serbia between 2010 and 2019: national data report [2024]
• South Africa
  • Journal of Oncology
    • Improving Breast Cancer Control via the Use of Community Health Workers in South Africa: A Critical Review [2011]
  • National Department of Health South Africa
    • Clinical Guidelines for Breast Cancer Control and Management [2019]
    • Breast Cancer Prevention and Control Policy [2017]
• Spain
  • International Journal of Environmental Research and Public Health
    • Breast Cancer Care Quality Indicators in Spain: A Systematic Review [2021]
• Sri Lanka
  • Ministry of Health Sri Lanka
    • National guidelines for the management of early and locally advanced breast cancer in Sri Lanka [2021]
• Sub-Saharan Africa
  • BMC Public Health
    • An analytical framework for breast cancer public policies in Sub-Saharan Africa: results from a comprehensive literature review and an adapted policy Delphi [2024]
  • International Agency for Research on Cancer
    • Breast Cancer Outcomes in Sub-Saharan Africa [2021]
  • JCO Global Oncology
    • Assessment of Breast Cancer Management in Sub-Saharan Africa [2021]
• Sweden
  • Breast
    • Breaking down the costs for breast cancer: Insights from Sweden's national quality register [2026]
• Türkiye
  • European Journal of Public Health
    • Causes of diagnostic and treatment delays in locally advanced breast cancer: a nationwide multicenter survey and electronic health records analysis in Turkiye [2025]
• Uganda
  • African Health Sciences
    • Breast cancer guidelines for Uganda (2nd Edition 2008) [2008]
• United Arab Emirates
  • JCO Global Oncology
    • Breast Cancer in the United Arab Emirates [2023]
• United Kingdom
  • BMJ Open
    • Age, patient experience and satisfaction with breast cancer care: a cohort study using linked national cancer patient experience survey and cancer registry data [2026]
  • British Journal of Cancer
    • Inflammatory breast cancer: time to standardise diagnosis assessment and management, and for the joining of forces to facilitate effective research [2015]
  • International Journal of Breast Cancer
    • A Nationwide Cross-Sectional Survey of UK Breast Surgeons' Views on the Management of Ductal Carcinoma In Situ [2015]
  • National Institute for Health and Care Excellence
    • Breast cancer (Quality standard) [2026]
    • Advanced breast cancer: diagnosis and treatment [2026]
    • Early and locally advanced breast cancer: diagnosis and management [2025]
    • Health Inequalities in Breast Cancer in England: A Pragmatic Review to Inform National Institute for Care and Excellence (NICE) Recommendations [2024]
    • Breast cancer
  • NHS Wales
    • National Optimal Pathway for Breast Cancer: Point of Suspicion to First Definitive Treatment in Adults (aged 16 and over) [2024]
  • Royal College of Surgeons of England
    • National Audit of Primary Breast Cancer State of the Nation Patient and Public Report 2024 [2024]
  • Scottish Government
    • Breast cancer clinical quality performance indicators [2016]
• United States
  • American Cancer Society
    • Breast Cancer Facts & Figures 2019-2020 [2019]
    • Breast Cancer
  • American College of Obstetricians and Gynecologists
    • Breast neoplasms
  • American Society of Clinical Oncology
    • Breast Cancer
  • American Society of Clinical Oncology Educational Book
    • Tailoring Management for Invasive Lobular Carcinoma: Imaging, Surgical Treatment, and Systemic Therapy Considerations [2026]
  • Cancer Causes and Control
    • Guideline-concordance along the cancer care continuum and breast cancer mortality by race and ethnicity: a SEER-Medicare study [2026]
  • Centers for Disease Control and Prevention
    • Breast Cancer
  • JNCI Cancer Spectrum
    • Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS) [2018]
  • Journal of Surgical Oncology
    • Disparities in Breast Cancer Screening, Diagnosis, and Outcomes Among Vietnamese American Women: A Systematic Review [2026]
  • M.D. Anderson Cancer Center
    • Inflammatory Breast Cancer
    • Breast Cancer
  • National Comprehensive Cancer Network
    • NCCN Guidelines Updates: Breast Cancer [2019]
    • Breast Cancer
  • Obstetrics & Gynecology
    • Executive Summary of the Early-Onset Breast Cancer Evidence Review Conference [2020]
  • OncoLink
    • Breast Cancer
• Western countries
  • Advances in Therapy
    • Direct and Indirect Costs of Breast Cancer and Associated Implications: A Systematic Review [2024]
• WHO
  • International Agency for Research on Cancer
    • Breast cancer
  • World Health Organization
    • Patient navigation for early detection, diagnosis and treatment of breast cancer: technical brief [2024]
    • Global breast cancer initiative implementation framework: assessing, strengthening and scaling up of services for the early detection and management of breast cancer [2023]
    • The Global Breast Cancer Initiative
    • Breast cancer: Fact sheet
• WHO Eastern Mediterranean Region
  • WHO Eastern Mediterranean Region
    • Guidelines for management of breast cancer [2006]
• {Related topics}
  • Topic
    • Triple negative breast cancer
    • Sentinel lymph node biopsy, axillary management
    • Menopause, hormone replacement therapy, breast cancer
    • Gynecologic oncology
    • Familial breast cancer, hereditary breast cancer, genetic predisposition
    • Breast imaging
    • Breast cancer treatment
    • Breast cancer stem cells
    • Breast cancer screening, mammography
    • Breast cancer risk
    • Breast cancer prevention
    • Breast cancer epidemiology
    • Breast cancer diagnosis
    • Breast cancer biomarkers and genomic tests
    • Breast cancer and pregnancy
    • Breast biopsy, breast pathology
    • Benign breast diseases

Breast cancer and pregnancy

• Australia, New Zealand
  • Birth
    • Perinatal outcomes of women with gestational breast cancer in Australia and New Zealand: A prospective population-based study [2022]
• Canada
  • Current Oncology
    • Outcome of patients with pregnancy during or after breast cancer: a review of the recent literature [2015]
• China
  • Breast Cancer Research and Treatment
    • Physicians’ attitudes towards reproduction in young patients with early breast cancer in China [2020]
  • Chinese Medical Journal
    • Clinical practice guidelines for pregnancy-associated breast cancer: Chinese society of breast surgery (CSBrS) practice guidelines 2021 [2021]
• Europe
  • European Society for Medical Oncology
    • ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC) [2023]
• France
  • Breast
    • Prognosis of triple-negative breast cancer associated with pregnancy: A propensity score-matched analysis from the French CALG (Cancer Associé à la Grossesse) network [2022]
• International
  • Annals Academy of Medicine Singapore
    • Pregnancy-associated breast cancer: Management of the mother, fetus and tumour [2025]
  • BMC Cancer
    • A systematic review and meta-analysis of pregnancy-associated breast cancer incidence rate [2025]
    • Prognosis of pregnancy-associated breast cancer: a meta-analysis [2020]
  • JAMA
    • Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study [2024]
  • Journal of Advanced Nursing
    • Women's experiences of gestational breast cancer and their interactions with the healthcare system: A scoping review [2023]
  • Journal of the National Cancer Institute
    • Breastfeeding after breast cancer in young BRCA carriers [2025]
  • Medical Sciences
    • Prognosis of Pregnancy-Associated Breast Cancer: A Systematic Review of Contemporary Observational Studies [2026]
• Republic of Korea
  • Breast
    • Prognosis of pregnancy after breast cancer diagnosis according to the type of treatment: A population-based study in Korea by the SMARTSHIP group [2022]
  • Cancer Research and Treatment
    • Outcomes of Pregnancy after Breast Cancer in Korean Women: A Large Cohort Study [2020]
  • Frontiers in Oncology
    • The Risk Factors, Incidence and Prognosis of Postpartum Breast Cancer: A Nationwide Study by the SMARTSHIP Group [2022]
  • Journal of Breast Cancer
    • Neoadjuvant Chemotherapy and Prognosis of Pregnancy-Associated Breast Cancer: A Time-Trends Study of the Korean Breast Cancer Registry Database [2018]
  • Oncologist
    • Prognostic Impact of Pregnancy in Korean Patients with Breast Cancer [2019]
  • PLoS ONE
    • Pregnancy-Associated Risk Factors of Postpartum Breast Cancer in Korea: A Nationwide Health Insurance Database Study [2016]
• Taiwan
  • Oncologist
    • Mortality of Pregnancy Following Breast Cancer Diagnoses in Taiwanese Women [2020]
• United Kingdom
  • European Journal of Cancer
    • Survival after breast cancer in women with a subsequent live birth: Influence of age at diagnosis and interval to subsequent pregnancy [2022]
  • NIHR Open Research
    • The UK Breast Cancer in Pregnancy (UKBCiP) Study. Incidence, diagnosis, management and short-term outcomes of breast cancer first diagnosed during pregnancy in the United Kingdom: A population-based descriptive study [2025]
  • Royal College of Obstetricians and Gynaecologists
    • Pregnancy and Breast Cancer [2025]
• United States
  • Academy of Breastfeeding Medicine
    • ABM Clinical Protocol #34: Breast Cancer and Breastfeeding [2020]
  • American Society of Breast Surgeons
    • Oncolactation for Patients with Breast Cancer: Executive Summary from the American Society of Breast Surgeons [2025]
    • Resource Guide on Oncolactation [2024]
  • Breast
    • Obstetric complications at time of delivery amongst breast cancer survivors: A population-based cohort study [2022]
  • Breast Cancer Research
    • Outcomes of children exposed in utero to chemotherapy for breast cancer [2014]
  • National Cancer Institute
    • Breast Cancer Treatment During Pregnancy (PDQ®)
• {Related topics}
  • Topic
    • Obstetrics, perinatology
    • Fertility preservation
    • Breast cancer

Breast cancer biomarkers and genomic tests

• Asia
  • Advances in Therapy
    • Addressing the Challenges in the Identification of HER2-Low and Ultralow Breast Cancer in Asia: A Delphi Consensus [2026]
• Brazil
  • BMC Health Services Research
    • Cost-Effectiveness analysis of the 21-Gene platform for guiding treatment decisions for early Hormone-Positive breast cancer: the perspective of the Brazilian public health system [2025]
  • Revista da Associação Médica Brasileira
    • Challenges in the evaluation of HER2 and HER2-low in breast cancer in Brazil and recommendations of a multidisciplinary working group [2024]
• Canada
  • Canada's Drug Agency
    • Oncotype DX in Women and Men with ER-Positive, HER2-Negative Early Stage Breast Cancer who are Lymph Node Negative: A Review of Clinical Effectiveness and Guidelines [2014]
    • Oncotype DX in Women and Men with ER-Positive HER2-Negative Early Stage Breast Cancer Who are Lymph Node-Positive: A Review of Clinical Effectiveness and Guidelines [2014]
  • Canadian Association of Pathologists
    • Ki67 in Breast Cancer Assay: An Ad Hoc Testing Recommendation from the Canadian Association of Pathologists Task Force [2023]
  • Current Oncology
    • Testing for her2 in breast cancer: current pathology challenges faced in Canada [2012]
  • Ontario Health
    • Clinical Utility of Multigene Profiling Assays in Early-Stage Invasive Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline [2022]
    • Gene Expression Profiling Tests for Early-Stage Invasive Breast Cancer: A Health Technology Assessment [2020]
• China
  • Breast Cancer Research
    • Challenges and improvements in HER2 scoring and histologic evaluation: insights from a national proficiency testing scheme for breast cancer diagnosis in China [2024]
  • Chinese Medical Journal
    • Clinical practice guidelines for multigene assays in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
  • Scientific Reports
    • Current evidence on circRNAs as potential theranostic markers for detecting chemoresistance in breast cancer: a systematic review and meta-analysis [2022]
    • Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results [2019]
• Denmark
  • Breast Cancer Research
    • High inter-laboratory variability in the assessment of HER2-low breast cancer: a national registry study on 50,714 Danish patients [2023]
• Europe
  • European Commission
    • Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative [2021]
  • European Journal of Cancer
    • Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM) [2017]
  • Future Oncology
    • Genomic tests to guide management of breast cancer in Europe: regulation, reimbursement, adoption, and challenges [2025]
• France
  • PLoS ONE
    • Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancers [2017]
• Germany
  • Institute for Quality and Efficiency in Health Care
    • Biomarker-based tests for the decision for or against adjuvant systemic chemotherapy in primary breast cancer [2016]
• India
  • Archives of Pathology & Laboratory Medicine
    • External Quality Assurance Helps Improve Infrastructure for Testing Breast Biomarkers Across a Lower- and Middle-Income Country: Our Experience With Breast Biomarker Testing in the National Cancer Grid External Quality Assurance System in India [2024]
  • Indian Journal of Medical Research
    • Challenges & recommendations for identification of human epidermal growth factor receptor -2 (HER2)-low metastatic breast cancer in India: Expert opinion statement [2025]
    • Improving accuracy of breast cancer biomarker testing in India [2017]
  • South Asian Journal of Cancer
    • Practical consensus recommendations on management of HR + ve early breast cancer with specific reference to genomic profiling [2018]
• International
  • Biosensors
    • Innovative Methodologies for the Early Detection of Breast Cancer: A Review Categorized by Target Biological Samples [2025]
  • BMC Cancer
    • Scoping review: (Bio)markers for the prognostication of breast cancer recurrence [2025]
  • Breast Cancer Research
    • A systematic review of candidate genes and their relevant pathways for metastasis among adults diagnosed with breast cancer [2024]
  • Cancer
    • Use of standard markers and incorporation of molecular markers into breast cancer therapy [2011]
  • Cancer Treatment and Research Communications
    • Circulating tumor DNA for breast cancer: Review of active clinical trials [2022]
  • Critical Reviews in Oncology/Hematology
    • Role of machine learning in molecular pathology for breast cancer: A review on gene expression profiling and RNA sequencing application [2025]
    • Gene expression signatures in older patients with breast cancer: A systematic review [2023]
  • International Journal of Molecular Sciences
    • Clinical Applications of Blood-Derived Extracellular Vesicle Biomarkers in Breast Cancer: A Scoping Review [2026]
    • The Prognostic Power of miR-21 in Breast Cancer: A Systematic Review and Meta-Analysis [2025]
    • Assessing the Role of MicroRNAs in Predicting Breast Cancer Recurrence-A Systematic Review [2023]
  • International Ki67 in Breast Cancer Working Group
    • Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study [2022]
    • Ki67 as a Companion Diagnostic: Good or Bad News? [2022]
    • Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group [2021]
  • Journal of Cancer Research and Clinical Oncology
    • The assessment of breast cancer biomarkers in diagnosis, prognosis and treatment monitoring: integrated analysis [2025]
  • Journal of Surgical Oncology
    • MicroRNA Expression in Breast Cancer Patients, an Integrative Review [2026]
  • Modern Pathology
    • International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-Low and Ultralow Categories [2026]
  • Seminars in Cancer Biology
    • Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer - ScienceDirect [2017]
• Iran
  • Journal of Cancer Research and Clinical Oncology
    • Molecular signatures of breast cancer in the Iranian population: a review of cell growth and cell cycle regulators [2025]
• Ireland
  • Health Information and Quality Authority
    • A rapid HTA of gene expression profiling tests for guiding the use of adjuvant chemotherapy in early-stage invasive breast cancer [2024]
• Italy
  • Breast
    • Integrating PIK3CA Testing into Clinical Practice for Advanced HR+/HER2- Breast Cancer: An Expert Consensus [2026]
  • Cancers
    • Definition of High-Risk Early Hormone-Positive HER2-Negative Breast Cancer: A Consensus Review [2022]
  • Oncotarget
    • Multigene tests for breast cancer: the physician’s perspective [2021]
• Japan
  • Genes
    • Significance of Multi-Cancer Genome Profiling Testing for Breast Cancer: A Retrospective Analysis of 3326 Cases from Japan's National Database [2024]
• Latin America
  • JCO Global Oncology
    • Practice-Changing Use of the 21-Gene Test for the Management of Patients With Early-Stage Breast Cancer in Latin America [2021]
  • PLoS ONE
    • HER2-low prevalence among Hispanic/Latino women with breast cancer: A systematic review and meta-analysis [2024]
• Malaysia
  • Malaysian Journal of Pathology
    • Guidelines for HER2 reporting in breast cancer: Recommendations by the Malaysian Breast Pathology Working Group [2025]
• Middle East, North Africa
  • Oncologist
    • Somatic mutations in Middle East and North Africa breast cancer patients: a systematic review [2025]
• Norway
  • Clinical Breast Cancer
    • Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives [2025]
  • ESMO Open
    • Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer-a prospective national multicentre study (EMIT-1) [2024]
• Portugal
  • Clinical Breast Cancer
    • The Use and Impact on Treatment Decision of the 21-Gene Recurrence Score Assay for Patients With HR+/HER2- Early Breast Cancer in Portugal: A Nationwide Retrospective Cohort Study [2026]
• Republic of Korea
  • Breast
    • Body mass index and progesterone receptor in postmenopausal ER-positive/HER2-negative breast cancer: A nation-wide study in Korean breast cancer society and the multi-institutional cohort [2025]
  • Breast Cancer Research
    • Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean Breast Cancer Society [2022]
  • Journal of Breast Cancer
    • Impact of the Updated Guidelines on Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Breast Cancer [2020]
• Rwanda
  • Bulletin of the World Health Organization
    • Breast cancer molecular diagnostics in Rwanda: a cost-minimization study of immunohistochemistry versus a novel GeneXpert® mRNA expression assay [2023]
• Singapore
  • Singapore Medical Journal
    • Concordance between core needle biopsy and surgical specimen for ER, PgR and Her2neu receptor status in breast cancer and study of difference in reliability between the two groups with the change in ASCO/CAP guidelines [2016]
• Spain
  • Sociedad Española de Oncología Médica
    • Biomarkers in breast cancer 2024: an updated consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology [2024]
    • Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer [2021]
    • Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology [2018]
• Sweden
  • Breast
    • Optimization of guidelines for Risk Of Recurrence/Prosigna testing using a machine learning model: a Swedish multicenter study [2025]
  • Cancers
    • Variability in Breast Cancer Biomarker Assessment and the Effect on Oncological Treatment Decisions: A Nationwide 5-Year Population-Based Study [2021]
• Switzerland
  • PLoS ONE
    • Impact of Modified 2013 ASCO/CAP Guidelines on HER2 Testing in Breast Cancer. One Year Experience [2015]
• United Kingdom
  • Breast Cancer Research and Treatment
    • The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience [2020]
  • British Journal of Cancer
    • Distinct temporal trends in breast cancer incidence from 1997 to 2016 by molecular subtypes: a population-based study of Scottish cancer registry data [2020]
  • Health Technology Assessment
    • Tumour profiling tests to guide adjuvant chemotherapy decisions in lymph node-positive early breast cancer: a systematic review and economic evaluation [2025]
    • Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis [2019]
  • Journal of Clinical Pathology
    • Updated UK Recommendations for HER2 assessment in breast cancer [2015]
  • National Institute for Health and Care Excellence
    • Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer [2024]
    • Magseed for locating impalpable breast cancer lesions [2020]
    • MammaTyper in vitro diagnostic test for determining breast cancer subtypes [2018]
• United States
  • American Society of Clinical Oncology
    • Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline Update [2023]
    • Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update Q and A [2022]
    • Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update [2022]
    • Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update Q and A [2022]
    • Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update [2022]
    • Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update [2020]
    • Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update—Integration of Results From TAILORx [2019]
    • Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update [2018]
    • Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update [2017]
    • Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline [2016]
    • Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline [2015]
    • Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update [2014]
  • Annals of Surgical Oncology
    • The 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database Study [2022]
  • Breast Cancer Research and Treatment
    • Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis [2016]
  • Cancer
    • Adjuvant chemotherapy in patients with invasive lobular carcinoma and use of the 21-gene recurrence score: A National Cancer Database analysis [2022]
  • Cancer Medicine
    • Surgeon and medical oncologist peer network effects on the uptake of the 21-gene breast cancer recurrence score assay [2021]
  • Clinical Breast Cancer
    • Circulating Biomarkers in Breast Cancer [2022]
  • College of American Pathologists
    • The Cancer Immunotherapy Biomarker Testing Landscape [2020]
    • Quantitative Image Analysis of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry for Breast Cancer: Guideline From the College of American Pathologists [2019]
  • Current Oncology
    • Oncotype DX Recurrence Score Predicts Survival in Invasive Micropapillary Breast Carcinoma: A National Cancer Database Analysis [2025]
  • Genetics in Medicine
    • Recommendations from the EGAPP Working Group: does the use of Oncotype DX tumor gene expression profiling to guide treatment decisions improve outcomes in patients with breast cancer? [2016]
  • JAMA Network Open
    • Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016 [2020]
  • npj Breast Cancer
    • The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study [2021]
• {Related topics}
  • Topic
    • Breast cancer
    • Breast biopsy, breast pathology

Breast cancer diagnosis

• Africa
  • JCO Global Oncology
    • Prevalence of Themes Linked to Delayed Presentation of Breast Cancer in Africa: A Meta-Analysis of Patient-Reported Studies [2020]
• Canada
  • Current Oncology
    • Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for Clinical Staging of Patients Newly Diagnosed with Breast Cancer [2024]
• China
  • Cancer Medicine
    • Disparities in stage at diagnosis among breast cancer molecular subtypes in China [2023]
• East Africa
  • PLoS ONE
    • Delayed presentation of breast cancer patients and contributing factors in East Africa: Systematic review and meta-analysis [2024]
• Ethiopia
  • BMC Cancer
    • Proportion of early-stage breast cancer at diagnosis in Ethiopia: a systematic review and meta-analysis [2024]
  • BMC Women's Health
    • Advanced-stage breast cancer diagnosis and its determinants in Ethiopia: a systematic review and meta-analysis [2024]
  • PLoS ONE
    • Late-stage diagnosis: The driving force behind high breast cancer mortality in Ethiopia: A systematic review and meta-analysis [2024]
• International
  • BMC Cancer
    • Experiences and perceptions of men following breast cancer diagnosis: a mixed method systematic review [2024]
  • Computer Methods and Programs in Biomedicine
    • Explainable multimodal fusion for breast carcinoma diagnosis: A systematic review, open problems, and future directions [2026]
• Ireland
  • Ireland's Health Services
    • HSE National Clinical Guideline: Diagnosis and staging of patients with breast cancer [2024]
    • National Breast Cancer GP Referral Guideline
• Low and middle income countries
  • International Journal of Community Based Nursing & Midwifery
    • Factors Associated with Delays in Breast Cancer Diagnosis in Low- and Middle-income Countries: A Scoping Review [2026]
  • Psycho-Oncology
    • Duration of the patient interval in breast cancer and factors associated with longer delays in low-and middle-income countries: A systematic review with meta-analysis [2023]
• Sub-Saharan Africa
  • Lancet Global Health
    • Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis [2016]
• United Kingdom
  • British Journal of Cancer
    • The impact of the first 2 years of the COVID-19 pandemic on breast cancer diagnoses: a population-based study in England [2023]
• United States
  • American College of Radiology
    • Stage I Breast Cancer: Initial Work up and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women
  • Journal of the American College of Radiology
    • Diagnostic Management Pathways for Workup of Abnormal Screening With Digital Mammography Versus Digital Breast Tomosynthesis [2025]
• Zambia
  • Ministry of Health Zambia
    • National guidelines for early diagnosis of breast cancer in Zambia [2019]
• {Related topics}
  • Topic
    • Breast imaging
    • Breast cancer screening, mammography
    • Breast cancer
    • Breast biopsy, breast pathology

Breast cancer epidemiology

• Africa
  • African Health Sciences
    • Clustering time trends of breast cancer incidence in Africa: a 27-year longitudinal study in 53 countries [2021]
  • Journal of Global Health
    • Estimating the incidence of breast cancer in Africa: a systematic review and meta-analysis [2018]
• Algeria
  • Cancer Treatment and Research Communications
    • Epidemiology of breast cancer in women based on diagnosis data from oncologists and senologists in Algeria [2020]
• Arab countries
  • Eastern Mediterranean Health Journal
    • No evidence that breast cancer occurs at higher rates among young Arab women [2024]
• Arctic countries
  • International Journal of Circumpolar Health
    • Breast cancer in the Arctic – changes over the past decades [2012]
• Asia
  • Breast Care
    • Current Status and Future Projections of Breast Cancer in Asia [2015]
  • Cancer
    • The Prevalence and Assessment of ErbB2-Positive Breast Cancer in Asia [2010]
  • Cancer Management and Research
    • Recent insights into breast cancer incidence trends among four Asian countries using age-period-cohort model [2019]
  • Current Oncology
    • Burdens of Breast Cancer and Projections for 2030 Among Women in Asia: Findings from the 2021 Global Burden of Disease Study [2025]
  • Journal of the National Cancer Institute
    • Female Breast Cancer Incidence Among Asian and Western Populations: More Similar Than Expected [2015]
  • Scientific Reports
    • Trends and Projections in Breast Cancer Mortality among four Asian countries (1990–2017): Evidence from five Stochastic Mortality Models [2020]
• Australia
  • Australian Institute of Health and Welfare
    • Metastatic breast cancer - first national estimates [2025]
  • BMC Cancer
    • A population-based study of breast cancer prevalence in Australia: predicting the future health care needs of women living with breast cancer [2014]
  • Cancer Australia
    • Breast cancer in Australia statistics
  • Cancer Epidemiology
    • Temporal trends in breast cancer incidence and mortality in Australia: An Age-Period-Cohort analysis [2026]
• Australia, Japan
  • Asian Pacific Journal of Cancer Prevention
    • Comparative Analysis of Breast Cancer Incidence Rates between Australia and Japan: Screening Target Implications [2020]
• Australia, New Zealand
  • Breast Cancer Trials
    • Breast Cancer Statistics
• Austria
  • Scientific Reports
    • Trends in female breast cancer incidence, mortality, and survival in Austria, with focus on age, stage, and birth cohorts (1983-2017) [2022]
• Bahamas
  • Breast Cancer : Basic and Clinical Research
    • Breast Cancer in the Bahamas in 2009–2011 [2016]
• Bahrain
  • Sultan Qaboos University Medical Journal
    • Epidemiology of Breast Cancer among Bahraini Women: Data from the Bahrain Cancer Registry [2014]
• Belgium
  • BMC Cancer
    • Exploring educational disparities in breast cancer dynamics: a comprehensive analysis of incidence, death within 5 years of diagnosis, and mortality in the Belgian context [2024]
• Brazil
  • BMC Public Health
    • Temporal trends in female breast cancer mortality in Brazil and correlations with social inequalities: ecological time-series study [2015]
  • BMC Women's Health
    • The role of health policy in the burden of breast cancer in Brazil [2017]
  • Frontiers in Oncology
    • Breast Cancer Mortality in Young Women in Brazil [2021]
  • JCO Global Oncology
    • Epidemiological Analyses Reveal a High Incidence of Breast Cancer in Young Women in Brazil [2021]
  • Lancet Global Health
    • Ethnoracial and social trends in breast cancer staging at diagnosis in Brazil, 2001–14: a case only analysis [2019]
  • Revista Brasileira de Epidemiologia
    • Temporal trend of breast cancer burden among younger and older Brazilian women, 1990-2019 [2025]
  • Revista da Associação Médica Brasileira
    • Female breast cancer mortality in Brazil and its regions [2014]
  • Scientific Reports
    • Effects of the high-inequality of income on the breast cancer mortality in Brazil [2019]
• Canada
  • Canadian Association of Radiologists Journal
    • Incidence of Breast Cancer in Younger Women: A Canadian Trend Analysis [2024]
  • Canadian Cancer Society
    • Breast cancer statistics
  • Canadian Journal of Public Health
    • The incidence of breast cancer in Canada 1971–2015: trends in screening-eligible and young-onset age groups [2020]
  • Oncologist
    • Breast cancer incidence and mortality, by age, stage and molecular subtypes, by race/ethnicity in Canada [2025]
  • Statistics Canada
    • Geographic variation in female breast cancer incidence and mortality in Canada [2026]
• Central African Republic
  • BMC Public Health
    • Epidemiology of breast cancer: retrospective study in the Central African Republic [2016]
• Central and Eastern Europe
  • Journal of Medical Economics
    • Breast cancer-related mortality in Central and Eastern Europe: years of life lost and productivity costs [2023]
• Central and South America
  • Cancer Epidemiology
    • Female breast cancer in Central and South America [2016]
• China
  • BMC Cancer
    • Epidemiology of breast cancer in Chinese women from 1990 to 2021: a systematic analysis and comparison with the global burden [2025]
  • BMC Public Health
    • Historical trends in breast Cancer among women in China from age-period-cohort modeling of the 1990–2015 breast Cancer mortality data [2020]
  • Cancer Biology & Medicine
    • Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030 [2021]
  • Chinese Medical Journal
    • Incidence, mortality, and disability-adjusted life years of female breast cancer in China, 2022 [2024]
    • Global and regional trends in incidence and mortality of female breast cancer and associated factors at national level in 2000 to 2019 [2022]
  • International Journal of Environmental Research and Public Health
    • Analysis on Incidence and Mortality Trends and Age-Period-Cohort of Breast Cancer in Chinese Women from 1990 to 2019 [2023]
  • Medicine
    • Trends in mortality rates of female breast cancer in China, 2004 to 2021 [2026]
    • Epidemiological and Clinicopathological Trends of Breast Cancer in Chinese Patients During 1993 to 2013 [2015]
• Croatia
  • Frontiers in Public Health
    • Breast cancer in reproductive-age women in Croatia: trends, demographic shifts, and correlation with human development index [2026]
  • Oncologist
    • COVID-19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population- and Registry-Based Study [2021]
• Cyprus
  • Data in Brief
    • Epidemiology of breast cancer in Cyprus: Data on newly diagnosed cases and survival rates [2018]
• Denmark
  • Acta Oncologica
    • Incidence and survival of primary metastatic breast cancer in Denmark; implication of breast cancer screening, classification, and staging practice [2024]
  • International Journal of Cancer
    • Divergent estrogen receptor-positive and -negative breast cancer trends and etiologic heterogeneity in Denmark [2013]
  • International Journal of Epidemiology
    • Incidence of metachronous contralateral breast cancer in Denmark 1978–2009 [2014]
• East and South Asia
  • Frontiers in Nutrition
    • Breast Cancer Mortality Trends and Predictions to 2030 and Its Attributable Risk Factors in East and South Asian Countries [2022]
• East Asia
  • BMC Cancer
    • Burden, trends, and risk factors for breast cancer in China from 1990 to 2019 and its predictions until 2034: an up-to-date overview and comparison with those in Japan and South Korea [2022]
• East Asia, United States
  • International Journal of Environmental Research and Public Health
    • Secular Trends of Breast Cancer in China, South Korea, Japan and the United States: Application of the Age-Period-Cohort Analysis [2015]
• Egypt
  • Journal of Thoracic Disease
    • Breast cancer in Egypt, China and Chinese: statistics and beyond [2014]
• Eritrea
  • International Journal of Breast Cancer
    • Incidence of Breast Cancer in Eritrea: A Retrospective Study from 2011 to 2017 [2019]
• Estonia
  • Cancer Control
    • Incidence-Based Breast Cancer Mortality Trends in Estonia Before and After the Introduction of Organized Mammography Screening: A Register-Based Study [2024]
• Ethiopia
  • BMC Cancer
    • Epidemiology and clinical characteristics of breast cancer in Ethiopia: a systematic review [2024]
  • BMJ Open
    • Survival status and predictors of mortality among patients with breast cancer in Ethiopia: a systematic review and meta-analysis [2025]
    • Breast cancer and its determinants in Ethiopia: a systematic review and meta-analysis [2024]
• Europe
  • Archives of Medical Science
    • Breast cancer mortality trends in Europe among women in perimenopausal and postmenopausal age (45+) [2020]
  • BMJ
    • Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database [2010]
  • Breast Care
    • Breast Cancer Statistics in the European Union: Incidence and Survival across European Countries [2019]
  • Europa Donna
    • Breast Cancer
  • European Journal of Cancer
    • European trends in breast cancer mortality, 1980–2017 and predictions to 2025 [2021]
  • European Journal of Public Health
    • Socioeconomic inequalities in breast cancer incidence and mortality in Europe—a systematic review and meta-analysis [2016]
  • JCO Global Oncology
    • Trends in Breast Cancer Mortality Between 2001 and 2017: An Observational Study in the European Union and the United Kingdom [2021]
• France
  • Breast
    • Increasing incidence of breast cancer in young women over time [2025]
  • Breast Cancer Research
    • Evolution of breast cancer incidence in young women in a French registry from 1990 to 2018: Towards a change in screening strategy? [2022]
• Germany
  • Breast Cancer Research and Treatment
    • Changes in the incidence of early-onset breast cancer in Germany between 2010 and 2022 [2023]
  • Deutsches Ärzteblatt International
    • Trends Over Time in Breast-Cancer-Specific Mortality in Germany [2021]
  • Geburtshilfe und Frauenheilkunde
    • Long-term Incidence and Mortality Trends for Breast Cancer in Germany [2020]
  • PLoS ONE
    • Incidence and Mortality Trends in German Women with Breast Cancer Using Age, Period and Cohort 1999 to 2008 [2016]
  • Robert Koch Institute
    • Breast cancer
• Germany, United States
  • Cancers
    • Divergent Patterns and Trends in Breast Cancer Incidence, Mortality and Survival Among Older Women in Germany and the United States [2020]
• Ghana
  • International Journal of Breast Cancer
    • Pattern of Breast Cancer Distribution in Ghana: A Survey to Enhance Early Detection, Diagnosis, and Treatment [2016]
• Ghana, United States
  • JAMA Network Open
    • Breast Cancer Incidence Rates in Ghanaian and US Black Women From 2013 Through 2015 [2025]
• Greece, Sweden
  • BMC Cancer
    • Paradoxes of breast cancer incidence and mortality in two corners of Europe [2022]
• Gulf Cooperation Council
  • Eastern Mediterranean Health Journal
    • Ecological study of breast cancer incidence among nationals and nonnationals in the Gulf Cooperation Council countries [2023]
  • PLoS ONE
    • Burden, and trends of breast cancer along with attributable risk factors in Gulf Cooperation Council countries from 1990 to 2019 and its projections [2025]
• Hong Kong
  • British Journal of Cancer
    • Breast cancer incidence and mortality in a transitioning Chinese population: current and future trends [2014]
  • Centre for Health Protection
    • Breast Cancer
• Iceland
  • Scientific Reports
    • In situ breast cancer incidence patterns in Iceland and differences in ductal carcinoma in situ treatment compared to Sweden [2020]
• India
  • Breast Cancer Research and Treatment
    • Burden of female breast cancer in India: estimates of YLDs, YLLs, and DALYs at national and subnational levels based on the national cancer registry programme [2024]
  • Cancer Causes and Control
    • Symposium report: breast cancer in India—trends, environmental exposures and clinical implications [2021]
  • Indian Journal of Surgical Oncology
    • Time Trends in Breast Cancer Among Indian Women Population: An Analysis of Population Based Cancer Registry Data [2015]
  • Scientific Reports
    • Economic burden of breast cancer in India, 2000-2021 and forecast to 2030 [2025]
• Indonesia
  • BMC Cancer
    • Breast cancer incidence in Indonesia: a sex-disaggregated analysis using WHO health equity assessment toolkit data [2025]
• International
  • Aging
    • Global incidence and mortality of breast cancer: a trend analysis [2021]
  • Asian Pacific Journal of Cancer Prevention
    • Mortality of Young Women due to Breast Cancer in Low, Middle and High-Income Countries: Systematic Literature Review and Meta-Analysis [2024]
  • BioMed Research International
    • Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures [2022]
  • BMC Cancer
    • Global, regional, and national burden of breast cancer in young women from 1990 to 2021: findings from the global burden of disease study 2021 [2025]
  • BMC Public Health
    • Global, regional, and national time trends in mortality for breast cancer, 1992-2021: an age-period-cohort analysis for the global burden of disease 2021 study [2025]
  • Breast
    • Global breast cancer incidence, mortality, and survival among indigenous women: A systematic review and meta-analysis [2026]
    • Trends in the global, national, and regional burden of breast cancer among adolescents and young adults from 1990 to 2021: Analyses of the 2021 global burden of disease study [2025]
    • Current and future burden of breast cancer: Global statistics for 2020 and 2040 [2022]
  • Breast Cancer Research
    • Metastatic recurrence in women diagnosed with non-metastatic breast cancer: a systematic review and meta-analysis [2024]
  • Cancer Causes and Control
    • Breast cancer inequities: the intersectional role of social epidemiology and tumor biology [2026]
  • Cancer Communications
    • Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020 [2021]
  • Cancer Epidemiology Biomarkers & Prevention
    • International Variation in Female Breast Cancer Incidence and Mortality Rates [2015]
  • Chinese Medical Journal
    • Global burden and trends of breast cancer: GLOBOCAN 2022 estimates of incidence and mortality in 185 countries [2026]
    • Global, regional, national incidence, and mortality of breast cancer in older women: A population-based cancer registry data analysis [2025]
  • Current Oncology
    • Beyond Biology: Uncovering Structural and Sociocultural Predictors of Breast Cancer Incidence Worldwide [2025]
  • EClinicalMedicine
    • Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns [2021]
  • Frontiers in Oncology
    • The Global, Regional, and National Burden and Trends of Breast Cancer From 1990 to 2019: Results From the Global Burden of Disease Study 2019 [2021]
    • The Burden and Trends of Breast Cancer From 1990 to 2017 at the Global, Regional, and National Levels: Results From the Global Burden of Disease Study 2017 [2020]
  • Frontiers in Public Health
    • Global burden and projections of breast cancer incidence and mortality to 2050: a comprehensive analysis of GLOBOCAN data [2025]
    • Breast cancer burden (1990-2040) in individuals aged 55 and above: a GBD 2021 analysis of global trends, sex-specific risk factors, and intervention impact [2025]
  • Global Health, Epidemiology and Genomics
    • The Global Burden and Trends of Premenopausal Breast Cancer by Modifiable Lifestyle Factors From 1990 to 2021 With Prediction Until 2039 [2026]
  • Journal of Advanced Research
    • Epidemiological and sociodemographic transitions of female breast cancer incidence, death, case fatality and DALYs in 21 world regions and globally, from 1990 to 2017: An Age-Period-Cohort Analysis [2021]
  • Journal of Global Health
    • Global burden and attributable risk factors of breast cancer in young women: historical trends from 1990 to 2019 and forecasts to 2030 by sociodemographic index regions and countries [2024]
  • Journal of Research in Medical Sciences
    • Worldwide trends in breast cancer incidence from 1993 to 2012: Age-period-cohort analysis and joinpoint regression [2020]
  • Journal of Surgical Research
    • Breast Masses in Adolescent Females: A Scoping Review [2026]
  • Lancet Global Health
    • Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study [2020]
  • Scientific Data
    • Global trends and forecasts of breast cancer incidence and deaths [2023]
  • Scientific Reports
    • The global burden of breast cancer among women of reproductive age: a comprehensive analysis [2025]
    • Worldwide Age at Onset of Female Breast Cancer: A 25-Year Population-Based Cancer Registry Study [2019]
  • Taiwanese Journal of Obstetrics and Gynecology
    • Favorable breast cancer mortality-to-incidence ratios of countries with good human development index rankings and high health expenditures [2024]
  • Thoracic Cancer
    • Global, Regional, and National Burden of Breast Cancer, 1990-2021, and Projections to 2050: A Systematic Analysis of the Global Burden of Disease Study 2021 [2025]
    • Burden of Breast Cancer and Its Attributable Risk Factors in the Belt and Road Initiative Countries, 1990-2021 [2025]
  • World Cancer Research Fund
    • Breast cancer statistics
• Iran
  • Archives of Iranian Medicine
    • Trends and the Age-Period-Cohort Effects on Mortality of Breast Cancer Among Iranian Women from 1990 to 2021 [2025]
  • BMC Cancer
    • Exploring the geospatial epidemiology of breast cancer in Iran: identifying significant risk factors and spatial patterns for evidence-based prevention strategies [2023]
  • BMC Women's Health
    • Pattern of burden cancer breast and relationshipin to human development index in Iran 2009 to 2019: an observational study based on the Global Burden of Diseases [2024]
  • Breast Cancer Research
    • National and subnational burden of female and male breast cancer and risk factors in Iran from 1990 to 2019: results from the Global Burden of Disease study 2019 [2023]
  • Eastern Mediterranean Health Journal
    • Incidence pattern and spatial analysis of breast cancer in Iranian women: Geographical Information System applications [2018]
  • Frontiers in Oncology
    • National and Subnational Incidence, Mortality, and Years of Life Lost Due to Breast Cancer in Iran: Trends and Age-Period-Cohort Analysis Since 1990 [2021]
  • Iranian Journal of Public Health
    • Age at Diagnosis of Breast Cancer in Iran: A Systematic Review and Meta-Analysis [2021]
  • PLoS ONE
    • Spatiotemporal disparity of breast cancer incidence in Iranian female populations at the district level from 2000 to 2021: Bayesian disease mapping [2025]
    • Geographical and socioeconomic inequalities in female breast cancer incidence and mortality in Iran: A Bayesian spatial analysis of registry data [2021]
• Iraq
  • Asian Pacific Journal of Cancer Prevention
    • Trends in Breast Cancer Incidence in Iraq During the Period 2000-2019 [2021]
• Ireland
  • Cancer Epidemiology
    • Examining the impact of the COVID-19 pandemic on invasive breast cancer incidence in Ireland: A population-based study [2025]
• Jamaica
  • JCO Global Oncology
    • Breast Cancer in Jamaica: Trends From 2010 to 2014—Is Mortality Increasing? [2020]
• Kazakhstan
  • Asian Pacific Journal of Cancer Prevention
    • Study on Breast Cancer in Kazakhstan Using the Functional Time Series [2023]
    • Epidemiology of Breast Cancer Mortality in Kazakhstan, trends and Geographic Distribution [2023]
    • Impact of Screening on Breast Cancer Incidence in Kazakhstan: Results of Component Analysis [2021]
  • Frontiers in Public Health
    • Prevalence, incidence, and mortality rates of breast cancer in Kazakhstan: data from the Unified National Electronic Health System, 2014-2019 [2023]
  • Iranian Journal of Public Health
    • Breast Cancer in Megapolises of Kazakhstan: Epidemiological Assessment of Incidence and Mortality [2019]
• Kyrgyzstan
  • Asian Pacific Journal of Cancer Prevention
    • Breast Cancer Incidence in Kyrgyzstan: Report of 15 Years of Cancer Registry [2022]
• Latin America
  • BMC Public Health
    • Disparities in breast cancer mortality among Latin American women: trends and predictions for 2030 [2023]
  • ecancermedicalscience
    • Locally advanced breast cancer in young women in Latin America [2019]
  • World Journal of Surgery
    • Breast Cancer Heterogeneity in Latin America: A Scoping Review of Clinical-Pathological Characteristics, Molecular Subtypes, and Survival [2025]
• Lebanon
  • Medicina
    • Breast Cancer Epidemiology among Lebanese Women: An 11-Year Analysis [2019]
• Lithuania
  • BMC Public Health
    • An analysis of time trends in breast and prostate cancer mortality rates in Lithuania, 1986-2020 [2022]
• Low and middle income countries
  • Frontiers in Public Health
    • Trend of disease burden and risk factors of breast cancer in developing countries and territories, from 1990 to 2019: Results from the Global Burden of Disease Study 2019 [2023]
• Mexico
  • Revista Brasileira de Ginecologia e Obstetrícia
    • Trends in breast cancer mortality in Mexican women [2025]
• Mongolia
  • Cancer Causes and Control
    • Breast cancer incidence in Mongolia [2012]
• Montenegro
  • European Review for Medical and Pharmacological Sciences
    • Trend of breast cancer mortality in Montenegro, 1990-2018 - Joinpoint regression [2022]
• Netherlands
  • BMC Cancer
    • Burden of early, advanced and metastatic breast cancer in The Netherlands [2018]
  • Breast
    • Trends in local, regional and contralateral breast tumor recurrence within five years after diagnosis in the Netherlands: a population-based study including 121347 patients [2026]
  • European Journal of Public Health
    • Breast cancer diagnosis and death in the Netherlands: a changing burden [2014]
  • International Journal of Cancer
    • Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017 [2021]
• Netherlands, Norway
  • Cancer Epidemiology
    • Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: A population-based study [2023]
• Norway
  • BMC Cancer
    • Long term trends of breast cancer incidence according to proliferation status [2022]
  • Breast Cancer Research
    • Incidence of breast cancer subtypes in immigrant and non-immigrant women in Norway [2022]
• Peru
  • BMC Cancer
    • Trends in breast cancer mortality in Peru and its geographical areas from 2013 to 2022 and prediction until 2027 [2025]
    • Breast cancer mortality trends in Peruvian women [2020]
• Poland
  • BMC Public Health
    • Trends of mortality due to breast cancer in Poland, 2000–2016 [2020]
  • Breast Cancer Research and Treatment
    • Changes in the survival of patients with breast cancer: Poland, 2000-2019 [2023]
  • Przeglad Menopauzalny = Menopause Review
    • Incidence of and mortality from breast cancer among women in Poland in the years 2001-2010 [2014]
• Republic of Korea
  • Cancer Research and Treatment
    • Age-Period-Cohort Analysis of Female Breast Cancer Mortality in Korea [2015]
  • Epidemiology and Health
    • Contrasting income-based inequalities in incidence and mortality of breast cancer in Korea, 2006-2015 [2024]
  • International Journal for Equity in Health
    • Increased breast cancer mortality only in the lower education group: age-period-cohort effect in breast cancer mortality by educational level in South Korea, 1983-2012 [2017]
  • Journal of Breast Cancer
    • Breast Cancer Statistics in Korea, 2018 [2021]
    • Breast Cancer Statistics in Korea in 2017: Data from a Breast Cancer Registry [2020]
    • Breast Cancer Epidemiology of the Working-Age Female Population Reveals Significant Implications for the South Korean Economy [2018]
    • Basic Findings Regarding Breast Cancer in Korea in 2015: Data from a Breast Cancer Registry [2018]
    • The Basic Facts of Korean Breast Cancer in 2013: Results of a Nationwide Survey and Breast Cancer Registry Database [2016]
    • The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database [2015]
    • The Basic Facts of Korean Breast Cancer in 2011: Results of a Nationwide Survey and Breast Cancer Registry Database [2014]
  • Journal of Epidemiology and Global Health
    • Assessing Trends in Hospitalizations for Breast Cancer among Women in Korea: A Utilization of the Korea National Hospital Discharge In-depth Injury Survey (2006-2020) [2024]
• Romania
  • BMC Cancer
    • Breast cancer mortality in Romania: trends, regional and rural-urban inequalities, and policy implications [2025]
• Saudi Arabia
  • BMC Public Health
    • Tracking the epidemiological trends of female breast cancer in Saudi Arabia since 1990 and forecasting future statistics using global burden of disease data, time-series analysis [2024]
  • Cancer Treatment and Research Communications
    • Trends in breast cancer incidence, age at diagnosis, and stage in Saudi Arabia, 2002-2022: a population-based study [2026]
  • Medicina
    • Breast Cancer Incidence Patterns in the Saudi Female Population: A 17-Year Retrospective Analysis [2022]
  • Saudi Medical Journal
    • Recent incidence and descriptive epidemiological survey of breast cancer in Saudi Arabia [2015]
• Sierra Leone
  • BMC Cancer
    • Sex-disaggregated analysis of breast cancer prevalence in Sierra Leone [2025]
• Sub-Saharan Africa
  • BMJ Open
    • Comparative examination of breast cancer burden in sub-Saharan Africa, 1990-2019: estimates from Global Burden of Disease 2019 study [2024]
  • Bulletin du Cancer
    • Prognostic factors of breast cancer and survival in Sub-Saharan Africa: A systematic review and meta-analysis [2025]
  • Cancer Reports
    • Stage at Diagnosis and Molecular Subtype Distribution of Breast Cancer in Sub-Saharan Africa: A Systematic Review [2026]
• Sweden
  • British Journal of Cancer
    • Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study [2022]
  • International Journal of Cancer
    • Age-specific breast cancer incidence by subtype, TNM stage and screening status in Sweden 2008-2019 estimated with multiple imputation [2026]
• Switzerland
  • Swiss Medical Weekly
    • Net survival of women diagnosed with breast tumours: a population-based study in Switzerland [2023]
• Taiwan
  • Future Oncology
    • The epidemiology, treatments and outcomes of patients with hormone receptor positive, human epidermal growth factor receptor 2 negative, node-positive early breast cancer in Taiwan [2024]
  • Scientific Reports
    • Forecast of a future leveling of the incidence trends of female breast cancer in Taiwan: an age-period-cohort analysis [2022]
• Taiwan, United States
  • Cancer Medicine
    • Comparison of annual percentage change in breast cancer incidence rate between Taiwan and the United States—A smoothed Lexis diagram approach [2017]
• Türkiye
  • Asian Pacific Journal of Cancer Prevention
    • Poor Prognostic Clinicopathological Features of Young Women with Breast Cancer in the MF18-04 Turkish National Breast Cancer Registry Study [2025]
• United Kingdom
  • Breast Cancer Research and Treatment
    • Breast cancer incidence and survival in Scotland by socio-economic deprivation and tumour subtype [2022]
  • British Journal of Cancer
    • Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healthcare pathway to diagnosis during 2020 in Wales, UK, using a national cancer clinical record system [2022]
  • Cancer Research UK
    • Breast cancer statistics
  • European Journal of Surgical Oncology
    • Ethnicity and breast cancer incidence in over 329,500 women in England in 2011-2019 [2026]
  • JAMA Network Open
    • Estimated Prevalence of Metastatic Breast Cancer in England, 2016-2021 [2022]
  • Scientific Reports
    • Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021 [2024]
• United States
  • American Cancer Society
    • Breast cancer statistics 2024 [2024]
    • Breast Cancer Statistics, 2022 [2022]
    • Breast cancer statistics, 2019 [2019]
    • Breast cancer statistics, 2017, racial disparity in mortality by state [2017]
    • Cancer statistics: Breast cancer in situ [2015]
    • Breast cancer statistics, 2015: Convergence of incidence rates between black and white women [2015]
    • Breast cancer statistics, 2013 [2013]
    • Breast Cancer Statistics
  • Breast Cancer Research
    • Trends in breast cancer death rates from ductal carcinoma in situ versus invasive cancer in the United States [2025]
    • Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992–2016 [2021]
  • Breast Cancer Research and Treatment
    • Breast cancer diagnosis and treatment during the COVID-19 pandemic in a nationwide, insured population [2022]
  • Cancer
    • Trends in breast cancer incidence rates by race/ethnicity: Patterns by stage, socioeconomic position, and geography in the United States, 1999-2017 [2022]
    • United States Breast Cancer Mortality Trends in Young Women According to Race [2014]
  • Cancer Causes and Control
    • Persistent poverty and breast cancer incidence by tumor subtype: intersections of rural/urban residence and race within USA Surveillance Epidemiology and End Results Registries, 2017 to 2021 [2026]
    • Persistent poverty and late-stage breast cancer diagnosis in the USA: impacts of rural residence, race, and time within Surveillance, Epidemiology, and End Results registries, 2004 to 2021 [2025]
    • Geographic differences in early-onset breast cancer incidence trends in the USA, 2001-2020, is it time for a geographic risk score? [2025]
  • Cancer Epidemiology
    • Breast cancer incidence trends in Asian women aged 20 or older as compared to other ethnic women in the United States from 2000 to 2018 by time period, age and tumor stage [2022]
  • Cancer Epidemiology Biomarkers & Prevention
    • Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States [2017]
  • Centers for Disease Control and Prevention
    • Trends in Breast Cancer Incidence, by Race, Ethnicity, and Age Among Women Aged >=20 Years — United States, 1999–2018 [2022]
    • Patterns and Trends in Age-Specific Black-White Differences in Breast Cancer Incidence and Mortality – United States, 1999–2014 [2016]
    • U.S. Cancer Statistics Breast Cancer Stat Bite
    • Metastatic Female Breast Cancer Incidence
    • Breast Cancer Statistics
  • International Journal of Environmental Research and Public Health
    • Modeling Geospatial Patterns of Late-Stage Diagnosis of Breast Cancer in the US [2017]
    • Geospatial Analysis of Inflammatory Breast Cancer and Associated Community Characteristics in the United States [2017]
    • Assessing the Racial and Ethnic Disparities in Breast Cancer Mortality in the United States [2017]
  • International Journal of Health Geographics
    • Geographic disparities in late stage breast cancer incidence: results from eight states in the United States [2015]
  • JAMA Network Open
    • Stage IV Breast Cancer Incidence and Survival, 2010-2021 [2026]
    • Breast Cancer Incidence in Asian American, Native Hawaiian, and Pacific Islander Populations, 2000-2022 [2026]
    • Incidence Rate Trends of Breast Cancer Overall and by Molecular Subtype by Race and Ethnicity and Age [2025]
    • Breast Cancer Incidence Trends in Older US Women by Race, Ethnicity, Geography, and Stage [2025]
    • Breast Cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status [2024]
    • Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015 [2020]
  • JNCI Cancer Spectrum
    • Breast Cancer Incidence Trends by Estrogen Receptor Status Among Asian American Ethnic Groups, 1990–2014 [2020]
    • Incidence and Survival Among Young Women With Stage I–III Breast Cancer: SEER 2000–2015 [2019]
  • Journal of the National Cancer Institute
    • Decreasing Incidence of Estrogen Receptor-Negative Breast Cancer in the United States: Trends by Race and Region [2022]
    • Annual Report to the Nation on the Status of Cancer, 1975–2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State [2015]
  • National Cancer Institute
    • Female Breast Cancer
• Vietnam
  • Cancer Biology & Medicine
    • Female breast cancer in Vietnam: a comparison across Asian specific regions [2015]
• WHO
  • International Agency for Research on Cancer
    • Breast
  • World Health Organization
    • Breast cancer
• WHO Eastern Mediterranean Region
  • BMC Women's Health
    • Incidence trend of breast Cancer in women of eastern Mediterranean region countries from 1998 to 2019: A systematic review and meta-analysis [2020]
• WHO Western Pacific Region
  • Journal of Advanced Research
    • Temporal trends of breast cancer burden in the Western Pacific Region from 1990 to 2044: Implications from the Global Burden of Disease Study 2019 [2024]
• {Related topics}
  • Topic
    • Breast cancer

Breast cancer prevention

• Australia
  • Australian Journal of General Practice
    • An update on breast cancer prevention [2025]
  • Preventing Chronic Disease: Public Health Research, Practice and Policy
    • Strategies for Piloting a Breast Health Promotion Program in the Chinese-Australian Population [2012]
• Europe
  • Nature Reviews Clinical Oncology
    • Personalized early detection and prevention of breast cancer: ENVISION consensus statement [2020]
• Hong Kong
  • Centre for Health Protection
    • Recommendations on Prevention and Screening for Breast Cancer For Health Professionals [2021]
  • Hong Kong Medical Journal
    • Recommendations on prevention and screening for breast cancer in Hong Kong [2018]
• Japan
  • Breast Cancer
    • The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2022 edition [2024]
• Spain
  • Sociedad Española de Oncología Médica
    • SEOM guide to primary and secondary prevention of cancer: 2014 [2014]
• United Kingdom
  • British Journal of General Practice
    • Prescribing tamoxifen in primary care for the prevention of breast cancer: a national online survey of GPs’ attitudes [2017]
  • Public Health Genomics
    • Clinician-Reported Barriers to Implementing Breast Cancer Chemoprevention in the UK: A Qualitative Investigation [2016]
• United States
  • Agency for Healthcare Research and Quality
    • Medication Use for the Risk Reduction of Primary Breast Cancer in Women: A Systematic Review for the U.S. Preventive Services Task Force  [2019]
  • American Society of Clinical Oncology
    • Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update [2019]
  • Breast Cancer Research and Treatment
    • The impact of cancer prevention guideline adherence on overall mortality in a high-risk cohort of women from the New York site of the Breast Cancer Family Registry [2015]
  • Centers for Disease Control and Prevention
    • Inclusion of Evidence-Based Breast Cancer Control Recommendations and Guidelines in State Comprehensive Cancer Control Plans [2020]
  • European Journal of Breast Health
    • Breast Cancer Prevention: Current Approaches and Future Directions [2018]
  • Journal of the National Cancer Institute
    • Practical Problems With Clinical Guidelines for Breast Cancer Prevention Based on Remaining Lifetime Risk [2015]
  • National Cancer Institute
    • Breast Cancer Prevention (PDQ®)
  • U.S. Preventive Services Task Force
    • Breast Cancer: Medication to Reduce Risk [2024]
• {Related topics}
  • Topic
    • Breast cancer

Breast cancer risk

• Africa
  • Current Oncology
    • Obesity and Risk of Pre- and Postmenopausal Breast Cancer in Africa: A Systematic Review [2025]
• Asia
  • Asian Pacific Association for the Study of the Liver
    • A Review of the Epidemiology of Breast Cancer in Asia: Focus on Risk Factors [2020]
  • Heliyon
    • Assessment of the risk of developing breast cancer using the Gail model in Asian females: A systematic review [2020]
  • Journal of Preventive Medicine and Public Health
    • Breast Density and Risk of Breast Cancer in Asian Women: A Meta-analysis of Observational Studies [2016]
• Australia
  • BMJ Open
    • Influence of lifestyle factors on breast cancer incidence from mid-life to older age: an Australian longitudinal cohort study [2026]
• Belarus
  • International Journal of Epidemiology
    • Breast cancer risk in residents of Belarus exposed to Chernobyl fallout while pregnant or lactating: standardized incidence ratio analysis, 1997 to 2016 [2022]
• Canada
  • Environment International
    • Associations between incident breast cancer and ambient concentrations of nitrogen dioxide from a national land use regression model in the Canadian National Breast Screening Study [2019]
  • International Journal of Breast Cancer
    • Adherence to cancer prevention guidelines and risk of breast cancer [2014]
• Caribbean
  • International Journal for Equity in Health
    • Social determinants of breast cancer in the Caribbean: a systematic review [2017]
• China
  • Chinese Medical Journal
    • Clinical practice guidelines for risk assessment to identify women at high risk of breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
  • Frontiers in Endocrinology
    • Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis [2022]
  • Journal of Breast Cancer
    • The Catechol-O-Methyltransferase Val158Met Polymorphism Contributes to the Risk of Breast Cancer in the Chinese Population: An Updated Meta-Analysis [2014]
  • Thoracic Cancer
    • Historical trends of breast cancer burden attributable to metabolic factors among Chinese women, 1990-2019: A population-based epidemiological study [2024]
• Denmark
  • Breast Cancer Research
    • Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality - a Danish population-based study [2019]
  • International Journal of Cancer
    • Antiplatelet drugs and breast cancer risk in a large nationwide Danish case-control study [2023]
• Europe
  • BMC Medicine
    • Dietary intake of trans fatty acids and breast cancer risk in 9 European countries [2021]
  • Cancer Epidemiology
    • European Code against Cancer 4th Edition: Breastfeeding and cancer [2015]
  • Cancers
    • Guidance for the Clinical Use of the Breast Cancer Polygenic Risk Scores [2025]
  • Environmental Health Perspectives
    • Long-Term Exposure to Ambient Air Pollution and Incidence of Postmenopausal Breast Cancer in 15 European Cohorts within the ESCAPE Project [2017]
• Finland
  • BMC Cancer
    • Incidence trends of early-onset breast cancer by lifestyle risk factors [2025]
  • European Journal of Epidemiology
    • The association between night shift work and breast cancer risk in the Finnish twins cohort [2023]
• France
  • British Journal of Radiology
    • Long-term breast cancer risk post childhood cancer radiotherapy: data-driven screening recommendations for survivors [2025]
  • Environment International
    • Risk of breast cancer associated with long-term exposure to benzo[a]pyrene (BaP) air pollution: Evidence from the French E3N cohort study [2021]
  • JAMA Network Open
    • Contraceptive Use in Premenopausal Women With Early Breast Cancer [2022]
• Germany
  • Breast Cancer Research and Treatment
    • Association between gout and subsequent breast cancer: a retrospective cohort study including 67,598 primary care patients in Germany [2023]
    • Positive association between body height and breast cancer prevalence: a retrospective study with 135,741 women in Germany [2022]
• Gulf Cooperation Council
  • World Journal of Clinical Oncology
    • Correlation between breast cancer and lifestyle within the Gulf Cooperation Council countries: A systematic review [2020]
• High-income countries
  • Alcoholism: Clinical and Experimental Research
    • Alcoholic beverage consumption and female breast cancer risk: A systematic review and meta-analysis of prospective cohort studies [2024]
• Indonesia
  • Breast Disease
    • Contraceptive use with breast cancer incidence in Indonesia [2024]
• International
  • Advances in Nutrition
    • Racial and Ethnic Disparities in the Impact of Obesity on Breast Cancer Risk and Survival: A Global Perspective [2015]
  • American Journal of Clinical Nutrition
    • Adulthood dietary and lifestyle patterns and risk of breast cancer: Global Cancer Update Programme (CUP Global) systematic literature review [2025]
  • Annals of Medicine
    • Development and performance of female breast cancer incidence risk prediction models: a systematic review and meta-analysis [2025]
    • The association between breast cancer and consumption of dairy products: a systematic review [2023]
  • Archives of Iranian Medicine
    • Global, Regional, and National Burden of Breast Cancer Attributable to Low Physical Activity in Women of Reproductive Age: Historical Trends from 1990 to 2021 and Projections to 2035 [2025]
    • Burden of Breast Cancer Attributable to a Diet High in Red Meat at Global, Regional, and National Levels: An Analysis of the Global Burden of Disease Study 2021 [2025]
  • Asian Pacific Journal of Cancer Prevention
    • Use and Applicability of the Gail Model to Calculate Breast Cancer Risk: A Scoping Review [2022]
  • BMC Cancer
    • A systematic review of prediction models for risk of breast cancer [2025]
    • Global, regional, and national mortality trends of female breast cancer by risk factor, 1990–2017 [2021]
  • BMC Public Health
    • Global determinants of breast cancer mortality: a comprehensive meta-analysis of clinical, demographic, and lifestyle risk factors [2025]
    • The global, regional, and national disease burden of breast cancer attributable to tobacco from 1990 to 2019: a global burden of disease study [2024]
  • BMC Women's Health
    • The relation between obesity and breast cancer risk in women by considering menstruation status and geographical variations: a systematic review and meta-analysis [2023]
  • Breast
    • Association between body mass index and risk of breast cancer according to breast cancer subtypes: A systematic review and meta-analysis [2026]
    • Association between alcohol consumption and breast cancer incidence and prognosis: A systematic review and meta-analysis [2026]
  • Breast Cancer : Targets and Therapy
    • Epidemiological characteristics of and risk factors for breast cancer in the world [2019]
  • Cancer
    • Fiber consumption and breast cancer incidence: A systematic review and meta-analysis of prospective studies [2020]
  • Cancer Causes and Control
    • Early menarche and breast cancer risk: a systematic review and meta-analysis of 74 case-control studies [2026]
  • Cancers
    • Hormonal Contraception and the Risk of Breast Cancer in Women of Reproductive Age: A Meta-Analysis [2023]
    • Oral Contraceptive Use and Breast Cancer Risk According to Molecular Subtypes Status: A Systematic Review and Meta-Analysis of Case-Control Studies [2022]
    • Oral Contraceptive Use and Breast Cancer Risk Assessment: A Systematic Review and Meta-Analysis of Case-Control Studies, 2009–2020 [2021]
  • Current Oncology Reports
    • Guidelines on Lifestyle Changes and Breast Cancer-where are we up to and how does this Apply to Black Women with Breast Cancer [2025]
  • Environmental Research
    • Environmental exposures and breast cancer risk in the context of underlying susceptibility: A systematic review of the epidemiological literature [2020]
  • Epidemiology and Psychiatric Sciences
    • Association of antipsychotic use with breast cancer: a systematic review and meta-analysis of observational studies with over 2 million individuals [2022]
  • Frontiers in Endocrinology
    • Global disease burden of breast cancer attributable to high fasting plasma glucose: a comprehensive analysis from the global burden of disease study [2025]
  • Frontiers in Oncology
    • Global epidemiology of breast cancer based on risk factors: a systematic review [2023]
    • Global Trends in Death, Years of Life Lost, and Years Lived With Disability Caused by Breast Cancer Attributable to Secondhand Smoke From 1990 to 2019 [2022]
  • Frontiers in Public Health
    • Global, regional, and national analyses of the burden among adult women of breast cancer attributable to diet high in red meat from 1990 to 2021: longitudinal observational study [2025]
  • Global Health Research and Policy
    • Consumption of fast foods and ultra-processed foods and breast cancer risk: a systematic review and meta-analysis [2025]
  • International Journal of Behavioral Nutrition and Physical Activity
    • The global, regional, and national disease burden of breast cancer attributable to low physical activity from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019 [2022]
  • International Journal of Environmental Research and Public Health
    • Use of Oral Contraceptives as a Potential Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis of Case-Control Studies Up to 2010 [2021]
    • Maternal Pregnancy Hormone Concentrations in Countries with Very Low and High Breast Cancer Risk [2020]
  • International Journal of Molecular Sciences
    • Exploring the Connection Between Ultra-Processed Foods and Breast Cancer: From Adiposity to Inflammation and Beyond [2026]
  • Journal of Clinical Oncology
    • Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer From the International Guideline Harmonization Group [2020]
  • Journal of Epidemiology
    • Dose-response Relationships Between Cigarette Smoking and Breast Cancer Risk: A Systematic Review and Meta-analysis [2023]
  • La Medicina del Lavoro
    • Occupational Exposure to Benzene and Risk of Breast Cancer: Systematic Review and Meta-Analysis [2024]
  • Lancet Oncology
    • Recommendations for Breast Cancer Surveillance for Female Childhood, Adolescent and Young Adult Cancer Survivors Treated with Chest Radiation: A Report from the International Late Effects of Childhood Cancer Guideline Harmonization Group [2013]
  • Maturitas
    • Pregnancy-related factors and risk of breast cancer in daughters: A systematic review and meta-analysis [2026]
    • Effect of duration of hormonal contraceptive use on breast cancer risk: a systematic review and meta-analysis of cohort studies [2025]
  • Medical Science Monitor
    • Epigenetic and Immune Mechanisms Linking Breastfeeding to Lower Breast Cancer Rates [2024]
  • Medicine
    • The impact of BMI on breast cancer - an updated systematic review and meta-analysis [2024]
  • Nutrients
    • Isoflavone Consumption and Risk of Breast Cancer: An Updated Systematic Review with Meta-Analysis of Observational Studies [2023]
  • Nutrition Reviews
    • Dietary Glycemic Index, Glycemic Load, Sugar, and Fiber Intake in Association With Breast Cancer Risk: An Updated Meta-analysis [2025]
  • Oncotarget
    • Relationship between ABO blood group antigens and Rh factor with breast cancer: A systematic review and meta-analysis [2025]
  • PLoS ONE
    • Investigating the relationship between insulin use and all-cause mortality, breast cancer mortality, and recurrence risk in diabetic patients with breast cancer: A comprehensive systematic review and meta-analysis [2024]
    • Epidemiological breast cancer prediction by country: A novel machine learning approach [2024]
  • Revista Brasileira de Ginecologia e Obstetrícia
    • Relationship between early age at menarche, older age at menopause and subtypes of breast cancer: a scoping review [2024]
• Iran
  • European Journal of Medical Research
    • Breast cancer risk factors in Iranian women: a systematic review and meta-analysis of matched case-control studies [2022]
  • International Journal of Preventive Medicine
    • Menstrual and Reproductive Factors and Risk of Breast Cancer in Iranian Female Population: A Systematic Review and Meta-Analysis [2022]
  • Iranian Journal of Basic Medical Sciences
    • Human papillomavirus and breast cancer in Iran: a meta- analysis [2016]
• Ireland
  • BMC Public Health
    • Factors associated with public awareness of the relationship between alcohol use and breast cancer risk [2023]
• Italy
  • International Journal of Environmental Research and Public Health
    • Geographic Inequalities in Breast Cancer in Italy: Trend Analysis of Mortality and Risk Factors [2020]
• Japan
  • BMC Public Health
    • Association of job category and occupational activity with breast cancer incidence in Japanese female workers: the JACC study [2020]
  • Breast Cancer
    • Alcohol consumption and breast cancer prognosis after breast cancer diagnosis: a systematic review and meta-analysis of the Japanese Breast Cancer Society Clinical Practice Guideline, 2022 edition [2023]
  • Breast Cancer Research and Treatment
    • Cholesterol and breast cancer risk: a cohort study using health insurance claims and health checkup databases [2023]
  • Cancer Medicine
    • Impact of reproductive factors on breast cancer incidence: Pooled analysis of nine cohort studies in Japan [2021]
• Latin America
  • Genes
    • Genetic Epidemiology of Breast Cancer in Latin America [2019]
• Low and middle income countries
  • BMC Cancer
    • Breast cancer determinants in low- to upper-middle-income countries: an umbrella review of meta-analyses of observational studies and an urgent call for implementation science [2025]
• Middle East
  • Nutrients
    • Dietary Patterns Associated with Breast Cancer in the Middle East: A Scoping Review [2024]
• Middle East, North Africa
  • BMJ Open
    • Burden and mortality of breast cancer attributed to diabetes and smoking in women: a secondary analysis based on Global Burden of Disease 2019 in North Africa and the Middle East [2025]
  • Nutrients
    • Associations Between Dietary Factors and Breast Cancer Risk: A Systematic Review of Evidence from the MENA Region [2025]
• Mongolia, United Kingdom
  • PLoS ONE
    • The Role of Hormones in the Differences in the Incidence of Breast Cancer between Mongolia and the United Kingdom [2014]
• Netherlands
  • Breast Cancer Research and Treatment
    • The proportion of postmenopausal breast cancer cases in the Netherlands attributable to lifestyle-related risk factors [2015]
  • Cancer Medicine
    • Risk of breast cancer in women after a salivary gland carcinoma or pleomorphic adenoma in the Netherlands [2020]
  • European Journal of Epidemiology
    • The association of a combined healthy lifestyle with the risk of postmenopausal breast cancer subtypes in the Netherlands Cohort Study [2023]
  • Oncologist
    • Evaluating the Age-Based Recommendations for Long-Term Follow-Up in Breast Cancer [2020]
• New Zealand
  • Breast Cancer Research and Treatment
    • Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study [2023]
• Norway
  • British Journal of Cancer
    • The fraction of breast cancer attributable to smoking: The Norwegian women and cancer study 1991–2012 [2016]
  • European Journal of Endocrinology
    • Low-dose aspirin and risk of breast cancer: a Norwegian population-based cohort study of one million women [2023]
• Palestine
  • JCO Global Oncology
    • Awareness of Palestinian Women About Breast Cancer Risk Factors: A National Cross-Sectional Study [2022]
• Qatar
  • Journal of Primary Care & Community Health
    • Assessing Breast Cancer Risk Estimates Based on the Gail Model and Its Predictors in Qatari Women [2017]
• Republic of Korea
  • Cancer Research and Treatment
    • Novel Breast Cancer Risk Assessment Tools for Pre- and Postmenopausal Asian Women: Development and Validation in a Nationwide Mammographic Screening Cohort [2025]
  • Scientific Reports
    • Impact of air pollution on breast cancer incidence and mortality: a nationwide analysis in South Korea [2020]
• Singapore
  • Scientific Reports
    • Incidence of breast cancer attributable to breast density, modifiable and non-modifiable breast cancer risk factors in Singapore [2020]
• South Africa
  • International Journal of Environmental Research and Public Health
    • The Relationship Between Climate Change and Breast Cancer and Its Management and Preventative Implications in South Africa [2025]
• Spain
  • BMC Cancer
    • An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain [2013]
  • Scientific Reports
    • Validating a breast cancer score in Spanish women. The MCC-Spain study [2018]
• Sweden
  • Breast Cancer Research and Treatment
    • Drug use disorder and risk of incident and fatal breast cancer: a nationwide epidemiological study [2021]
  • Fertility and Sterility
    • Ovarian stimulation and risk of breast cancer in Swedish women [2017]
  • Schizophrenia Bulletin
    • Antipsychotic Use and Risk of Breast Cancer in Women With Severe Mental Illness: Replication of a Nationwide Nested Case-Control Database Study [2024]
• Switzerland
  • Frontiers in Public Health
    • Estimating 10-year risk of lung and breast cancer by occupation in Switzerland [2023]
    • Breast cancer and occupation: Non-parametric and parametric net survival analyses among Swiss women (1990-2014) [2023]
  • Gland Surgery
    • The impact of overweight and obesity on breast cancer: data from Switzerland, so far a country little affected by the current global obesity epidemic [2014]
• Taiwan
  • BMC Cancer
    • Female breast cancer incidence predisposing risk factors identification using nationwide big data: a matched nested case-control study in Taiwan [2022]
  • BMJ Open
    • Thyroid disorders and breast cancer risk in Asian population: a nationwide population-based case–control study in Taiwan [2018]
  • Breast
    • Cost-effectiveness of genetic risk-stratified screening for breast cancer in Taiwan [2025]
  • International Journal of Environmental Research and Public Health
    • Breast Cancer Incidence among Female Workers by Different Occupations and Industries: A Longitudinal Population-Based Matched Case-Control Study in Taiwan [2022]
  • International Journal of Obesity
    • Body mass index and breast cancer: analysis of a nation-wide population-based prospective cohort study on 1 393 985 Taiwanese women [2015]
  • Scientific Reports
    • Reproductive and environmental exposures and the breast cancer risk in Taiwanese women [2021]
• Türkiye
  • Balkan Medical Journal
    • Modifiable Risk Factors for Breast Cancer Mortality in Türkiye from 1990 to 2019: A Temporal Analysis of Global Burden of Disease Data [2024]
• Ukraine
  • European Journal of Epidemiology
    • Breast cancer risk in Ukrainian women exposed to Chornobyl fallout while pregnant or lactating: standardized incidence ratio analysis, 1998 to 2016 [2022]
• United Kingdom
  • BMJ
    • Age and sex can predict cancer risk in people referred with breast symptoms [2023]
  • Breast Cancer Research and Treatment
    • Reproductive history differs by molecular subtypes of breast cancer among women aged <= 50 years in Scotland diagnosed 2009-2016: a cross-sectional study [2022]
  • British Journal of Cancer
    • Proactive breast cancer risk assessment in primary care: a review based on the principles of screening [2023]
    • Ethnic differences in breast cancer incidence in England are due to differences in known risk factors for the disease: prospective study [2013]
  • Cancer Medicine
    • Breastfeeding reduces the risk of breast cancer: A call for action in high-income countries with low rates of breastfeeding [2023]
    • Thyroid dysfunction and breast cancer risk among women in the UK Biobank cohort [2021]
  • Cancer Research UK
    • Breast cancer risk
  • College of Sexual and Reproductive Healthcare
    • Contraception and Breast Cancer
  • JAMA Network Open
    • Association of Nongenetic Factors With Breast Cancer Risk in Genetically Predisposed Groups of Women in the UK Biobank Cohort [2020]
  • PLoS Medicine
    • Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysis [2023]
• United States
  • American Cancer Society
    • Challenges in DCIS Risk Communication and Decision-Making: Report from an American Cancer Society and National Cancer Institute Workshop [2012]
  • American Journal of Epidemiology
    • Maximum and Time-Dependent Body Mass Index and Breast Cancer Incidence Among Postmenopausal Women in the Black Women's Health Study [2022]
  • Applied Geography
    • Identifying county-level factors for female breast cancer incidence rate through a large-scale population study [2020]
  • BMC Public Health
    • Demographic disparities in the limited awareness of alcohol use as a breast cancer risk factor: empirical findings from a cross-sectional study of U.S. women [2024]
  • BMC Women's Health
    • Awareness of the alcohol-breast cancer link among breast cancer survivors in the United States: a national cross-sectional survey [2025]
  • Breast Cancer Research
    • Generational trends in reproductive factors among women in the US: implications for breast cancer incidence [2026]
  • Breast Cancer Research and Treatment
    • Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk [2023]
  • Breast Cancer Surveillance Consortium
    • Association of Breast Density With Breast Cancer Risk Among Women Aged 65 Years or Older by Age Group and Body Mass Index [2021]
    • Breast Cancer Population Attributable Risk Proportions Associated with Body Mass Index and Breast Density by Race/Ethnicity and Menopausal Status [2020]
    • Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer [2017]
    • Association between air pollution and mammographic breast density in the Breast Cancer Surveilance Consortium [2017]
    • Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer [2016]
    • Identifying women with dense breasts at high risk for interval cancer: a cohort study [2015]
    • Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk [2007]
  • Cancer
    • Accelerometer-measured physical activity and postmenopausal breast cancer incidence in the Women's Health Accelerometry Collaboration [2023]
    • Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women’s Health Initiative [2020]
    • A review of body size and breast cancer risk in Hispanic and African American women [2011]
  • Cancer Causes and Control
    • Endocrine-disrupting pesticides and breast cancer incidence in the United States: an ecological analysis [2026]
    • Where are we now and where do we go from here? A structured literature review analyzing the current state of breast density research trends and discussions [2025]
  • Cancer Epidemiology Biomarkers & Prevention
    • Impact of BMI on Prevalence of Dense Breasts by Race and Ethnicity [2023]
  • Clinical Breast Cancer
    • Universal Genetic Counseling and Testing for Black Women: A Risk-Stratified Approach to Addressing Breast Cancer Disparities [2025]
  • Critical Reviews in Oncology/Hematology
    • The relation between excess adiposity and breast cancer in women: Clinical implications and management [2024]
  • Environment International
    • Air pollution and breast cancer incidence in a United States-wide prospective cohort study: Examining sensitive periods of exposure [2025]
    • Carcinogenic industrial air pollution and postmenopausal breast cancer risk in the National Institutes of Health AARP Diet and Health Study [2024]
  • Frontiers in Public Health
    • Race, Age, and Obesity Disparities in Adult Physical Activity Levels in Breast Cancer Patients And Controls [2014]
  • JAMA Network Open
    • Trends in Parity and Breast Cancer Incidence in US Women Younger Than 40 Years From 1935 to 2015 [2020]
  • JAMA Oncology
    • Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States [2016]
  • Journal of the National Cancer Institute
    • Ambient fine particulate matter and breast cancer incidence in a large prospective US cohort [2024]
    • Ethylene oxide emissions and incident breast cancer and non-Hodgkin lymphoma in a US cohort [2023]
  • Molecular and Cellular Endocrinology
    • US EPA's regulatory pesticide evaluations need clearer guidelines for considering mammary gland tumors and other mammary gland effects [2020]
  • National Cancer Institute
    • Postpartum Remodeling, Lactation, and Breast Cancer Risk: Summary of a National Cancer Institute–Sponsored Workshop [2013]
    • Breast Cancer Risk Assessment Tool
  • National Comprehensive Cancer Network
    • Breast Cancer Risk Reduction, Version 2.2015 [2015]
  • PLoS ONE
    • A complex systems model of breast cancer etiology: The Paradigm II Model [2023]
• Western countries
  • Archives of Gynecology and Obstetrics
    • Association between hysterectomy, oophorectomy, and risk of breast cancer: a meta-analysis [2025]
  • International Journal of Environmental Research and Public Health
    • Oral Contraceptive Use and Assessment of Breast Cancer Risk among Premenopausal Women via Molecular Characteristics: Systematic Review with Meta-Analysis [2022]
• {Related topics}
  • Topic
    • Familial breast cancer, hereditary breast cancer, genetic predisposition
    • Breast cancer

Breast cancer screening, mammography

• Albania
  • Institute of Public Health
    • Breast Cancer Screening in Albania During 2007-2008 [2013]
• Asia
  • Asian Pacific Journal of Cancer Prevention
    • Prevalence of Breast Cancer Screening in Asia: Systematic Review and Meta-Analysis [2024]
  • BMC Cancer
    • A systematic literature review on mammography: deep learning techniques for breast cancer detection with global and Asian perspectives [2025]
  • Cancer Medicine
    • At what age should screening mammography be recommended for Asian women? [2015]
  • Hong Kong Medical Journal
    • Understanding breast cancer screening—past, present, and future [2018]
  • Korean Journal of Radiology
    • Breast Cancer Screening in Asian Countries: Epidemiology, Screening Practices, Outcomes, Challenges, and Future Directions [2025]
• Australia
  • Australian and New Zealand Journal of Public Health
    • BreastScreen Australia national data by factors of interest for risk-based screening: routinely reported data and opportunities for enhancement [2022]
  • Australian Institute of Health and Welfare
    • BreastScreen Australia monitoring report 2025 [2024]
    • BreastScreen Australia data dictionary: version 1.3 [2024]
    • Access to BreastScreen Australia screening services [2024]
  • Australian Journal of General Practice
    • The early detection of breast cancer: An update from the Red book [2025]
  • Breast
    • Women's views on using artificial intelligence in breast cancer screening: A review and qualitative study to guide breast screening services [2024]
  • Cancer Council
    • Breast Cancer Early Detection Policy
  • Clinical Oncology Society of Australia
    • Mammographic / Breast Density - Facts and Issues paper [2021]
  • Journal of Clinical Medicine
    • Breast Density Notification: An Australian Perspective [2020]
  • Journal of Medical Radiation Sciences
    • Radiation Risk in 2D Mammography Screening: A Scoping Review of Modelling Strategies and Emerging AI Applications [2026]
  • Public Health Research and Practice
    • Public health advocacy in action: the case of unproven breast cancer screening in Australia [2016]
  • Royal Australian College of General Practitioners
    • Breast cancer
• Australia, New Zealand
  • Royal Australian and New Zealand College of Radiologists
    • RANZCR Breast Density Position Statement [2023]
• Belgium
  • Radiography
    • Image quality standards in digital mammography: A consensus statement [2026]
• Brazil
  • BMC Public Health
    • Barriers and facilitators of the implementation of mammography screening in the Brazilian public health system: scoping review [2025]
  • Cadernos de Saúde Pública
    • Guidelines for early detection of breast cancer in Brazil. III - Challenges for implementation [2018]
    • Guidelines for early detection of breast cancer in Brazil. II - New national recommendations, main evidence, and controversies [2018]
    • Guidelines for early detection of breast cancer in Brazil. I - Development methods [2018]
  • Ciência & Saúde Coletiva
    • Social health determinants associated with mammography performance according to the 2013 and 2019 National Health Survey [2025]
  • Epidemiologia e Serviços de Saúde
    • Evaluation of breast cancer screening indicators in the female population using the National Health System, Brazil, 2018-2019: a descriptive study [2023]
    • Assessment of actions for breast cancer early detection in Brazil using process indicators: a descriptive study with Sismama data, 2010-2011 [2017]
  • Federação Brasileira das Associações de Ginecologia e Obstetrícia
    • Recommendations for the Screening of Breast Cancer of the Brazilian College of Radiology and Diagnostic Imaging, Brazilian Society of Mastology and Brazilian Federation of Gynecology and Obstetrics Association [2023]
    • Breast Cancer Screening: Updated Recommendations of the Brazilian College of Radiology and Diagnostic Imaging, Brazilian Breast Disease Society, and Brazilian Federation of Gynecological and Obstetrical Associations [2017]
  • Frontiers in Public Health
    • Breast cancer screening and diagnosis in older adults women in Brazil: why it is time to reconsider the recommendations [2023]
  • International Journal of Public Health
    • COVID-19 and Breast Cancer in Brazil [2023]
  • Journal of Global Health
    • 10-year opportunistic mammographic screening scenario in Brazil and its impact on breast cancer early detection: a nationwide population-based study [2022]
  • Radiologia Brasileira
    • Contribution of the Unified Health Care System to mammography screening in Brazil, 2013 [2016]
  • Revista da Associação Médica Brasileira
    • Breast cancer screening in Brazil. Barriers related to the health system [2017]
• Canada
  • BMJ
    • Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial [2014]
  • BMJ Open
    • Breast cancer screening best practices: a Canadian multidisciplinary consensus-based approach for primary care providers [2026]
  • Canada's Drug Agency
    • Digital Breast Tomosynthesis for the Screening and Diagnosis of Breast Cancer: A Review of the Diagnostic Accuracy, Cost-Effectiveness and Guidelines [2019]
  • Canadian Association of Radiologists Journal
    • Addressing Misinformation About the Canadian Breast Screening Guidelines [2023]
  • Canadian Family Physician
    • Breast density notification [2023]
    • Examining screening mammography participation among women aged 40 to 74 [2017]
  • Canadian Journal of Surgery
    • CJS debate: Is mammography useful in average-risk screening for breast cancer? [2016]
  • Canadian Partnership Against Cancer
    • Breast screening in Canada, 2023-24
  • Canadian Society of Breast Imaging
    • Canadian Society Breast Imaging Position Statement on Mammographic Breast Density and Supplemental Screening [2026]
  • Canadian Task Force on Preventive Health Care
    • Screening for breast cancer: a systematic review update to inform the Canadian Task Force on Preventive Health Care guideline [2024]
    • Patient preferences for breast cancer screening: a systematic review update to inform recommendations by the Canadian Task Force on Preventive Health Care [2024]
    • Breast Cancer (Update) – Draft Recommendations (2024) [2024]
  • CMAJ
    • Applying the 2011 Canadian guidelines for breast cancer screening in practice [2012]
  • CMAJ Open
    • The cost-effectiveness of adding tomosynthesis to mammography-based breast cancer screening: an economic analysis [2021]
  • Current Oncology
    • When "One Size Fits All" Fits None: A Commentary on the Impacts of the"Draft Canadian Breast Cancer Screening Guidelines" on Racialized Populations in Canada [2025]
    • How Did CNBSS Influence Guidelines for So Long and What Can That Teach Us? [2022]
    • Screening for breast cancer in 2018—what should we be doing today? [2018]
    • Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies [2016]
  • Government of Alberta
    • Alberta breast cancer screening—clinical practice guideline 2022 update [2022]
  • House of Commons of Canada
    • Breast Cancer Screening Guidelines
  • JAMA Network Open
    • Cost-Effectiveness of Breast Cancer Screening Using Digital Mammography in Canada [2025]
  • Journal of Breast Imaging
    • The Fundamental Flaws of the CNBSS Trials: A Scientific Review [2022]
  • Journal of Medical Screening
    • The randomized trial of mammography screening that was not-A cautionary tale [2022]
  • Ontario Health
    • Supplemental Screening as an Adjunct to Mammography for Breast Cancer Screening in People With Dense Breasts: A Health Technology Assessmen [2023]
    • Breast Screening for Survivors of Breast Cancer [2017]
    • Women's Experiences of Inaccurate Breast Cancer Screening Results: A Systematic Review and Qualitative Meta-synthesis [2016]
    • Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: A Health Technology Assessment [2016]
    • Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening in Women at Less Than High Risk for Breast Cancer: A Health Technology Assessment [2016]
    • Breast Screening Recommendations Summary
    • Breast (Chest) Density Information for Healthcare Providers
  • PLOS Computational Biology
    • Is mammography screening beneficial: An individual-based stochastic model for breast cancer incidence and mortality [2020]
• Chile
  • Breast
    • Mammogram screening in Chile: Using mixed methods to implement health policy planning at the primary care level [2011]
  • Revista de Saúde Pública
    • Effectiveness of breast cancer screening policies in countries with medium-low incidence rates [2018]
• China
  • BMC Women's Health
    • The association between mammographic density and breast cancer risk in Chinese women: a systematic review and meta-analysis [2024]
    • Breast cancer screening and early diagnosis in China: a systematic review and meta-analysis on 10.72 million women [2024]
  • Cancer Biology & Medicine
    • Interpretation of breast cancer screening guideline for Chinese women [2019]
  • China CDC Weekly
    • Breast Cancer Screening Rates Among Women Aged 20 Years and Above — China, 2015 [2021]
  • International Journal of Environmental Research and Public Health
    • Recommending Breast Cancer Screening to My Mum: Examining the Interplay of Threat, Efficacy, and Virality on Recommendation Intention in the Chinese Context [2023]
  • Korean Journal of Radiology
    • Breast Cancer Screening Programs in China: Implementation, Challenges, and Future Perspectives [2026]
  • Oncologist
    • Breast Cancer Challenges and Screening in China: Lessons From Current Registry Data and Population Screening Studies [2015]
  • Population Health Metrics
    • Estimating disability-adjusted life years for breast cancer and the impact of screening in female populations in China, 2015-2030: an exploratory prevalence-based analysis applying local weights [2022]
  • Preventing Chronic Disease: Public Health Research, Practice and Policy
    • Breast Cancer Screening Among Adult Women in China, 2010 [2013]
• Croatia
  • Croatian Medical Journal
    • Results of the National Breast Cancer Screening Program in Croatia (2006-2016) [2022]
• Czech Republic
  • BMC Public Health
    • Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme [2011]
• Côte d'Ivoire
  • Reproductive Health
    • Age at first menstruation and clinical breast cancer screening utilization: insights from the 2021 Côte d'Ivoire demographic and health survey [2024]
• Democratic Republic of the Congo
  • BMC Public Health
    • From the set-up of a screening program of breast cancer patients to the identification of the first BRCA mutation in the DR Congo [2014]
• Denmark
  • Clinical Epidemiology
    • Morbidity as a Predictor for Participation in the Danish National Mammography Screening Program: A Cross-Sectional Study [2020]
    • Danish Quality Database for Mammography Screening [2016]
  • eLife
    • Nationwide mammography screening participation in Denmark during the COVID-19 pandemic: An observational study [2023]
  • International Journal of Cancer
    • Benefit-to-harm ratio of the Danish breast cancer screening programme [2017]
• East Africa
  • BMC Public Health
    • Barriers and enablers of breast cancer screening among women in East Africa: a systematic review [2023]
• Ethiopia
  • Journal of Primary Care & Community Health
    • Perception, Awareness, Knowledge, and Attitude (PAKA) Towards Breast Cancer in Ethiopia: A Systematic Review and Meta-Analysis [2025]
  • PLoS ONE
    • Breast self-examination practice and its determinants among women in Ethiopia: A systematic review and meta-analysis [2021]
• Europe
  • BMC Cancer
    • The impact of mammography screening programmes on incidence of advanced breast cancer in Europe: a literature review [2018]
  • BMC Public Health
    • Development of breast cancer mortality considering the implementation of mammography screening programs – a comparison of western European countries [2019]
  • Cancer Epidemiology Biomarkers & Prevention
    • European Breast Cancer Service Screening Outcomes: A First Balance Sheet of the Benefits and Harms [2014]
  • Cancers
    • Extending Age Ranges in Breast Cancer Screening in Four European Countries: Model Estimations of Harm-to-Benefit Ratios [2021]
  • DenseBreast-info.org
    • DenseBreast-info/Europe
  • European Commission
    • Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC) [2022]
    • Digital breast tomosynthesis compared to diagnostic mammographic projections (including magnification) among women recalled at screening mammography: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC) [2021]
    • Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators [2020]
    • Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines [2020]
    • European guidelines on breast cancer screening and diagnosis
  • European Menopause and Andropause Society
    • EMAS position statement: Individualized breast cancer screening versus population-based mammography screening programmes [2014]
  • European Society of Breast Imaging
    • ESR Essentials: screening for breast cancer - general recommendations by EUSOBI [2024]
    • Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies [2017]
    • Mammography: an update of the EUSOBI recommendations on information for women [2017]
    • Mammography: EUSOBI recommendations for women's information [2012]
  • International Journal of Cancer
    • The potential of breast cancer screening in Europe [2021]
  • International Journal of Oncology
    • Breast cancer in European Union: An update of screening programmes as of March 2014 (Review) [2014]
  • Journal of Health Economics
    • Effects of organized screening programs on breast cancer screening, incidence, and mortality in Europe [2023]
  • Preventive Medicine
    • Presence, characteristics and equity of access to breast cancer screening programmes in 27 European countries in 2010 and 2014. Results from an international survey [2016]
• Finland
  • International Journal of Cancer
    • Cancer incidence and mortality patterns in women with breast symptoms in the mammography screening programme: A matched cohort analysis [2019]
• France
  • BMC Medical Ethics
    • Women's participation in breast cancer screening in France - an ethical approach [2014]
  • Collège National des Gynécologues et Obstétriciens Français
    • French college of gynecologists and obstetricians (CNGOF) recommendations for clinical practice: Place of breast self-examination in screening strategies [2024]
• Germany
  • BMC Public Health
    • Sociodemographic inequalities in breast cancer screening attendance in Germany following the implementation of an Organized Screening Program: Scoping Review [2024]
  • Breast Care
    • Relevance of Health Economics in the Early Detection of Breast Cancer in Germany – the View of the Professional Association of Practicing Gynecologic Oncologists e.V. (BNGO) [2013]
  • Cancer Prevention Research
    • Estimating the Breast Cancer Burden in Germany and Implications for Risk-based Screening [2021]
  • Frontiers in Oncology
    • Assessing and Explaining Geographic Variations in Mammography Screening Participation and Breast Cancer Incidence [2019]
  • Institute for Quality and Efficiency in Health Care
    • Review of age limits in the mammography screening programme [2022]
  • International Journal of Cancer
    • Breast cancer incidence and mortality before and after implementation of the German mammography screening program [2020]
  • RöFo
    • Extending the Age Range in Mammography Screening: A Benefit-Risk Assessment from a Radiation Protection Perspective [2026]
    • Guideline for determining the mean glandular dose according to DIN 6868-162 and threshold contrast visibility according to the quality assurance guideline for digital mammography systems [2014]
• Ghana
  • BMC Health Services Research
    • Mapping evidence on knowledge of breast cancer screening and its uptake among women in Ghana: a scoping review [2022]
  • BMC Public Health
    • Unmet need for breast cancer screening among women of reproductive age in Ghana: a secondary analysis of the 2022 demographic and health survey [2025]
  • Heliyon
    • The prevalence and predictive factors of breast cancer screening among older Ghanaian women [2020]
• High-income countries
  • BMC Women's Health
    • Breast cancer screening motivation and behaviours of women aged over 75 years: a scoping review [2024]
  • BMJ Open
    • Performance of artificial intelligence in breast cancer screening programmes: a systematic review [2025]
  • Cancer Control
    • Improving Breast Cancer Outcomes by Enhanced Activities in Early Detection and Diagnosis: An Umbrella Review and Meta-Analyses of Randomised Controlled Trials in High-Income Contexts With Universal Healthcare Coverage [2026]
  • European Journal of Radiology Open
    • A scoping review of programme specific mammographic breast density related guidelines and practices within breast screening programmes [2023]
  • Journal of Clinical Epidemiology
    • Effect of screening mammography on the risk of breast cancer deaths and of all-cause deaths: a systematic review with meta-analysis of cohort studies [2024]
• Hong Kong
  • Hong Kong Medical Journal
    • Update on the Recommendations on Breast Cancer Screening by the Cancer Expert Working Group on Cancer Prevention and Screening [2022]
• Hungary
  • BMC Public Health
    • Breast cancer screening and its associating factors among hungarian women aged 45-65: a cross-sectional study based on the European health interview surveys from 2009 to 2019 [2023]
• Iceland
  • Breast Cancer : Targets and Therapy
    • Population-based service mammography screening: the Icelandic experience [2013]
• India
  • BMC Public Health
    • Prevalence and associated factors of mammography uptake among the women aged 45 years and above: policy implications from the longitudinal ageing study in India wave I survey [2025]
• Indonesia
  • Value in Health Regional Issues
    • Cost-Effectiveness Analysis of Mammography-Based Breast Cancer Screening in Indonesia [2025]
• International
  • Advances in Clinical and Experimental Medicine
    • Diagnostic accuracy of digital breast tomosynthesis and digital mammography in women with dense or non-dense breast tissue: A systematic review and meta-analysis [2025]
  • Asian Pacific Journal of Cancer Prevention
    • Cultural, Religious and Socio-Ethical Misconceptions among Muslim Women towards Breast Cancer Screening: A Systematic Review [2022]
  • BMC Women's Health
    • Factors influencing breast cancer screening practices among women worldwide: a systematic review of observational and qualitative studies [2024]
  • Breast
    • A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis [2023]
    • Global guidelines for breast cancer screening: A systematic review [2022]
  • Breast Cancer Research
    • Studies of parenchymal texture added to mammographic breast density and risk of breast cancer: a systematic review of the methods used in the literature [2022]
  • Breast Health Global Initiative
    • Breast cancer early detection: A phased approach to implementation [2020]
  • Bulletin of the World Health Organization
    • Screening programmes and breast cancer mortality: an observational study of 194 countries [2025]
  • Cancer Medicine
    • Systematic reviews as a “lens of evidence”: Determinants of cost-effectiveness of breast cancer screening [2019]
  • Cancers
    • Worldwide Review and Meta-Analysis of Cohort Studies Measuring the Effect of Mammography Screening Programmes on Incidence-Based Breast Cancer Mortality [2020]
  • Clinical and Experimental Medicine
    • Performance of digital breast tomosynthesis with digital mammography for detecting breast cancer in the diagnostic setting: a meta-analysis [2025]
  • Global Health Action
    • The global role, impact, and limitations of Community Health Workers (CHWs) in breast cancer screening: a scoping review and recommendations to promote health equity for all [2021]
  • International Federation of Gynecology and Obstetrics
    • National policies for screening and early detection of breast cancer around the globe: Practices, barriers, and solutions [2025]
  • JNCI Cancer Spectrum
    • Clinical guidelines for the management of mammographic density: a systematic review of breast screening guidelines worldwide [2024]
  • Journal of Medical Internet Research
    • Challenges in Implementing Artificial Intelligence in Breast Cancer Screening Programs: Systematic Review and Framework for Safe Adoption [2025]
  • Journal of Medical Screening
    • Assessing the impact of the COVID-19 pandemic on breast cancer screening and diagnosis rates: A rapid review and meta-analysis [2022]
  • Journal of the American Board of Family Medicine
    • Breast Cancer Screening in Older Women: the importance of shared decision making [2020]
  • Life
    • Screening for Breast Cancer: A Comparative Review of Guidelines [2024]
  • Radiography
    • Strategies enhancing the patient experience in mammography: A scoping review [2024]
  • Revista Brasileira de Ginecologia e Obstetrícia
    • Artificial intelligence in mammography: a systematic review of the external validation [2024]
• Iran
  • Journal of Research in Medical Sciences
    • Status of breast cancer screening strategies and indicators in Iran: A scoping review [2022]
• Ireland
  • European Journal of Radiology
    • Evaluation of recall rates in the Irish national breast screening programme: Insights from two million screening mammograms [2025]
  • Health Information and Quality Authority
    • Review of information management practices at BreastCheck [2018]
  • Journal of Medical Screening
    • Interval cancer audit and disclosure in breast screening programmes: An international survey [2023]
• Israel
  • International Journal of Cancer
    • Correlation between cumulative mammographic density and age-specific incidence of breast cancer: A biethnic study in Israel [2022]
• Italy
  • BMC Health Services Research
    • Integrating mammography screening programmes into specialist breast centres in Italy: insights from a national survey of Senonetwork breast centres [2022]
  • La radiologia medica
    • Italian guidelines for the use of digital breast tomosynthesis in breast cancer screening programmes: GRADE-ADOLOPMENT of the European guidelines [2026]
    • Structured reporting of x-ray mammography in the first diagnosis of breast cancer: a Delphi consensus proposal [2022]
    • Digital breast tomosynthesis (DBT): recommendations from the Italian College of Breast Radiologists (ICBR) by the Italian Society of Medical Radiology (SIRM) and the Italian Group for Mammography Screening (GISMa) [2017]
• Japan
  • Asian Pacific Journal of Cancer Prevention
    • Analysis of Predictors of Breast Cancer Screening among Japanese Women Using Nationally Representative Survey Data, 2001–2013 [2021]
  • Breast Cancer
    • The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition [2024]
    • The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition [2020]
  • Cancer Epidemiology
    • Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020 [2023]
• Jordan
  • Ministry of Health Jordan
    • Breast Cancer Screening and Diagnosis Guidelines [2017]
  • PLoS ONE
    • Exploring socio-demographic determinants of breast self-examination practices among Jordanian women: insights from the 2023 population-based survey [2026]
• Kazakhstan
  • International Journal of Environmental Research and Public Health
    • Evaluation of a National Breast Cancer Screening Program in a Middle-Income Country: The Case of Kazakhstan [2026]
• Kenya
  • Ministry of Health Kenya
    • Breast Cancer Screening and Early Diagnosis Action Plan 2021-2025 [2021]
  • PLoS ONE
    • Multilevel analysis of undergoing clinical breast examination and its associated factors among mothers of reproductive age in Kenya: Kenyan Demographic and Health Survey 2022 [2025]
    • Clinical breast cancer screening uptake and associated factors among reproductive age women in Kenya: further analysis of Kenyan Demographic and Health Survey 2022 [2025]
    • Awareness and its determinant factors towards breast examination to detect breast cancer among reproductive age women in Kenya: Multi level analysis of the recent demographic and health survey data [2024]
• Kuwait
  • Annals of Saudi Medicine
    • Kuwait National Mammography Screening Program: outcomes of 5 years of screening in Kuwaiti women [2021]
• Latin America and the Caribbean
  • Pan American Health Organization
    • Mammography Services Quality Assurance: Baseline Standards for Latin America and the Caribbean [2016]
• Lesotho
  • BMC Cancer
    • Factors associated with the uptake of clinical breast examination among women of reproductive age in Lesotho: analysis of a national survey [2023]
  • PLoS ONE
    • Factors influencing breast cancer screening among reproductive age women in Lesotho: Analysis of the 2023-24 demographic and health survey using the Andersen Behavioral Model [2025]
• Lithuania
  • Acta Medica Lituanica
    • Breast Cancer Screening Program in Lithuania: Trends in Breast Cancer Mortality Before and During the Introduction of the Mammography Screening Program [2020]
  • Cancer Control
    • Trends in Breast Cancer Incidence and Stage Distribution Before and During the Introduction of the Mammography Screening Program in Lithuania [2019]
  • International Journal of Environmental Research and Public Health
    • Predictors and Trend in Attendance for Breast Cancer Screening in Lithuania, 2006–2014 [2019]
• Low and middle income countries
  • British Journal of Radiology
    • From struggle to strength: transforming breast cancer screening for women in low- and middle-income countries [2026]
  • Clinics
    • Breast cancer screening in developing countries [2017]
  • Indian Journal of Medical Research
    • Screening for breast cancer: Cost-effective solutions for low- & middle-income countries [2021]
  • Journal of Global Health
    • Economic evaluations of mammography to screen for breast cancer in low- and middle-income countries: A systematic review [2022]
• Luxembourg
  • Cancer Epidemiology
    • Clinical outcomes by breast cancers diagnostic modes: A comprehensive evaluation of a national breast cancer screening programme [2025]
• Malaysia
  • Asian Pacific Journal of Cancer Prevention
    • Risk-Stratified Breast Cancer Screening in Malaysia: Challenges and Opportunities [2024]
    • Breast Cancer Screening in Malaysia: A Policy Review [2021]
  • BMC Public Health
    • Breast cancer and breast cancer screening use-beliefs and behaviours in a nationwide study in Malaysia [2023]
• Mexico
  • Revista de Investigación Clínica
    • Estimation of the Cost-Effectiveness of Breast Cancer Screening Using Mammography in Mexico Through a Simulation [2016]
• Namibia
  • BMC Public Health
    • Prevalence and determinants of breast self-examination practices among women in their reproductive age in Namibia: an analysis of the 2013 Namibia demographic and Health Survey [2023]
• Netherlands
  • BMJ
    • Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study [2017]
  • National Institute for Public Health and the Environment
    • Breast Cancer Screening Programme
• New Zealand
  • Health New Zealand
    • Impact analysis: Extending BreastScreen Aotearoa to include women aged 70-74 years [2019]
    • Cohort and Case Control Analyses of Breast Cancer Mortality [2015]
    • BreastScreen Aotearoa
• Nigeria
  • PLoS ONE
    • Cost-effectiveness analysis of mammography screening for early detection of breast cancer in Nigeria [2026]
• Nordic countries
  • Radiography
    • Factors affecting women's participation in mammography screening in Nordic countries: A systematic review [2023]
• Norway
  • European Journal of Public Health
    • Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway [2014]
  • European Radiology
    • How do AI markings on screening mammograms correspond to cancer location? An informed review of 270 breast cancer cases in BreastScreen Norway [2024]
  • International Journal of Cancer
    • Cost-effectiveness of the Norwegian breast cancer screening program [2017]
• Oman
  • Ministry of Health Oman
    • Early Detection and Screening of Breast Cancer Guideline
• Pakistan
  • PLoS ONE
    • Awareness regarding breast cancer amongst women in Pakistan: A systematic review and meta-analysis [2024]
• Palestine
  • BMC Public Health
    • Women's awareness of breast cancer symptoms: a national cross-sectional study from Palestine [2022]
• Peru
  • PLoS ONE
    • Cost-Effectiveness Analysis of Breast Cancer Control Interventions in Peru [2013]
• Portugal
  • European Journal of Public Health
    • Mammography use for breast cancer screening in Portugal: results from the 2005/2006 National Health Survey [2013]
  • Preventing Chronic Disease: Public Health Research, Practice and Policy
    • Mammography Use in Portugal: National Health Survey 2014 [2017]
• Qatar
  • BMJ Open
    • Do socioeconomic factors influence breast cancer screening practices among Arab women in Qatar? [2015]
  • International Journal of Environmental Research and Public Health
    • Breast Cancer Knowledge, Attitudes and Practices amongst Women in Qatar [2022]
• Republic of Korea
  • BMC Women's Health
    • Retrospective observation on contribution and limitations of screening for breast cancer with mammography in Korea: detection rate of breast cancer and incidence rate of interval cancer of the breast [2016]
  • Breast
    • Global mammographic asymmetry and short-term breast cancer risk by breast density: a nationwide screening cohort of 5.5 million women [2026]
  • Cancer Research and Treatment
    • Temporal Trend in Uptake of the National General Health Checkups and Cancer Screening Program among Korean Women with Breast Cancer [2024]
  • Epidemiology and Health
    • Trends in breast cancer screening rates among Korean women: results from the Korean National Cancer Screening Survey, 2005-2020 [2022]
    • Effect of mammography screening on the long-term survival of breast cancer patients: results from the National Cancer Screening Program in Korea [2022]
  • Korean Journal of Radiology
    • Performance of Screening Mammography: A Report of the Alliance for Breast Cancer Screening in Korea [2016]
    • Clinical Image Evaluation of Film Mammograms in Korea: Comparison with the ACR Standard [2013]
  • Scientific Reports
    • Impact of health disparities on national breast cancer screening participation rates in South Korea [2023]
• Saudi Arabia
  • Ministry of Health Saudi Arabia
    • Clinical Practice Guideline on the Use of Screening Strategies for the Detection of Breast Cancer [2014]
  • Saudi Medical Journal
    • Facilitators and barriers to mammogram screening uptake among Saudi women: A systematic review [2025]
  • Women's Health
    • Level and predictors of breast cancer awareness among Saudi women: A nationwide study [2022]
• Singapore
  • Annals Academy of Medicine Singapore
    • Advancing breast cancer and lung cancer screening: Expert perspectives to advance programmes in Singapore [2025]
    • Barriers to breast cancer screening in Singapore: A literature review [2022]
  • PLoS ONE
    • Factors associated with false-positive mammography at first screen in an Asian population [2019]
  • Singapore Medical Journal
    • The Case for Breast Cancer Screening in Singapore [2002]
• Slovenia
  • PLoS ONE
    • Prognostic factors and outcomes in women with breast cancer in Slovenia in relation to step-wise implementation of organized screening [2022]
• South Africa
  • SA Journal of Radiology
    • Screening mammography with special reference to guidelines in South Africa [2018]
  • Value in Health Regional Issues
    • Breast Cancer Screening Using Clinical Breast Examination: A Cost-Effectiveness Analysis for South Africa [2025]
• Spain
  • PLoS ONE
    • Cost-Effectiveness of Double Reading versus Single Reading of Mammograms in a Breast Cancer Screening Programme [2016]
    • Association between the Adherence to the International Guidelines for Cancer Prevention and Mammographic Density [2015]
• Sri Lanka
  • Ministry of Health Sri Lanka
    • Early Detection and Management of Breast Symptoms [2014]
• Sub-Saharan Africa
  • BMC Cancer
    • Breast cancer screening in sub-Saharan Africa: a systematic review and ethical appraisal [2022]
  • BMC Public Health
    • Influence of distance to health facilities on clinical breast cancer screening behaviour among women in five sub-Saharan African countries [2023]
  • BMJ Open
    • Prevalence and determinants of breast cancer screening in four sub-Saharan African countries: a population-based study [2020]
  • Frontiers in Public Health
    • The prevalence and predictors of clinical breast cancer screening in Sub-Saharan African countries: a multilevel analysis of Demographic Health Survey [2024]
  • Journal of Medical Imaging and Radiation Sciences
    • A model to enhance breast cancer screening among rural women aged 40-75 years in Sub-Saharan Africa (SSA): A scoping review [2024]
• Sweden
  • European Radiology
    • Results from a Swedish model-based analysis of the cost-effectiveness of AI-assisted digital mammography [2026]
  • JAMA Oncology
    • Breast Cancer Incidence After a False-Positive Mammography Result [2024]
  • Journal of the Royal Society of Medicine
    • Statistical analyses in Swedish randomised trials on mammography screening and in other randomised trials on cancer screening: a systematic review [2015]
• Switzerland
  • BMC Health Services Research
    • Breast cancer screening attendance in two Swiss regions dominated by opportunistic or organized screening [2016]
  • New England Journal of Medicine
    • Abolishing Mammography Screening Programs? A View from the Swiss Medical Board [2014]
• Syria
  • Cancer Treatment and Research Communications
    • Assessing Syrian women's knowledge of breast cancer risk factors, warning signs, and barriers to preventive measures: A cross-sectional study [2023]
• Taiwan
  • BMC Medicine
    • Performance measures of 8,169,869 examinations in the National Breast Cancer Screening Program in Taiwan, 2004-2020 [2023]
  • BMC Public Health
    • Socioeconomic inequalities in uptake of outreach mammography before and after accessibility improvement of Taiwan's national universal breast cancer screening policy [2024]
  • International Journal of Environmental Research and Public Health
    • Inequality in the Utilization of Breast Cancer Screening between Women with and without Disabilities in Taiwan: A Propensity-Score-Matched Nationwide Cohort Study [2022]
  • Journal of Epidemiology and Global Health
    • Cost-Effectiveness Analysis of Digital Breast Tomosynthesis and Mammography in Breast Cancer Screening: A Markov Modeling Study [2024]
• Tanzania
  • BMC Women's Health
    • Women's empowerment and its influence on the uptake of breast cancer screening in Tanzania: an analysis of 2022 Tanzania demographic health survey data [2024]
  • Cancer Control
    • Breast Cancer Screening among Young Women in Tanzania: Findings from the 2022 Demographic and Health Survey [2025]
• Tunisia
  • Health Research Policy and Systems
    • Contextual differences considered in the Tunisian ADOLOPMENT of the European guidelines on breast cancer screening [2021]
• Uganda
  • Cancer
    • Breast cancer early detection and diagnostic capacity in Uganda [2020]
  • PLoS ONE
    • National diagnostic reference levels for digital diagnostic and screening mammography in Uganda [2024]
• United Arab Emirates
  • Ministry of Health and Prevention
    • The National Guideline for Breast Cancer Screening and Diagnosis [2023]
• United Kingdom
  • Applied Health Economics and Health Policy
    • A structured process for the validation of a decision-analytic model: application to a cost-effectiveness model for risk-stratified national breast screening [2024]
  • BMC Cancer
    • Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders’ views on a low-risk breast screening pathway [2020]
  • BMJ Open
    • Improving screening recall services for women with false-positive mammograms: a comparison of qualitative evidence with UK guidelines [2015]
  • British Journal of Cancer
    • Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): cost-effectiveness and budget impact analysis [2026]
    • The cost-effectiveness of risk-stratified breast cancer screening in the UK [2023]
    • The projected impact of the COVID-19 lockdown on breast cancer deaths in England due to the cessation of population screening: a national estimation [2022]
    • Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study [2016]
    • Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom [2014]
    • The benefits and harms of breast cancer screening: an independent review [2013]
  • British Journal of Radiology
    • Evidence-informed recommendations on managing breast screening atypia: perspectives from an expert panel consensus meeting reviewing results from the Sloane atypia project [2024]
  • Cancer Medicine
    • A case-control study to evaluate the impact of the breast screening programme on breast cancer incidence in England [2023]
  • Health Technology Assessment
    • Mammographic surveillance in breast cancer patients aged 50 years or older: a synopsis of the Mammo-50 RCT [2026]
    • Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT [2020]
  • JAMA Network Open
    • Cost-Effectiveness of AI for Risk-Stratified Breast Cancer Screening [2024]
  • National Institute for Health and Care Excellence
    • Contrast-enhanced spectral mammography for breast cancer [2022]
    • Artificial intelligence in mammography [2021]
  • Nature Communications
    • Cost-effectiveness requirements for implementing artificial intelligence technology in the Women's UK Breast Cancer Screening service [2023]
  • NHS Digital
    • Breast Screening Programme
  • NHS England
    • Statement on reporting of breast density
    • NHS breast screening (BSP) programme
    • NHS Breast screening programme screening standards valid for data collected from 1 April 2021
    • NHS Breast screening programme screening standards valid for data collected from 1 April 2017
    • Guidance for radiology and advanced radiographic practice in the NHS Breast Screening Programme
    • Breast screening: very high risk women surveillance protocols
    • Breast screening: professional guidance
    • Breast screening: mammography imaging equipment evaluation
    • Breast screening: information leaflets
    • Breast screening: guidance on implementation of Ionising Radiation (Medical Exposure) Regulations (2017)
    • Breast screening supporting information
    • Breast screening programme: standards
    • Breast Screening: Attended not screened
  • Office for Health Improvement and Disparities
    • Breast screening pathway requirements specification
  • Psycho-Oncology
    • A Systematic Review of Barriers to Breast Cancer Screening, and of Interventions Designed to Increase Participation, Among Women of Black African and Black Caribbean Descent in the UK [2025]
  • Public Health Scotland
    • Scottish breast screening programme statistics
  • Public Health Wales
    • Breast screening
  • UK National Screening Committee
    • UK National Screening Committee's approach to reviewing evidence on artificial intelligence in breast cancer screening [2022]
    • Breast cancer
• United States
  • Agency for Healthcare Research and Quality
    • Screening for Breast Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force [2024]
    • Supplemental Screening for Breast Cancer in Women With Dense Breasts [2016]
    • Screening for Breast Cancer: A Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation [2016]
    • Screening for Breast Cancer With Digital Breast Tomosynthesis [2016]
  • American Association of Physicists in Medicine
    • AAPM Medical Physics Practice Guideline MPPG 17.a: Quality management for mammography review workstation displays [2025]
    • Joint AAPM Task Group 282/EFOMP Working Group Report: Breast dosimetry for standard and contrast-enhanced mammography and breast tomosynthesis [2023]
  • American Cancer Society
    • Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society [2015]
    • Breast Cancer Screening Guidelines
  • American College of Obstetricians and Gynecologists
    • The U.S. Food and Drug Administration Requires Notification of Breast Density in Mammography Reports [2023]
    • Management of Women With Dense Breasts Diagnosed by Mammography [2015]
  • American College of Physicians
    • Screening for Breast Cancer in Asymptomatic, Average-Risk Adult Females: A Guidance Statement From the American College of Physicians (Version 2) [2026]
    • Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of Physicians [2019]
  • American College of Radiology
    • Updated Recommendations by the American College of Radiology for Breast Cancer Screening in Individuals at Higher-Than-Average Risk [2023]
    • Breast Cancer Screening Recommendations Inclusive of All Women at Average Risk: Update from the ACR and Society of Breast Imaging [2021]
    • Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR [2018]
    • Female Breast Cancer Screening
    • ACR–AAPM–SIIM Practice Parameter for Determinants of Image Quality In Mammography
    • ACR Practice Parameter for the Performance of Screening and Diagnostic Mammography
    • ACR Practice Parameter for the Performance of Digital Breast Tomosynthesis (DBT)
  • American Society of Breast Surgeons
    • Position Statement on Screening Mammography [2019]
  • Annals of Internal Medicine
    • Aggregate Cost of Mammography Screening in the United States: Comparison of Current Practice and Advocated Guidelines [2014]
  • Association of Women's Health, Obstetric and Neonatal Nurses
    • Breast Cancer Screening [2017]
  • BMJ Open
    • National yearly cost of breast cancer screening in the USA and projected cost of advocated guidelines: a simulation study with life table modelling [2025]
  • Breast Cancer Research and Treatment
    • Breast Cancer Screening in the Era of Density Notification Legislation: Summary of 2014 Massachusetts Experience and Suggestion of An Evidence-Based Management Algorithm by Multi-disciplinary Expert Panel [2015]
  • Breast Cancer Surveillance Consortium
    • Racial and Ethnic Variation in Diagnostic Mammography Performance among Women Reporting a Breast Lump [2023]
    • National Performance Benchmarks for Screening Digital Breast Tomosynthesis: Update from the Breast Cancer Surveillance Consortium [2023]
    • Mammography adherence in relation to function-related indicators in older women [2022]
    • Diagnostic Mammography Performance across Racial and Ethnic Groups in a National Network of Community-Based Breast Imaging Facilities [2022]
    • Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women [2021]
    • Function-related Indicators and Outcomes of Screening Mammography in Older Women: Evidence from the Breast Cancer Surveillance Consortium Cohort [2021]
    • Screening Mammography Outcomes: Risk of Breast Cancer and Mortality by Comorbidity Score and Age [2020]
    • Trends in Clinical Breast Density Assessment From the Breast Cancer Surveillance Consortium [2019]
    • Digital Breast Tomosynthesis: Radiologist Learning Curve [2019]
    • Quantifying performance thresholds for recommending screening mammography: a revealed preference analysis of USPSTF guidelines [2018]
    • National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium [2017]
    • Change in Breast Cancer Screening Intervals Since the 2009 USPSTF Guideline [2017]
    • Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes [2016]
    • Performance of digital screening mammography among older women in the United States [2015]
    • One versus Two Breast Density Measures to Predict 5- and 10-Year Breast Cancer Risk [2015]
    • Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection [2015]
    • Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status [2015]
    • Timeliness of abnormal screening and diagnostic mammography follow-up at facilities serving vulnerable women [2013]
    • Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? [2013]
    • Reported mammographic density: film-screen versus digital acquisition [2013]
    • Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy [2013]
    • Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI [2013]
    • Facility characteristics do not explain higher false-positive rates in diagnostic mammography at facilities serving vulnerable women [2012]
    • Timeliness of follow-up after abnormal screening mammogram: variability of facilities [2011]
    • Effectiveness of computer-aided detection in community mammography practice [2011]
    • Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study [2011]
    • Accuracy of diagnostic mammography at facilities serving vulnerable women [2011]
    • Time trends in radiologists' interpretive performance at screening mammography from the community-based Breast Cancer Surveillance Consortium, 1996-2004 [2010]
    • Performance of first mammography examination in women younger than 40 years [2010]
    • Physician workload in mammography [2008]
    • An assessment of the quality of mammography care at facilities treating medically vulnerable populations [2008]
    • Factors associated with imaging and procedural events used to detect breast cancer after screening mammography [2007]
    • Improving the concordance of mammography assessment and management recommendations [2006]
  • Cancer
    • Mammography screening and risk factor prevalence by sexual identity: A comparison of two national surveys [2025]
    • Performance of digital screening mammography among older women in the U.S [2014]
    • Mammographic Screening Interval in Relation to Tumor Characteristics and False-positive Risk by Race/Ethnicity and Age [2013]
  • Cancer Causes and Control
    • Estimated health outcomes of breast cancer screening in the national breast and cervical cancer early detection program by race/ethnicity [2025]
  • Cancer Epidemiology Biomarkers & Prevention
    • Associations between Insurance Status, Financial Hardship, and Rurality on Receipt of Guideline-Concordant Mammography [2025]
  • Cancer Medicine
    • Adherence to Breast Cancer Screening Guidelines Among Age-Eligible US Women: Findings From NHIS 2021 [2025]
    • Factors associated with mammography use: A side-by-side comparison of results from two national surveys [2020]
  • Centers for Disease Control and Prevention
    • Vital Signs: Mammography Use and Association with Social Determinants of Health and Health-Related Social Needs Among Women — United States, 2022 [2024]
    • Screening for Breast Cancer
    • Mammography
  • DenseBreast-info.org
    • Mammography Screening Guidelines in Average Risk Women
  • Food and Drug Administration
    • Mammography Quality Standards Act (MQSA) and MQSA Program
  • Frontiers in Public Health
    • Social determinants of health and health inequities in breast cancer screening: a scoping review [2024]
  • International Journal of Environmental Research and Public Health
    • Breast Cancer Screening among African Immigrants in the United States: An Integrative Review of Barriers, Facilitators, and Interventions [2024]
    • The Impact of IT-Based Healthcare Communication on Mammography Screening Utilization among Women in the United States: National Health Interview Survey (2011-2018) [2022]
  • JAMA Internal Medicine
    • The Divide Between Breast Density Notification Laws and Evidence-Based Guidelines for Breast Cancer Screening [2015]
  • JAMA Network Open
    • Trends in Mammography Use Among Women Aged 40 to 74 Years in the US, 2002-2022 [2026]
    • Socioeconomic and Geographic Differences in Mammography Trends Following the 2009 USPSTF Policy Update [2025]
    • New Recommendations for Breast Cancer Screening-In Pursuit of Health Equity [2024]
    • Changes to the US Preventive Services Task Force Screening Guidelines and Incidence of Breast Cancer [2024]
    • Inclusion of the US Preventive Services Task Force Recommendation for Mammography in State Comprehensive Cancer Control Plans in the US [2022]
  • JAMA Oncology
    • Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis [2022]
  • Journal of General Internal Medicine
    • Racial Disparities Persist in Cancer Screening: New USPSTF Colorectal Cancer Screening Guidelines Illuminate Inadequate Breast Cancer Screening Guidelines for Black Women [2022]
    • Guideline-Inconsistent Breast Cancer Screening for Women over 50: A Vignette-Based Survey [2014]
  • Journal of the American College of Radiology
    • Associations of State Supplemental Nutrition Assistance Program Eligibility Policies With Mammography [2024]
    • Impact of the COVID-19 Pandemic on Breast Imaging: An Analysis of the National Mammography Database [2022]
  • Journal of the National Cancer Institute
    • Breast cancer screening during the COVID-19 pandemic: moving from disparities to health equity [2023]
  • Journal of Women's Health
    • Screening Mammography Among Older Women: A Review of United States Guidelines and Potential Harms [2019]
    • Prevalence of Out-Of-Pocket Payments for Mammography Screening Among Recently Screened Women [2019]
  • Milbank Quarterly
    • Why Was the US Preventive Services Task Force's 2009 Breast Cancer Screening Recommendation So Objectionable? A Historical Analysis [2022]
  • National Academies of Sciences, Engineering, and Medicine
    • Assessing and Improving the Interpretation of Breast Images [2015]
  • National Cancer Institute
    • Breast Cancer Screening (PDQ®)
  • National Comprehensive Cancer Network
    • NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023 [2023]
  • PLoS ONE
    • Impact of the 2009 US Preventive Services Task Force Guidelines on Screening Mammography Rates on Women in Their 40s [2014]
  • Radiology
    • Registry-based Study of Trends in Breast Cancer Screening Mammography before and after the 2009 U.S. Preventive Services Task Force Recommendations [2014]
  • StatPearls
    • Mammography BI RADS Grading
    • Mammography
    • Breast Cancer Screening in the Average-Risk Patient
  • U.S. Preventive Services Task Force
    • Breast Cancer: Screening [2024]
• Western countries
  • Journal of Clinical Epidemiology
    • Systematic review and meta-analysis of prognostic characteristics for breast cancers in populations with digital vs film mammography indicate the transition may have increased both early detection and overdiagnosis [2024]
• WHO
  • International Agency for Research on Cancer
    • Atlas of breast cancer early detection [2023]
    • Breast Cancer Screening [2016]
    • Breast-Cancer Screening — Viewpoint of the IARC Working Group [2015]
    • Breast self-examination (BSE)
  • World Health Organization
    • WHO position paper on mammography screening [2014]
• WHO Eastern Mediterranean Region
  • WHO Eastern Mediterranean Region
    • Guidelines for the early detection and screening of breast cancer [2006]
• {Related topics}
  • Topic
    • Breast imaging
    • Breast cancer diagnosis
    • Breast cancer
    • Benign breast diseases

Breast cancer stem cells

• International
  • Cancers
    • Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic Strategies [2024]
  • Cells
    • Preclinical and Clinical Trials of New Treatment Strategies Targeting Cancer Stem Cells in Subtypes of Breast Cancer [2023]
• United States
  • International Journal of Molecular Sciences
    • Protein Marker-Dependent Drug Discovery Targeting Breast Cancer Stem Cells [2025]
  • Scientific Reports
    • Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity [2013]
• {Related topics}
  • Topic
    • Breast cancer

Breast cancer treatment

• Africa
  • JCO Global Oncology
    • Adherence to Oral Anticancer Medications Among Women With Breast Cancer in Africa: A Scoping Review [2023]
• Arab countries
  • Health and Quality of Life Outcomes
    • Quality of life in Arab women with breast cancer: a review of the literature [2016]
• Asia
  • BMJ Open
    • Health-related quality of life in Asian patients with breast cancer: a systematic review [2018]
  • Journal of Breast Cancer
    • Patient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice Guide [2016]
  • Systematic Reviews
    • Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: a systematic review and meta-analysis [2024]
• Asia-Pacific
  • Drug Safety
    • Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel [2023]
• Australia
  • Asia-Pacific Journal of Clinical Oncology
    • Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in Australia [2026]
  • Australian Journal of General Practice
    • Update on the management of early-stage breast cancer [2019]
    • Advanced breast cancer [2019]
  • Australian Prescriber
    • Trastuzumab deruxtecan for breast cancer [2022]
  • Breast Cancer Trials
    • Breast Cancer Treatment in Australia
  • Cancer Australia
    • Guidance for the management of early breast cancer: Recommendations and practice points [2020]
  • PLoS ONE
    • Women Commencing Anastrozole, Letrozole or Tamoxifen for Early Breast Cancer: The Impact of Comorbidity and Demographics on Initial Choice [2014]
  • Royal Australian College of General Practitioners
    • Bone loss associated with aromatase inhibitor therapy for breast cancer and androgen deprivation therapy for prostate cancer
• Australia, New Zealand
  • Royal Australian and New Zealand College of Obstetricians and Gynaecologists
    • Tamoxifen and the endometrium [2019]
• Austria
  • Oncologist
    • Influence of the American ODAC Statement on Austrian Bevacizumab Prescribing Practice for Metastatic Breast Cancer [2012]
  • Wiener klinische Wochenschrift
    • Updated Austrian treatment algorithm in HER2+ metastatic breast cancer [2022]
    • Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update [2022]
• Brazil
  • Breast Cancer : Targets and Therapy
    • Lapatinib in patients with metastatic breast cancer following initial treatment with trastuzumab: an economic analysis from the Brazilian public health care perspective [2012]
  • Current Oncology
    • Treatment Disparities, Heterogeneities, and Barriers to Access for Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A National Survey from Brazil [2025]
  • Epidemiologia e Serviços de Saúde
    • Frequency and factors associated with delay in breast cancer treatment in Brazil, according to data from the Oncology Panel, 2019-2020 [2023]
  • International Journal of Environmental Research and Public Health
    • Waiting Time between Breast Cancer Diagnosis and Treatment in Brazilian Women: An Analysis of Cases from 1998 to 2012 [2020]
  • Lancet Global Health
    • Racial disparities in breast cancer survival after treatment initiation in Brazil: a nationwide cohort study [2024]
  • Scientific Reports
    • Incidence of palliative treatment among breast cancer patients undergoing neoadjuvant therapy: an analysis of the Brazilian public health system [2025]
• Bulgaria
  • Frontiers in Public Health
    • Treatment patterns, adherence to international guidelines, and financial mechanisms of the market access of advanced breast cancer therapy in Bulgaria [2023]
• Canada
  • Alberta Health Services
    • Systemic Therapy for Early Breast Cancer - Quick Reference Guide
    • Follow-up Care for Early-Stage Breast Cancer
  • BC Cancer Agency
    • Ixabepilone [2014]
  • Breast Cancer Research and Treatment
    • A Canadian national guideline on the neoadjuvant treatment of invasive breast cancer, including patient assessment, systemic therapy, and local management principles [2022]
    • Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey [2021]
  • Canada's Drug Agency
    • Trastuzumab deruxtecan (Enhertu) [2023]
    • Pertuzumab (Perjeta) [2022]
    • Regional Chemotherapy for the Treatment of Breast Cancer: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines [2018]
  • Canadian Family Physician
    • Breast Cancer Survivorship Tool [2020]
    • Follow-up after treatment for breast cancer: Practical guide to survivorship care for family physicians [2016]
  • Canadian Journal of Physiology and Pharmacology
    • Preventing broken hearts in women with breast cancer: a concise review on chemotherapy-mediated cardiotoxicity [2024]
  • Cancers
    • Efficacy of Fulvestrant in Women with Hormone-Resistant Metastatic Breast Cancer (mBC): A Canadian Province Experience [2021]
  • Current Oncology
    • Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update) [2026]
    • Multidisciplinary Practical Guidance for Implementing Adjuvant CDK4/6 Inhibitors for Patients with HR-Positive, HER2-Negative Early Breast Cancer in Canada [2025]
    • Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Setting [2024]
    • An Overview of Long-Acting GnRH Agonists in Premenopausal Breast Cancer Patients: Survivorship Challenges and Management [2024]
    • Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective [2023]
    • Management of Oligometastatic Breast Cancer: An Expert Committee's Opinion [2023]
    • Key Considerations for the Treatment of Advanced Breast Cancer in Older Adults: An Expert Consensus of the Canadian Treatment Landscape [2023]
    • Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain [2022]
    • Systemic treatment approaches in her2-negative advanced breast cancer—guidance on the guidelines [2015]
    • Optimal systemic therapy for early breast cancer in women: a clinical practice guideline [2015]
    • Endocrine therapy for postmenopausal women with hormone receptor–positive her2–negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement [2013]
    • Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor–positive metastatic breast cancer in Canada [2013]
  • Journal of Bone Oncology
    • Are adjuvant bisphosphonates now standard of care of women with early stage breast cancer? A debate from the Canadian Bone and the Oncologist New Updates meeting [2015]
  • Ontario Health
    • Systemic targeted therapy for her2-positive early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline [2015]
    • Adjuvant endocrine therapy for early breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline [2015]
    • Adjuvant chemotherapy for early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline [2015]
    • Cancer Care Ontario’s Position Statement on Guidelines for Breast Cancer Well Follow-Up Care [2012]
    • Tamoxifen
    • Paclitaxel
    • Letrozole
    • Gemcitabine
    • Fulvestrant
    • Exemestane
    • Docetaxel
    • Capecitabine
    • Anastrozole
• Canada, Europe
  • Breast Cancer
    • Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual disease following neoadjuvant therapy [2024]
• Canada, United States
  • American Society of Clinical Oncology
    • Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update [2022]
    • Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline [2017]
  • CA: A Cancer Journal for Clinicians
    • Clinical practice guidelines on the evidence-based use of integrative therapies during and following breast cancer treatment [2017]
• Central and Eastern Europe
  • Pathology & Oncology Research
    • Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer [2022]
    • Breast Cancer Survivorship Programme: Follow-Up, Rehabilitation, Psychosocial Oncology Care. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer [2022]
• China
  • Annals of Translational Medicine
    • Chemotherapy or endocrine therapy, first-line treatment for patients with hormone receptor-positive HER2-negative metastatic breast cancer in China: a real-world study [2021]
  • Breast
    • Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study [2023]
  • Cancer Biology & Medicine
    • Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification [2022]
  • Cancer Chemotherapy and Pharmacology
    • Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer [2020]
  • Cancer Innovation
    • Clinical practice guidelines for full-cycle standardized management of bone health in breast cancer patients [2024]
  • Cancer Medicine
    • Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation-wide multicenter study [2021]
  • Chinese Medical Journal
    • Clinical practice guidelines for neoadjuvant therapy in patients with early-stage breast cancer: Chinese Society of Breast Surgery practice guidelines 2022 [2024]
    • Clinical practice guidelines for breast cancer implantable intravenous infusion ports: Chinese Society of Breast Surgery practice guidelines 2021 [2021]
  • Clinical Breast Cancer
    • Cost-Effectiveness Analysis of Adjuvant Endocrine Therapy With Ovarian Suppression in Premenopausal Patients With Hormone Receptor-Positive Early Breast Cancer in China [2024]
  • Frontiers in Oncology
    • Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: A Nation-Wide Multicenter Epidemiological Study in China [2021]
  • Frontiers in Public Health
    • The outcome of neoadjuvant chemotherapy and the current trend of surgical treatment in young women with breast cancer: A multicenter real-world study (CSBrS-012) [2023]
  • Journal of Cachexia, Sarcopenia and Muscle
    • Cost-Effectiveness of Fracture Prevention in Postmenopausal Women With Early Breast Cancer in China [2025]
  • Journal of Evidence-Based Medicine
    • Using Integrative Therapies to Improve Patient-Reported Outcomes in Breast Cancer Survivors: A Living Evidence-Based Clinical Practice Guideline [2025]
  • Journal of Oncology
    • Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China [2021]
  • OncoTargets and Therapy
    • Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective [2016]
    • Lapatinib for the treatment of breast cancer in the People’s Republic of China [2014]
  • PLoS ONE
    • Pyrotinib versus lapatinib therapy for HER2 positive metastatic breast cancer patients after first-line treatment failure: A meta-analysis and systematic review [2023]
  • Scientific Reports
    • Cost-effectiveness of CDK4/6 inhibitors for second-line HR+/HER2- advanced or metastatic breast cancer in China [2025]
  • Supportive Care in Cancer
    • Financial toxicity in female patients with breast cancer: a national cross-sectional study in China [2022]
  • Translational Breast Cancer Research
    • A round table discussion: clinical landscape of trastuzumab deruxtecan in breast cancer: a retrospective and prospective view [2022]
• China, United States
  • Breast
    • Cost-effectiveness of inavolisib plus palbociclib-fulvestrant versus palbociclib plus fulvestrant as first-line treatment in HR+/HER2-advanced breast cancer [2026]
  • JAMA Network Open
    • Trends in Disparities and Transitions of Treatment in Patients With Early Breast Cancer in China and the US, 2011 to 2021 [2023]
• Denmark
  • Acta Oncologica
    • Survival outcomes for HER2-low breast cancer: Danish national data [2024]
    • Capecitabine monotherapy as first-line treatment in advanced HER2-normal breast cancer - a nationwide, retrospective study [2024]
  • Breast Cancer Research and Treatment
    • A direct comparison of classical oral Navelbine vs metronomic Navelbine in metastatic breast cancer: results from the Danish Breast Cancer Group's (DBCG) NAME-trial [2025]
  • Journal of the National Cancer Institute
    • The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis [2022]
• Egypt
  • Journal of the Egyptian National Cancer Institute
    • Primary therapy of early breast cancer: Egyptian view of 2021 St. Gallen consensus [2022]
• Europe
  • Annals of Oncology
    • Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel [2016]
  • BMC Cancer
    • Patterns of resource utilization and cost for postmenopausal women with hormone-receptor–positive, human epidermal growth factor receptor-2–negative advanced breast cancer in Europe [2015]
  • BMC Health Services Research
    • Adherence to breast cancer guidelines is associated with better survival outcomes: a systematic review and meta-analysis of observational studies in EU countries [2020]
  • Breast
    • Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective [2017]
  • Clinical Breast Cancer
    • A European, Observational Study of Endocrine Therapy Administration in Patients With an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer [2017]
  • Critical Reviews in Oncology/Hematology
    • Systemic treatment for hormone receptor-positive/HER2-negative advanced/metastatic breast cancer: A review of European real-world evidence studies [2022]
  • ESMO Open
    • Flexible care in breast cancer [2021]
  • European Medicines Agency
    • Xeloda
    • Tyverb
    • Tukysa
    • Taxotere
    • Perjeta
    • Nerlynx
    • Herceptin
    • Faslodex
    • Enhertu
    • Abraxane
  • European Menopause and Andropause Society
    • Osteoporosis management in patients with breast cancer: EMAS position statement [2017]
  • European Society for Medical Oncology
    • Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies [2020]
  • European Society of Breast Cancer Specialists
    • EUSOMA quality indicators for non-metastatic breast cancer: An update [2024]
    • European Society of Breast Cancer Specialists/Advanced Breast Cancer Global Alliance quality indicators for metastatic breast cancer care [2023]
  • Journal of Cancer Research and Clinical Oncology
    • Therapy delay due to COVID-19 pandemic among European women with breast cancer: prevalence and associated factors [2023]
• Europe, United States
  • Cancer Treatment Reviews
    • Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality [2022]
  • Cancers
    • FDA and EMA Approvals of New Breast Cancer Drugs—A Comparative Regulatory Analysis [2020]
  • Clinical Breast Cancer
    • Optimal Strategies for Successful Initiation of Neratinib in Patients with HER2-Positive Breast Cancer [2021]
  • Current Oncology
    • Association of the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) Scores with Guideline Recommendations in Breast Cancer [2026]
• Finland
  • European Journal of Health Economics
    • Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland [2024]
  • Pharmacoepidemiology and Drug Safety
    • Age, Age-Related Comorbidities and Survival in Palbociclib, Ribociclib and Abemaciclib Users With Advanced Breast Cancer: A Nation-Wide Retrospective Cohort Study [2026]
• France
  • BMC Medicine
    • Are breast cancer patients with suboptimal adherence to cardiovascular treatment more likely to discontinue adjuvant endocrine therapy? Competing risk survival analysis in a nationwide cohort of postmenopausal women [2023]
  • Breast Cancer Research and Treatment
    • Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare database [2024]
  • ESMO Open
    • Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort [2024]
  • European Journal of Cancer
    • Recent treatment and survival trends in older versus younger women with HR-positive HER2-negative metastatic breast cancer in the real-life multicenter French ESME cohort [2026]
  • Haute Autorité de Santé
    • PHESGO (pertuzumab, trastuzumab) [2021]
    • NERLYNX [2020]
  • International Journal of Cancer
    • Optimizing the integration of modern systemic therapies and advanced radiotherapy techniques in breast cancer management: An expert opinion from the Institut Curie Breast Radiotherapy Group [2026]
  • JAMA Network Open
    • Comparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France [2022]
• Germany
  • BMC Cancer
    • The adherence paradox: guideline deviations contribute to the increased 5-year survival of breast cancer patients [2015]
    • Trastuzumab in advanced breast cancer - a decade of experience in Germany [2014]
  • Breast Cancer
    • Adjuvant chemotherapeutic treatment of 1650 patients with early breast cancer in routine care in Germany: data from the prospective TMK cohort study [2018]
  • Breast Care
    • International Consensus Conference for Advanced Breast Cancer, Lisbon 2019: ABC5 Consensus - Assessment by a German Group of Experts [2020]
    • Treatment of Early Breast Cancer Patients: Evidence, Controversies, Consensus: Focusing on Systemic Therapy – German Experts' Opinions for the 16th International St. Gallen Consensus Conference (Vienna 2019) [2019]
    • ABC4 Consensus: Assessment by a German Group of Experts [2018]
    • ABC3 Consensus: Assessment by a German Group of Experts [2016]
    • 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus – Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts [2015]
    • Guideline Conformity Treatment in Young Women with Early-Onset Breast Cancer in Germany [2014]
    • Breast Cancer and Osteoporosis – Management of Cancer Treatment-Induced Bone Loss in Postmenopausal Women with Breast Cancer [2014]
    • 13th St. Gallen International Breast Cancer Conference 2013: Primary Therapy of Early Breast Cancer Evidence, Controversies, Consensus – Opinion of a German Team of Experts (Zurich 2013) [2013]
    • Adopting Guidelines into Clinical Practice: Implementation of Trastuzumab in the Adjuvant Treatment of Breast Cancer in Lower Saxony, Germany, in 2007 [2011]
  • Deutsche Gesellschaft für Radioonkologie
    • Post-neoadjuvant treatment with capecitabine and trastuzumab emtansine in breast cancer patients-sequentially, or better simultaneously? [2021]
  • Geburtshilfe und Frauenheilkunde
    • Treatment of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: German Expert Opinions on the 17th International St. Gallen Consensus Conference [2021]
    • AGO Algorithms for the Treatment of Breast Cancer: Update 2021 [2021]
    • Use of Taxanes in Metastatic HER2-negative Breast Cancer – a Status Report [2020]
    • ABC5 International Consensus Conference on Advanced Breast Cancer, Lisbon, 16 November 2019: Commentary by the German panel of experts on the ABC5 voting results [2020]
    • Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer [2018]
    • 4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017 : ABC4 Consensus: Assessment by a Panel of German Experts [2018]
    • Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus [2017]
    • ABC3 Consensus Commented from the Perspective of the German Guidelines [2016]
    • Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015) [2015]
  • Institute for Quality and Efficiency in Health Care
    • Palbociclib (breast cancer) - Benefit assessment according to §35a Social Code Book V [2017]
  • International Journal of Cancer
    • A cost-effectiveness analysis of breast cancer treatment in certified versus non-certified hospitals in Germany [2026]
    • Time trends of neoadjuvant chemotherapy for early breast cancer [2020]
  • Journal of Cancer Research and Clinical Oncology
    • The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer - the SERAPHINA study [2025]
    • Contributing and limiting factors to guideline-adherent therapy in senior and elderly breast cancer patients: a questionnaire-based cross-sectional study using clinical and cancer registry data in Germany [2023]
  • Oncology Research and Treatment
    • Treatment Navigation in Breast Cancer Management: Process Cost Analysis Based on German Case Studies [2026]
• Ghana
  • PLoS ONE
    • Geospatial availability of breast cancer treatment modalities and hypothetical access improvement in Ghana: A nationwide survey [2023]
• Greece
  • BMC Cancer
    • Real-world management strategies and clinical outcomes of metastatic HER2-positive breast cancer in Greece in the second-line setting and beyond (the togetHER study) [2025]
  • BMC Health Services Research
    • Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line treatment of hormone receptor-positive metastatic breast cancer in Greece: An economic evaluation study [2015]
• High-income countries
  • Aging
    • Bisphosphonates and breast cancer survival: a meta-analysis and trial sequential analysis of 81508 participants from 23 prospective epidemiological studies [2021]
  • Cancer Reports
    • Tamoxifen use and risk of endometrial cancer in breast cancer patients: A systematic review and dose-response meta-analysis [2023]
  • JMIR Cancer
    • Use of AI to Predict and Support Medication Adherence in Patients With Breast Cancer: Systematic Review [2026]
  • Journal of Breast Cancer
    • Bisphosphonates and Prevention of the Perimenopausal Breast Cancer Recurrence: A Systematic Review and Meta-Analysis [2022]
  • Lancet
    • Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors in 22 031 postmenopausal women already treated with at least 5 years of endocrine therapy [2025]
• Hong Kong
  • Hong Kong Medical Journal
    • Preoperative considerations and benefits of neoadjuvant chemotherapy: insights from a 12-year review of the Hong Kong Breast Cancer Registry [2023]
    • Cost-minimisation analysis of intravenous versus subcutaneous trastuzumab regimen for breast cancer management in Hong Kong [2023]
• India
  • Indian Journal of Medical Research
    • Consensus on contentious issues relevant for breast cancer management for the Indian scenario: Statements following a multicentre expert group meeting [2021]
    • Breast cancer survivorship in India [2021]
  • Indian Journal of Surgery
    • Indian Solutions for Indian Problems—Association of Breast Surgeons of India (ABSI) Practical Consensus Statement, Recommendations, and Guidelines for the Treatment of Breast Cancer in India [2017]
  • JCO Global Oncology
    • Cost-Effectiveness Analysis of Denosumab in the Prevention of Skeletal-Related Events Among Patients With Breast Cancer With Bone Metastasis in India [2024]
    • Cost Effectiveness of Trastuzumab for Management of Breast Cancer in India [2020]
  • South Asian Journal of Cancer
    • Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in India [2021]
• Indonesia
  • PLoS ONE
    • Economic evaluation of trastuzumab in HER2-positive early breast cancer in Indonesia: A cost-effectiveness analysis [2024]
• International
  • Annals of Oncology
    • Tailoring treatment to cancer risk and patient preference: the 2025 St Gallen International Breast Cancer Consensus Statement on individualizing therapy for patients with early breast cancer [2025]
    • Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023 [2023]
    • Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 [2021]
    • Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 [2015]
  • Annals of Surgical Oncology
    • St. Gallen International Breast Cancer Consensus-Based Clinical Decision Validation: Concordance Assessment Between Deep Large Language Model Outputs and Global Expert Panel Recommendations [2026]
  • Asian Pacific Journal of Cancer Prevention
    • Pertuzumab and Pathological Complete Response in Early HER2+ Breast Cancer: A Systematic Review and Meta-analysis of Real-World Studies [2026]
  • Biomedicines
    • Systematic Review on the Use of Biosimilars of Trastuzumab in HER2+ Breast Cancer [2022]
  • BMJ Open
    • Evidence-based recommendations on care for breast cancer survivors for primary care providers: a review of evidence-based breast cancer guidelines [2017]
  • Breast
    • The effects of adjuvant endocrine therapy on long-term outcomes from ductal carcinoma in situ: a systematic review and meta-analysis [2025]
    • Reducing stigma, isolation, and misconceptions in advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 8) [2025]
    • Meeting the informational needs of people with advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 6) [2025]
    • Increasing awareness of and referral to support services in advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 7) [2025]
    • Improving the quality of life of people with advanced breast cancer: a global expert review and call-to-action for 2025-2035 (goal 3) [2025]
    • Improving survival outcomes of people with ABC: a global expert review and call-to-action for 2025-2035 (Goal 1) [2025]
    • Improving equitable access to comprehensive care for people with advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 9) [2025]
    • Improving communication between healthcare professionals and patients living with advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 5) [2025]
    • Ensuring access to multidisciplinary care in advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 4) [2025]
    • Collecting high-quality data for advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 2) [2025]
    • Clinical and economic research of bone modifiers as adjuvant therapy for early breast cancer: A systematic literature review [2025]
    • Advancing the legal rights of people with advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 10) [2025]
    • Global representativeness and impact of funding sources in cost-effectiveness research on systemic therapies for advanced breast cancer: A systematic review [2024]
    • 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7) [2024]
    • The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A quantitative systematic review [2022]
    • Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: A systematic review [2022]
    • Customizing early breast cancer therapies - The 2021 St. Gallen International Breast Cancer Consensus Conference [2022]
    • Anthracyclines in the treatment of early breast cancer friend or foe? [2022]
    • Quality and reporting of clinical guidelines for breast cancer treatment: A systematic review [2020]
  • Breast Cancer Research and Treatment
    • Pharmacological interventions for anthracycline-induced cardiotoxicity in breast cancer: a systematic review and meta-analysis of randomized controlled trials [2025]
  • Breast Care
    • St. Gallen/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer [2021]
    • St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment [2019]
  • Breast Health Global Initiative
    • Breast cancer treatment: A phased approach to implementation [2020]
  • British Journal of Cancer
    • Systematic review of clinical practice guidelines for long-term breast cancer survivorship: assessment of quality and evidence-based recommendations [2025]
  • Cancer Genomics & Proteomics
    • Pharmacogenetics of Toxicities Related to Endocrine Treatment in Breast Cancer: A Systematic Review and Meta-analysis [2024]
  • Cancer Medicine
    • Tyrosine kinase inhibitors in HER2-positive breast cancer brain metastases: A systematic review and meta-analysis [2023]
    • Fulvestrant in the treatment of hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: A review [2019]
  • Cancer Treatment Reviews
    • Revisiting ovarian function suppression with GnRH agonists for premenopausal women with breast cancer: Who should use and the impact on survival outcomes [2024]
    • Risk-based decision-making in the treatment of HER2-positive early breast cancer: Recommendations based on the current state of knowledge [2021]
  • Clinical and Translational Science
    • Pharmacogenetics of taxane-induced neurotoxicity in breast cancer: Systematic review and meta-analysis [2022]
  • Clinical Breast Cancer
    • Prognostic Value of Immune-Inflammation Indexes for Breast Cancer Patients Undergoing Endocrine Therapy: A Systematic Review and Meta-analysis [2025]
  • Clinical Pharmacology & Therapeutics
    • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy [2018]
  • Cochrane Database of Systematic Reviews
    • Psychological interventions for women with non-metastatic breast cancer [2023]
    • Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer [2022]
    • Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer [2021]
    • Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer [2020]
    • Taxanes for adjuvant treatment of early breast cancer [2019]
    • Fulvestrant for hormone-sensitive metastatic breast cancer [2017]
    • Bisphosphonates and other bone agents for breast cancer [2017]
  • Critical Reviews in Oncology/Hematology
    • Trastuzumab deruxtecan in breast cancer [2024]
    • Adjuvant treatment with trastuzumab of patients with HER2-positive, T1a-bN0M0 breast tumors: A systematic review and meta-analysis [2023]
  • Cureus
    • A Comprehensive Review of Taxane Treatment in Breast Cancer: Clinical Perspectives and Toxicity Profiles [2024]
  • Current Breast Cancer Reports
    • Incidence, Diagnosis, and Treatment of Cardiac Toxicity from Trastuzumab in Patients with Breast Cancer [2017]
  • Current Oncology
    • Risk of Cardiovascular Events and Lipid Profile Change in Patients with Breast Cancer Taking Aromatase Inhibitor: A Systematic Review and Meta-Analysis [2023]
  • ESMO Open
    • Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysis [2022]
  • European Society for Medical Oncology
    • 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) [2020]
    • 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4) [2018]
    • 3rd ESO–ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3) [2017]
  • Experimental and Therapeutic Medicine
    • Tyrosine kinase inhibitors in breast cancer (Review) [2022]
  • Expert Review of Pharmacoeconomics & Outcomes Research
    • Quality-adjusted life years for HER2-positive, early-stage breast cancer using trastuzumab-containing regimens in the context of cost-effectiveness studies: a systematic review [2024]
    • Economic evaluation of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer: systematic review and quality assessment [2021]
  • Frontiers in Oncology
    • Pertuzumab combined with trastuzumab compared to trastuzumab in the treatment of HER2-positive breast cancer: A systematic review and meta-analysis of randomized controlled trials [2022]
    • Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs [2019]
  • Frontiers in Pharmacology
    • Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis [2023]
    • Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer [2022]
  • Geburtshilfe und Frauenheilkunde
    • Update Breast Cancer 2021 Part 3 – Current Developments in the Treatment of Early Breast Cancer: Review and Assessment of Specialised Treatment Scenarios by an International Expert Panel [2021]
  • Health Expectations
    • Shared decision making in breast cancer treatment guidelines: Development of a quality assessment tool and a systematic review [2020]
  • International Journal of Environmental Research and Public Health
    • Applications of Artificial Intelligence (AI) in Breast Cancer Care Delivery and Education: A Scoping Review [2026]
  • International Journal of Molecular Sciences
    • Pertuzumab in Combination with Trastuzumab and Docetaxel as Adjuvant Doublet Therapy for HER2-Positive Breast Cancer: A Systematic Review [2025]
    • Epothilones as Natural Compounds for Novel Anticancer Drugs Development [2023]
  • JAMA Network Open
    • Cardiotoxic Effects of Antibody Drug Conjugates vs Standard Chemotherapy in ERBB2-Positive Advanced Breast Cancer: A Systematic Review and Meta-Analysis [2025]
  • JCO Clinical Cancer Informatics
    • Mapping the Evidence on the Impact of mHealth Interventions on Patient-Reported Outcomes in Patients With Breast Cancer: A Systematic Review [2024]
  • JCO Global Oncology
    • Are NCCN Resource-Stratified Guidelines for Breast Cancer Systemic Therapy Achievable? A Population-Based Study of Global Need and Economic Impact [2021]
  • Journal of Bone Oncology
    • Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG [2017]
  • Journal of Cancer
    • Addition of Capecitabine in Breast Cancer First-line Chemotherapy Improves Survival of Breast Cancer Patients [2019]
  • Journal of Cancer Survivorship
    • Strategies to self-manage side-effects of adjuvant endocrine therapy among breast cancer survivors: an umbrella review of empirical evidence and clinical guidelines [2022]
  • Journal of Comparative Effectiveness Research
    • A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib [2024]
  • Journal of Managed Care & Specialty Pharmacy
    • Impact of CDK4/6 inhibitors on health-related quality of life outcomes in patients with metastatic breast cancer: A systematic review and meta-analysis [2025]
  • Journal of the National Cancer Institute
    • Taxanes for the treatment of breast cancer during pregnancy: an international cohort study [2024]
  • Molecular and Clinical Oncology
    • Anthracycline-induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment [2019]
  • Molecular Medicine
    • Neratinib for HER2-positive breast cancer with an overlooked option [2020]
  • npj Breast Cancer
    • Evidence-based guidelines for managing patients with primary ER+ HER2- breast cancer deferred from surgery due to the COVID-19 pandemic [2020]
  • Oncologist
    • Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel [2022]
  • Oncotarget
    • Role of cooperative groups and funding source in clinical trials supporting guidelines for systemic therapy of breast cancer [2018]
  • Patient
    • Differences in Preferences for Drug Therapy Between Patients with Metastatic Versus Early-Stage Breast Cancer: A Systematic Literature Review [2024]
  • Plants
    • Current Perspectives on Taxanes: Focus on Their Bioactivity, Delivery and Combination Therapy [2021]
  • PLoS ONE
    • The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis [2022]
    • The adverse effects of bisphosphonates in breast cancer: A systematic review and network meta-analysis [2021]
    • Global treatment costs of breast cancer by stage: A systematic review [2018]
  • Revista Peruana de Medicina Experimental y Salud Pu´blica
    • Trastuzumab-emtansine versus other anti-HER2 regimens in early or unresectable or metastatic HER-2 positive breast cancer: systematic review and network meta-analysis [2024]
  • Supportive Care in Cancer
    • MASCC/ISOO Clinical Practice Statement: Adjuvant bone-modifying agents in primary breast cancer patients - prevention of medication-related osteonecrosis of the jaw [2024]
  • Systematic Reviews
    • Chemotherapy-related cardiotoxicity and its symptoms in patients with breast cancer: a scoping review [2024]
  • Targeted Oncology
    • A Decade After Approval of the First CDK4/6 Inhibitor: A Look Back at Palbociclib's Journey from Discovery to Approval and What's Next in CDK Inhibition in Breast Cancer [2025]
  • Therapeutic Advances in Medical Oncology
    • The incidence and relative risk of adverse events in patients treated with bisphosphonate therapy for breast cancer: a systematic review and meta-analysis [2019]
• Iran
  • BMC Health Services Research
    • Trastuzumab deruxtecan versus trastuzumab emtansine for human epidermal growth factor receptor 2 positive metastatic breast cancer: cost-effectiveness analysis from Iranian experience [2025]
  • PharmacoEconomics
    • Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy [2018]
• Ireland
  • Ireland's Health Services
    • Breast SACT Regimens
• Ireland, Netherlands
  • PLoS ONE
    • Treatment Strategies and Survival of Older Breast Cancer Patients – An International Comparison between the Netherlands and Ireland [2015]
• Italy
  • BMC Cancer
    • An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project [2018]
  • Breast
    • Influence of adherence with guideline-driven recommendations on survival in women operated for breast cancer: Real-life evidence from Italy [2020]
  • Cancer Treatment Reviews
    • Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project [2024]
  • Critical Reviews in Oncology/Hematology
    • The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus report [2025]
  • ESMO Open
    • Multidisciplinary clinical guidelines in proactive monitoring, early diagnosis, and effective management of trastuzumab deruxtecan (T-DXd)-induced interstitial lung disease (ILD) in breast cancer patients [2023]
  • Future Oncology
    • Management of trastuzumab deruxtecan-related adverse events in breast cancer: Italian expert panel recommendations [2025]
  • Oncologist
    • Cardiovascular risk after adjuvant trastuzumab in early breast cancer: an Italian population-based cohort study [2020]
  • Tumori
    • The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives [2025]
• Italy, Spain
  • Breast
    • "Positioning of tucatinib in the new clinical scenario of HER2-positive metastatic breast cancer: An Italian and Spanish consensus paper" [2024]
• Japan
  • Breast
    • Chemotherapy is associated with differential survival outcomes in apocrine carcinoma: A nationwide cohort study from the Japanese National Clinical Database-Breast Cancer Registry [2026]
  • Breast Cancer
    • Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines [2024]
    • The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment [2024]
    • Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese Community [2024]
    • The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition [2023]
    • The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition [2020]
    • Evidence produced in Japan: tegafur-based preparations for postoperative chemotherapy in breast cancer [2013]
  • Breast Cancer Research and Treatment
    • A population-based recurrence risk management study of patients with pT1 node-negative HER2+ breast cancer: a National Clinical Database study [2019]
  • Molecular and Clinical Oncology
    • Pertuzumab for the treatment of patients with human epidermal growth factor receptor 2-positive breast cancer in Japan [2015]
• Latin America
  • JCO Global Oncology
    • Advanced Breast Cancer Guidelines in Latin America: Assessment, Adaptation, and Implementation of Fifth Advanced Breast Cancer Consensus Guidelines [2024]
• Latin America and the Caribbean
  • Oncologist
    • Health-Related Quality of Life in Patients with Breast Cancer in Latin America and the Caribbean: A Systematic Review and Meta-Analysis [2021]
• Lebanon
  • BMC Cancer
    • Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients [2015]
• Lithuania
  • Medicina
    • Guidelines for diagnostics and treatment of aromatase inhibitor-induced bone loss in women with breast cancer: A consensus of Lithuanian medical oncologists, radiation oncologists, endocrinologists, and family medicine physicians [2014]
• Low and middle income countries
  • BMC Cancer
    • Essential medicines for breast cancer in low and middle income countries [2015]
  • Breast Health Global Initiative
    • Supportive care during treatment for breast cancer: Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement [2013]
    • Supportive care after curative treatment for breast cancer (survivorship care): Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement [2013]
• Morocco
  • Breast Journal
    • Management of breast cancer during COVID-19 pandemic in Morocco [2020]
• Netherlands
  • Acta Oncologica
    • Impact of age and comorbidities on real-world outcomes in advanced breast cancer patients treated with palbociclib in first line: a nation-wide Danish retrospective study [2025]
  • BMC Cancer
    • Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands [2016]
  • Breast
    • Less endocrine therapy in HR+/HER2- breast cancer: a nationwide trend despite unchanged guidelines [2026]
    • Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and 5-year survival [2022]
  • Breast Cancer Research and Treatment
    • Characteristics, treatment and survival in de novo and metachronous metastatic breast cancer: a nationwide comparative analysis [2026]
    • Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry [2024]
    • The increasing importance of histologic grading in tailoring adjuvant systemic therapy in 30,843 breast cancer patients [2021]
    • The association of socioeconomic status on treatment strategy in patients with stage I and II breast cancer in the Netherlands [2021]
    • Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry [2021]
  • British Journal of Cancer
    • Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer [2018]
  • European Journal of Cancer
    • Health economic outcomes and costs of CDK4/6 inhibitor use in first- versus second-line for advanced breast cancer: A cost-effectiveness analysis of the phase 3 SONIA trial [2025]
• Netherlands, United Kingdom
  • European Journal of Cancer
    • Differences in treatment and survival of older patients with operable breast cancer between the United Kingdom and the Netherlands - A comparison of two national prospective longitudinal multi-centre cohort studies [2022]
• New Zealand
  • Breast
    • New Zealand experience with implementation of the ESO-ESMO consensus guidelines for advanced breast cancer-report of achievements and lessons learned [2022]
  • Breast Cancer Foundation NZ
    • 2nd New Zealand Consensus Guidelines for Advanced Breast Cancer (ABC-NZ2) [2022]
  • International Journal of Environmental Research and Public Health
    • Use of Non-Cancer Medications in New Zealand Women at the Diagnosis of Primary Invasive Breast Cancer: Prevalence, Associated Factors and Effects on Survival [2020]
  • PLoS Medicine
    • Adjuvant Trastuzumab in HER2-Positive Early Breast Cancer by Age and Hormone Receptor Status: A Cost-Utility Analysis [2016]
• Nigeria
  • ecancermedicalscience
    • Assessment of guideline adherence in breast cancer management among oncologists in Nigeria [2021]
  • JAMA Network Open
    • Health Care Professional Adherence to Breast Cancer Management Guidelines in Nigeria [2025]
• Norway
  • Breast Cancer Research and Treatment
    • Stage-specific survival has improved for young breast cancer patients since 2000: but not equally [2020]
• Philippines
  • BMC Health Services Research
    • Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines [2019]
• Poland
  • Contemporary Oncology
    • Evaluation of vinorelbine-based chemotherapy as the second or further-line treatment in patients with metastatic breast cancer [2013]
• Republic of Korea
  • BMC Cancer
    • Multimodal treatments and the risk of breast cancer-related lymphedema: insights from a nationally representative cohort in South Korea [2025]
  • Breast
    • Clinical effect of bisphosphonate in patients with hormone receptor-positive early breast cancer: A nationwide real-world data analysis [2026]
    • Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (-) metastatic breast cancer patients in Korea (KCSG BR21-15) [2025]
  • Cancer Research and Treatment
    • Quality Assessment and Trend for Breast Cancer Treatment Practice across South Korea Based on Nationwide Analysis of Korean Health Insurance Data during 2013-2017 [2023]
  • ClinicoEconomics and Outcomes Research
    • Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea [2016]
  • Frontiers in Oncology
    • Effect of Tamoxifen on the Risk of Osteoporosis and Osteoporotic Fracture in Younger Breast Cancer Survivors: A Nationwide Study [2020]
  • Journal of Breast Cancer
    • Differences in Clinical Outcomes between Luminal A and B Type Breast Cancers according to the St. Gallen Consensus 2013 [2015]
    • Meeting Highlights: The First Korean Breast Cancer Treatment Consensus Conference [2014]
  • Journal of Korean Medical Science
    • Nationwide Analysis of Treatment Patterns for Korean Breast Cancer Survivors Using National Health Insurance Service Data [2018]
  • Journal of the American Heart Association
    • Effects of Endocrine Therapy on Cardiovascular Diseases and Type 2 Diabetes Among Breast Cancer Survivors: The National Health Insurance Service Database of Korea [2022]
  • Medicina
    • Osteoporosis Associated with Breast Cancer Treatments Based on Types of Hormonal Therapy: A Cross-Sectional Study Using Korean National Sample Data [2023]
  • Nutrients
    • Adherence to Guidelines for Cancer Survivors and Health-Related Quality of Life among Korean Breast Cancer Survivors [2015]
  • Osteoporosis International
    • Differential fracture risk in breast cancer patients based on endocrine therapy and age: a nationwide cohort study [2025]
  • Scientific Reports
    • Risk factors for and incidence of osteoporosis in patients with breast cancer by gender : a nationwide cohort study [2025]
  • Women’s Health Nursing
    • Rebuilding life after breast cancer treatment among Korean breast cancer survivors: an integrative review [2026]
• Serbia
  • JBUON
    • Serbian consensus of neoadjuvant therapy for breast cancer: NeoPULSE [2018]
• Singapore
  • Annals Academy of Medicine Singapore
    • Singapore Cancer Network (SCAN) Guidelines for Bisphosphonate Use in the Adjuvant Breast Cancer Setting [2015]
    • Singapore Cancer Network (SCAN) Guidelines for Adjuvant Trastuzumab Use in Early Stage HER2 Positive Breast Cancer [2015]
  • JCO Clinical Cancer Informatics
    • Augmenting Large Language Models With National Comprehensive Cancer Network Guidelines for Improved and Standardized Adjuvant Therapy Recommendations in Postoperative Breast Cancer Cases [2025]
  • Scientific Reports
    • Impact of deviation from guideline recommended treatment on breast cancer survival in Asia [2020]
• South Africa
  • Breast Cancer Research and Treatment
    • The impact of HIV on non-adherence for tamoxifen among women with breast cancer in South Africa [2023]
• Spain
  • BMJ Quality & Safety
    • Socioeconomic inequalities in adherence to clinical practice guidelines and breast cancer survival: a multicentre population-based study in Spain [2025]
  • Breast Cancer Research and Treatment
    • Adherence of long-term breast cancer survivors to follow-up care guidelines: a study based on real-world data from the SURBCAN cohort [2022]
  • Clinical and Translational Oncology
    • Safety profile of trastuzumab deruxtecan in advanced breast cancer: Expert opinion on adverse event management [2024]
    • Management of early-stage HER2-positive breast cancer and attitudes towards HER2DX test in Spain: insights from a nationwide survey [2024]
    • Galician consensus on management of cardiotoxicity in breast cancer: risk factors, prevention, and early intervention [2017]
    • Defining the optimal sequence for the systemic treatment of metastatic breast cancer [2016]
  • Health and Quality of Life Outcomes
    • Health-related quality of life in Spanish breast cancer patients: a systematic review [2011]
  • Journal of Drug Assessment
    • Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists [2019]
  • Oncologist
    • GEICAM Guidelines for the Management of Patients with Breast Cancer During Spain's COVID-19 Pandemic [2020]
  • Scientific Reports
    • Adequacy of early-stage breast cancer systemic adjuvant treatment to Saint Gallen-2013 statement: the MCC-Spain study [2021]
  • Sociedad Española de Oncología Médica
    • SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (UPDATE 2025) [2026]
    • SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (UPDATE 2025) [2026]
    • Strategies to enhance management of HER2-positive breast cancer in the elderly: an expert consensus perspective [2025]
    • SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (2022) [2023]
    • SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022) [2023]
    • Expert consensus to optimize the treatment of elderly patients with luminal metastatic breast cancer [2022]
    • SEOM clinical guidelines in early stage breast cancer (2018) [2019]
    • SEOM clinical guidelines in advanced and recurrent breast cancer (2018) [2019]
    • Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of General Medicine (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish Society for General and Family Physicians (SEMG), Spanish Society of Obstetrics and Gynecology (SEGO), Spanish Society of Radiation Oncology (SEOR), Spanish Society of Senology and Breast Pathology (SESPM), and Spanish Society of Cardiology (SEC) [2018]
    • SEOM clinical guidelines in metastatic breast cancer 2015 [2015]
• Sub-Saharan Africa
  • BMJ Open
    • Adherence to Choosing Wisely Africa recommendations in breast cancer care: a cross-sectional study across three Sub-Saharan African centres [2025]
  • Breast Cancer Research
    • Inequities in breast cancer treatment in sub-Saharan Africa: findings from a prospective multi-country observational study [2019]
  • JAMA Network Open
    • Survival Patterns Among Patients With Breast Cancer in Sub-Saharan Africa: A Systematic Review and Meta-Analysis [2024]
  • Lancet Oncology
    • Treatment guideline concordance, initiation, and abandonment in patients with non-metastatic breast cancer from the African Breast Cancer-Disparities in Outcomes (ABC-DO) cohort in sub-Saharan Africa: a prospective cohort study [2022]
• Sweden
  • Acta Oncologica
    • Adherence to adjuvant endocrine therapy after breast cancer in Sweden - a nationwide cohort study in 1-, 3- and 5-year survivors with a focus on regional differences [2024]
  • BMC Cancer
    • Endocrine therapy and COVID-19 outcomes in women with breast cancer: a nationwide register- based matched cohort study [2026]
  • Breast
    • Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy [2023]
• Switzerland
  • Cancers
    • Management and Outcome of Young Women (<=40 Years) with Breast Cancer in Switzerland [2022]
• Taiwan
  • Breast
    • Effectiveness and healthcare costs of eribulin versus capecitabine among metastatic breast cancer patients in Taiwan [2021]
  • Cancer Medicine
    • Gonadotropin-releasing hormone agonist treatment and ischemic heart disease among female patients with breast cancer: A cohort study [2023]
  • Journal of Cancer
    • Metronomic vinorelbine is an excellent and safe treatment for advanced breast cancer: a retrospective, observational study [2021]
  • PLoS ONE
    • Is tamoxifen good enough for the Asian population in ER+ HER2- post-menopausal women with early breast cancer? A nationwide population-based cohort study [2024]
  • Scientific Reports
    • Association of treatment delay and stage with mortality in breast cancer: a nationwide cohort study in Taiwan [2022]
    • Health Services Utilisation in Breast Cancer Survivors in Taiwan [2014]
• Thailand
  • Value in Health Regional Issues
    • Economic Evaluation and Budget Impact of Biosimilar Trastuzumab for HER2-Positive Metastatic Breast Cancer in Thailand: Policy Implications for Access and Affordability [2026]
• Türkiye
  • Turkish Journal of Surgery
    • Turkish national consensus on breast cancer management during temporary state of emergency due to COVID-19 outbreak [2020]
• United Kingdom
  • BMJ Open
    • Societal costs of chemotherapy in the UK: an incidence-based cost-of-illness model for early breast cancer [2021]
  • Breast
    • Management and outcomes for older women with early breast cancer treated with primary endocrine therapy (PET) [2024]
  • British Journal of Cancer
    • Evidence into practice: a national cohort study of NICE-recommended oncological drug therapy utilisation among women diagnosed with invasive breast cancer in England [2023]
    • A real-world study of the first use of palbociclib for the treatment of advanced breast cancer within the UK National Health Service as part of the novel Ibrance® Patient Program [2023]
    • Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study [2021]
  • Cancer Biology & Medicine
    • The decision-making process for senior cancer patients: treatment allocation of older women with operable breast cancer in the UK [2015]
  • European Journal of Cancer
    • Survival following adjuvant trastuzumab-based treatment among older patients with HER2-positive early invasive breast cancer: A national population-based cohort study using routine data [2024]
  • Health Technology Assessment
    • Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT [2020]
  • Indian Journal of Surgery
    • Breast Cancer Management Guidelines During COVID-19 Pandemic [2020]
  • National Institute for Health and Care Excellence
    • Trastuzumab deruxtecan for treating hormone receptor-positive HER2-low metastatic breast cancer after 2 or more endocrine treatments (terminated appraisal) [2025]
    • Ribociclib with an aromatase inhibitor for adjuvant treatment of hormone receptor-positive HER2-negative early breast cancer at high risk of recurrence [2025]
    • Elacestrant for treating oestrogen receptor-positive HER2-negative advanced breast cancer with an ESR1 mutation after endocrine treatment [2025]
    • Capivasertib with fulvestrant for treating hormone receptor-positive HER2-negative advanced breast cancer after endocrine treatment [2025]
    • Trastuzumab deruxtecan for treating HER2-low metastatic or unresectable breast cancer after chemotherapy [2024]
    • Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatments [2023]
    • Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapies [2022]
    • Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy [2022]
    • Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer [2022]
    • Abemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence [2022]
    • Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapies [2021]
    • Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy [2021]
    • Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy [2021]
    • Trastuzumab emtansine for adjuvant treatment of HER2-positive early breast cancer [2020]
    • Pertuzumab for adjuvant treatment of HER2-positive early stage breast cancer [2019]
    • Neratinib for extended adjuvant treatment of hormone receptor-positive, HER2-positive early stage breast cancer after adjuvant trastuzumab [2019]
    • Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer [2019]
    • Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancer [2018]
    • Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancer [2018]
    • Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimen [2018]
    • Trastuzumab emtansine for treating HER2-positive advanced breast cancer after trastuzumab and a taxane [2017]
    • Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer [2017]
    • Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer [2017]
    • Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer [2016]
    • Everolimus with exemestane for treating advanced breast cancer after endocrine therapy [2016]
    • Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens [2016]
    • Early and metastatic HER2-positive breast cancer: subcutaneous trastuzumab [2013]
    • Lapatinib or trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone-receptor-positive breast cancer that overexpresses HER2 [2012]
    • Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer [2012]
    • Fulvestrant for the treatment of locally advanced or metastatic breast cancer [2011]
    • Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer [2011]
    • Gemcitabine for the treatment of metastatic breast cancer [2007]
  • PharmacoEconomics - Open
    • Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology Appraisal [2023]
  • UK Parliament
    • Treatment of lobular breast cancer [2024]
• United States
  • American Cancer Society
    • American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline [2015]
  • American College of Medical Genetics and Genomics
    • Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy [2012]
  • American College of Obstetricians and Gynecologists
    • Aromatase Inhibitors in Gynecologic Practice [2018]
    • Tamoxifen and Uterine Cancer [2014]
  • American College of Radiology
    • Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer
    • Locally Advanced Breast Cancer
  • American Family Physician
    • Breast Cancer Treatment [2021]
  • American Journal of Managed Care
    • Integrating Trastuzumab Biosimilars and HER2-Directed Therapies into HER2-Positive Breast Cancer Management [2020]
  • American Society of Breast Surgeons
    • Analysis of the Impact of the COVID-19 Pandemic on the Multidisciplinary Management of Breast Cancer: Review from the American Society of Breast Surgeons COVID-19 and Mastery Registries [2021]
  • American Society of Clinical Oncology
    • Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline Q and A [2024]
    • Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline [2024]
    • Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer-Cyclin-Dependent Kinase 4 and 6 Inhibitors: ASCO Guideline Rapid Recommendation Update [2024]
    • Endocrine and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer-Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update [2024]
    • Testing for ESR1 Mutations to Guide Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update [2023]
    • Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor-Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update [2023]
    • Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor-Negative Metastatic Breast Cancer and Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A [2023]
    • Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline Update Q and A [2022]
    • Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline Update [2022]
    • Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline Update Q and A [2022]
    • Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline Update [2022]
    • Chemotherapy and Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That Is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Rapid Recommendation Update [2022]
    • Adjuvant Abemaciclib Plus Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A [2022]
    • Abemaciclib With Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update [2022]
    • Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline [2021]
    • Endocrine Treatment and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: ASCO Guideline Update [2021]
    • Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Update [2021]
    • Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update [2020]
    • Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline [2019]
    • Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Clinical Practice Guideline Update [2018]
    • Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update [2018]
    • Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update [2018]
    • Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline [2018]
    • Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update [2018]
    • Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update [2017]
    • Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) –Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline [2016]
    • Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression [2016]
    • Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update [2013]
  • Annals of Surgical Oncology
    • The Metaplastic Conundrum: A National Cancer Database Analysis of Metaplastic versus Triple-Negative Ductal Breast Cancer [2025]
    • Neoadjuvant Chemotherapy is Associated with Worse 5-Year Overall Survival in Patients with Metaplastic Breast Cancer Compared with Primary Surgery: A National Cancer Database Analysis [2025]
  • ASCO Educational Book
    • Advances in the Management of Menopausal Symptoms, Fertility Preservation, and Bone Health for Women With Breast Cancer on Endocrine Therapy [2023]
    • What’s the Price? Toxicities of Targeted Therapies in Breast Cancer Care [2020]
  • BMC Cancer
    • Epidemiology and outcomes associated with brain metastases among patients with metastatic breast cancer - a cohort study in US electronic health record data [2025]
  • Breast
    • Expert consensus on treating HR+/HER2- metastatic breast cancer based on real-world practice patterns observed in the RETRACT survey of US oncologists [2025]
    • Management of HR+/HER2+ lobular breast cancer and trends do not mirror better outcomes [2022]
  • Breast Cancer : Basic and Clinical Research
    • Endocrine Therapy Plus Anti-HER2 Therapy as Adjuvant Systemic Therapy for Luminal HER2-Positive Breast Cancer: An Analysis of the National Cancer Database [2020]
  • Breast Cancer : Targets and Therapy
    • Disparities in Guideline-Concordant Initial Systemic Treatment in Women with HER2-Negative Metastatic Breast Cancer: A SEER-Medicare Analysis [2021]
  • Breast Cancer Research and Treatment
    • Cost-effectiveness of DPYD genotyping prior to capecitabine administration for metastatic breast cancer [2026]
    • Socioeconomic status impacts tumor biology, treatment, and outcomes in over 200,000 patients with invasive lobular carcinoma of the breast: an analysis of the National Cancer Database [2025]
    • National trends and survival outcomes associated with non-guideline-concordant treatment of inflammatory breast cancer [2025]
    • Trends in HR+ metastatic breast cancer survival before and after CDK4/6 inhibitor introduction in the United States: a SEER registry analysis of patients with HER2- and HER2+ metastatic breast cancer [2024]
    • Clinico-pathologic factors and survival of patients with breast cancer diagnosed with de novo brain metastasis: a national cancer database analysis [2024]
    • Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium [2020]
    • Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG) [2018]
    • Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG) [2018]
    • Assessing racial/ethnic disparities in chemotherapy treatment among breast cancer patients in context of changing treatment guidelines [2013]
  • Cancer Control
    • Socioeconomic Status and Breast Cancer Treatment in the United States: Results From a Systematic Literature Review [2025]
  • Cancer Management and Research
    • Ixabepilone: a new treatment option for the management of taxane-resistant metastatic breast cancer [2009]
  • Cancer Medicine
    • Impact of Travel Burden on Timeliness of Care and Overall Survival for Breast Cancer: A National Cancer Database Analysis [2025]
    • Estimating the overall survival benefit of adjuvant chemo-endocrine therapy in women over age 50 with pT1-2N0 early stage breast cancer and 21-gene recurrence score >=26: A National Cancer Database analysis [2024]
    • Physician experiences and preferences in the treatment of HR+/HER2- metastatic breast cancer in the United States: a physician survey [2015]
  • Cancer Treatment Reviews
    • Clinical management, monitoring, and prophylaxis of adverse events of special interest associated with datopotamab deruxtecan [2024]
  • Cancers
    • Racial/Ethnic Differences and Trends in Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer [2022]
  • Clinical Cardiology
    • Are Aromatase Inhibitors Associated with Higher Myocardial Infarction Risk in Breast Cancer Patients? A Medicare Population-Based Study [2018]
  • Current Breast Cancer Reports
    • Lessons Learned: Management of Breast Cancer Patients throughout the COVID-19 Pandemic [2021]
  • Current Oncology
    • Perioperative Drug Management of Systemic Therapies in Breast Cancer: A Literature Review and Treatment Recommendations [2025]
  • Drug Design, Development and Therapy
    • Management of advanced breast cancer with the epothilone B analog, ixabepilone [2009]
  • Expert Review of Anticancer Therapy
    • Treatment of small (T1mic, T1a, and T1b) node-negative HER2+ breast cancer - a review of current evidence for and against the use of anti-HER2 treatment regimens [2022]
  • Food and Drug Administration
    • U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review [2022]
    • FDA approves neratinib for metastatic HER2-positive breast cancer [2020]
    • FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor–Positive, HER2-Negative Metastatic Breast Cancer [2015]
  • Frontiers in Oncology
    • Ixabepilone: Overview of Effectiveness, Safety, and Tolerability in Metastatic Breast Cancer [2021]
  • International Journal of Clinical Oncology
    • Real-world treatment patterns and clinical outcomes with tucatinib-based therapy in patients with HER2-positive metastatic breast cancer: analyses of two nationwide administrative health claims databases [2025]
  • JAMA Network Open
    • Trends in Nonsurgical Management for Low-Risk, Hormone Receptor-Positive Ductal Carcinoma In Situ [2026]
    • Trends in Guideline-Concordant Care for Inflammatory Breast Cancer [2025]
    • Racial Disparities in Receipt of Guideline-Concordant Care in Older Adults With Early Breast Cancer [2024]
    • Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2 (HER2)–Positive Breast Cancer [2020]
  • JAMA Oncology
    • Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States [2017]
  • JCO Oncology Practice
    • Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach [2020]
  • JNCCN
    • Potential Impact of Revised NCI Eligibility Criteria Guidance: Prior Malignancy Exclusion in Breast Cancer Clinical Trials [2022]
    • Initiation of Trastuzumab by Women Younger Than 64 Years for Adjuvant Treatment of Stage I-III Breast Cancer [2018]
  • Journal of Cancer
    • Current Approaches and Challenges in Monitoring Treatment Responses in Breast Cancer [2014]
  • Journal of Cancer Survivorship
    • Current practice patterns and gaps in guideline-concordant breast cancer survivorship care [2023]
  • Journal of Clinical Oncology
    • Late Breast Cancer Survivorship: Side Effects and Care Recommendations [2022]
    • Cardiac Surveillance Guidelines for Trastuzumab-Containing Therapy in Early-Stage Breast Cancer: Getting to the Heart of the Matter [2016]
    • Decline in the Use of Anthracyclines for Breast Cancer [2012]
  • Journal of Managed Care & Specialty Pharmacy
    • First-line cyclin-dependent kinase 4 and 6 inhibitors in combination with an aromatase inhibitor for HR+/HER2- metastatic breast cancer: A real-world cost-effectiveness assessment in a US Medicare-eligible population [2025]
    • Capivasertib cost-effectiveness in treating advanced breast cancer: A US health care perspective [2025]
    • Cost-effectiveness of early vs delayed use of abemaciclib combination therapy for patients with high-risk hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer [2024]
  • Journal of Medical Economics
    • Cost-effectiveness analysis of capivasertib plus fulvestrant in the PIK3CA/AKT1/PTEN-altered subgroup with HR+/HER2- advanced breast cancer: a United States payer perspective [2026]
    • Real-world perioperative treatment patterns and economic burden of recurrence in early-stage HER2-negative breast cancer: a SEER-Medicare study [2025]
    • Cost-effectiveness analysis of ribociclib versus abemaciclib as first-line treatments for postmenopausal women with HR+/HER2- advanced breast cancer: a Medicare perspective [2025]
    • Comparative cost-effectiveness of ribociclib and palbociclib as first-line treatment for HR+/HER2- advanced breast cancer in postmenopausal women: analysis from a Medicare perspective [2025]
  • Journal of the Advanced Practitioner in Oncology
    • Neratinib for the Treatment of Early-Stage HER2-Positive Breast Cancer [2018]
  • National Cancer Institute
    • Drugs Approved for Breast Cancer
    • Childhood Breast Cancer Treatment (PDQ®)
    • Breast Cancer Treatment (PDQ®)
  • National Comprehensive Cancer Network
    • Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology [2026]
    • NCCN Guidelines® Insights: Breast Cancer, Version 5.2025 [2025]
    • NCCN resource-stratified and harmonized guidelines: A paradigm for optimizing global cancer care [2020]
  • npj Breast Cancer
    • HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now [2021]
    • Clinical development of immunotherapies for HER2+ breast cancer: a review of HER2-directed monoclonal antibodies and beyond [2020]
  • Signal Transduction and Targeted Therapy
    • Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management [2023]
  • Society for Immunotherapy of Cancer
    • Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer [2021]
  • Society for Integrative Oncology
    • Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment [2017]
  • StatPearls
    • Trastuzumab
    • Tamoxifen
• Uruguay
  • Medicine
    • Trastuzumab-induced cardiotoxicity in early breast cancer over a 10-year period in Uruguay [2022]
• Vietnam
  • PLoS ONE
    • Cost-effectiveness of one-year adjuvant trastuzumab therapy in treatment for early-stage breast cancer patients with HER2+ in Vietnam [2024]
• Western countries
  • Breast
    • Improving medication adherence to endocrine therapy in breast cancer patients: a mixed-methods systematic review of effective communication strategies for healthcare providers [2025]
  • ESMO Open
    • Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer [2022]
  • Maturitas
    • The effects of lifestyle and behavioural interventions on cancer recurrence, overall survival and quality of life in breast cancer survivors: A systematic review and network meta-analysis [2024]
• {Related topics}
  • Topic
    • Osteoporosis: risk factors
    • Breast cancer treatment: surgery, radiotherapy
    • Breast cancer

Breast cancer treatment: surgery, radiotherapy

• Africa
  • BMC Women's Health
    • The use of standardised tools to measure post-mastectomy quality of life among women in Africa: a scoping review [2025]
• Australia
  • Australian Family Physician
    • Conservation surgery and radiation therapy in early breast cancer – An update [2017]
  • Breast
    • Rates of reoperation after breast conserving cancer surgery in Western Australia before and after publication of the SSO-ASTRO margins guideline [2023]
  • Radiotherapy and Oncology
    • Variation in the use of radiotherapy fractionation for breast cancer: Survival outcome and cost implications [2020]
• Austria, Germany, Switzerland
  • BMC Cancer
    • Are heart toxicities in breast cancer patients important for radiation oncologists? A practice pattern survey in German speaking countries [2017]
• Belgium
  • JAMA Network Open
    • Cost-Effectiveness of Proton Therapy Compared With Photon Therapy in Breast Cancer [2026]
• Brazil
  • Revista da Associação Médica Brasileira
    • Recommendations for hypofractionated whole-breast irradiation [2018]
    • Treatment with intensity-modulated radiation therapy (IMRT) for breast cancer [2014]
• Canada
  • Alberta Health Services
    • Phyllodes Tumour of the Breast
    • Breast Reconstruction Following Prophylactic or Therapeutic Mastectomy for Breast Cancer
  • Breast Cancer Research and Treatment
    • COVID-19 vaccination and breast cancer surgery timing [2021]
  • Canada's Drug Agency
    • Intraoperative Mammography for Breast Cancer Surgery: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines [2019]
  • Canadian Family Physician
    • Breast reconstruction [2018]
  • Canadian Partnership Against Cancer
    • Pan-Canadian standards for breast cancer surgery [2019]
  • CMAJ Open
    • Update to the Canadian clinical practice guideline for best-practice management of breast cancer-related lymphedema: study protocol [2022]
  • Current Oncology
    • National Variations in the Work-Up, Investigation, and Surgical Management of Ductal Carcinoma In Situ of the Breast across Canadian Surgeons [2021]
    • Consensus statement on tumour bed localization for radiation after oncoplastic breast surgery [2020]
    • Locoregional therapy of locally advanced breast cancer: a clinical practice guideline [2015]
  • Ontario Health
    • Postmastectomy Breast Reconstruction in Patients with Non-Metastatic Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline [2025]
    • Postmastectomy Breast Reconstruction in Patients with Non-Metastatic Breast Cancer [2025]
    • Management of Ductal Carcinoma in Situ of the Breast [2024]
    • Management of Ductal Carcinoma In Situ: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline [2024]
    • Wire-Free, Nonradioactive Localization Techniques to Guide Surgical Excision of Nonpalpable Breast Tumours: A Health Technology Assessment [2023]
• Central and Eastern Europe
  • Pathology & Oncology Research
    • Radiotherapy of Breast Cancer-Professional Guideline 1st Central-Eastern European Professional Consensus Statement on Breast Cancer [2022]
    • Modern Breast Cancer Surgery 1st Central-Eastern European Professional Consensus Statement on Breast Cancer [2022]
• China
  • Aesthetic Plastic Surgery
    • Current Trends in Revision Surgery After Breast Reconstruction in China: Insights from a Nationwide Cross-Sectional Survey [2026]
  • BMC Medical Education
    • Disparities in training and education among young breast surgeons: a nationwide survey in China [2025]
  • Cancer Management and Research
    • Surgical Management Strategy for Breast Cancer Patients During the COVID-19 Outbreak [2020]
  • Chinese Medical Journal
    • Clinical practice guidelines for pre-operative evaluation of breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
    • Clinical practice guidelines for post-mastectomy breast reconstruction: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
    • Clinical practice guidelines for modified radical mastectomy of breast cancer: Chinese Society of Breast Surgery (CSBrs) practice guidelines 2021 [2021]
    • Clinical practice guidelines for endoscopic breast surgery in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
    • Clinical practice guideline for breast-conserving surgery in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
  • Journal of Cancer
    • Management of early-stage breast cancer patients during the coronavirus disease 2019 (COVID-19) pandemic: The experience in China from a surgical standpoint [2021]
  • Oncologist
    • Current Status and Factors Influencing Surgical Options for Breast Cancer in China: A Nationwide Cross-Sectional Survey of 110 Hospitals [2020]
• Denmark
  • Radiotherapy and Oncology
    • Evaluating Danish Breast Cancer Group locoregional radiotherapy guideline adherence in clinical treatment data 2008-2016: The DBCG RT Nation study [2024]
• Denmark, Netherlands
  • Breast Cancer Research and Treatment
    • Breast-contour preserving procedures for early-stage breast cancer: a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands [2020]
• Estonia
  • International Journal for Equity in Health
    • The impact of sociodemographic factors on the utilization of radiation therapy in breast cancer patients in Estonia: a register-based study [2021]
• Europe
  • Breast
    • A multidisciplinary view of mastectomy and breast reconstruction: Understanding the challenges [2021]
  • Clinical Oncology
    • Postmastectomy Radiation Therapy Planning After Immediate Implant-based Reconstruction Using the European Society for Radiotherapy and Oncology-Advisory Committee in Radiation Oncology Practice Consensus Guidelines for Target Volume Delineation [2021]
  • European Organisation for Research and Treatment of Cancer
    • Patterns of practice of regional nodal irradiation in breast cancer: results of the European Organization for Research and Treatment of Cancer (EORTC) NOdal Radiotherapy (NORA) survey [2015]
  • European Society for Radiotherapy and Oncology
    • ESTRO recommendations on preoperative radiation therapy in breast cancer: current and future perspectives - Endorsed by ASTRO [2026]
    • Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO) [2024]
    • In regard to “The Italian Association of Radiotherapy and Oncology Recommendation for Breast Tumor Recurrence: Grades of Recommendation, Assessment, Development and Evaluation Criteria” [2021]
    • ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost – GEC-ESTRO Breast Cancer Working Group practical recommendations [2018]
  • European Society of Plastic, Reconstructive & Aesthetic Surgery
    • Quality indicators for breast reconstruction following cancer-an international Delphi consensus study supported by the European Society of Plastic, Reconstructive and Aesthetic Surgery - PubMed [2025]
  • European Society of Regional Anaesthesia and Pain Therapy
    • PROSPECT guideline for oncological breast surgery: a systematic review and procedure-specific postoperative pain management recommendations [2020]
  • Radiotherapy and Oncology
    • The changing landscape in radiotherapy for breast cancer: Lessons from long term follow-up in some European breast cancer trials [2016]
• France
  • Cancer/Radiothérapie
    • Institut Curie guidelines on breast target volume delineation for patients treated in lateral position [2020]
  • Reports of Practical Oncology and Radiotherapy
    • Should the management of radiation therapy for breast cancer be standardized? Results of a survey on current French practices in breast radiotherapy [2021]
• Germany
  • Breast Care
    • Breast Cancer Surgery and Financial Reimbursement in Germany [2012]
  • Deutsche Gesellschaft für Radioonkologie
    • DEGRO practical guidelines: radiotherapy of breast cancer-regional nodal irradiation [2026]
    • DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal carcinomatosis in patients with breast cancer [2024]
    • Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward [2021]
    • DEGRO practical guideline for partial-breast irradiation [2020]
    • Current controversies in radiotherapy for breast cancer [2017]
    • DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences [2016]
    • DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases [2015]
    • DEGRO practical guidelines: radiotherapy of breast cancer I [2013]
  • Deutsches Ärzteblatt International
    • Case Numbers and Process Quality in Breast Surgery in Germany [2015]
  • European Journal of Surgical Oncology
    • AGO Breast Committee recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2026 [2026]
    • AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025 [2025]
  • Geburtshilfe und Frauenheilkunde
    • AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022 [2022]
  • Institute for Quality and Efficiency in Health Care
    • Relationship between volume of services and quality of treatment outcome in the surgical treatment of breast cancer - rapid report [2020]
  • Strahlentherapie und Onkologie
    • Implant-based reconstruction and adjuvant radiotherapy in breast cancer patients-current status and DEGRO recommendations [2025]
    • Radiotherapy statements of the 18th St. Gallen International Breast Cancer Consensus Conference-a German expert perspective [2024]
  • Surgical Oncology
    • Trend shift from autologous to implant-based breast reconstruction [2025]
• High-income countries
  • BMC Cancer
    • A comparison of acellular dermal matrices (ADM) efficacy and complication profile in women undergoing implant-based breast reconstruction: a systematic review and network meta-analysis [2024]
  • Society of Interventional Radiology
    • New Frontiers in the Role of Locoregional Therapies in Breast Cancer: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel [2023]
• India
  • Indian Journal of Medical Research
    • Breast conservation surgery & oncoplasty in India – Current scenario [2021]
    • Adjuvant radiation therapy in breast cancer: Recent advances & Indian data [2021]
• International
  • American Society of Clinical Oncology Educational Book
    • Right-Sizing Locoregional Management in the Era of Neoadjuvant Therapy for Breast Cancer [2026]
    • Personalizing Locoregional Therapy in Patients With Breast Cancer in 2024: Tailoring Axillary Surgery, Escalating Lymphatic Surgery, and Implementing Evidence-Based Hypofractionated Radiotherapy [2024]
  • Asian Pacific Journal of Cancer Prevention
    • Novel Prevention Approaches of Breast Cancer Surgery Related Complications: Systematic Review and Network Meta-Analysis [2024]
  • Biomolecules and Biomedicine
    • Comparison of robotic, conventional, and endoscopic nipple-sparing mastectomy with immediate prosthetic breast reconstruction for breast cancer: A systematic review and meta-analysis [2025]
  • BMC Women's Health
    • Conservative interventions and clinical outcome measures used in the perioperative rehabilitation of breast cancer patients undergoing mastectomy: a scoping review [2022]
  • BMJ Open
    • Evaluation of guidelines regarding surgical treatment of breast cancer using the AGREE Instrument: a systematic review [2017]
  • Breast
    • Risk factors for breast fibrosis and unfavorable cosmetic outcomes after breast conserving therapy in the contemporary treatment era: a systematic review [2026]
    • Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy [2022]
    • Should oncoplastic breast conserving surgery be used for the treatment of early stage breast cancer? Using the GRADE approach for development of clinical recommendations [2021]
  • Breast Cancer Research and Treatment
    • Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologists [2023]
    • Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy [2018]
  • Breast Journal
    • Preserving Nipple Sensitivity after Breast Cancer Surgery: A Systematic Review and Meta-Analysis [2022]
  • Cancer
    • Breast cancer recurrence after immediate and delayed postmastectomy breast reconstruction-A systematic review and meta-analysis [2022]
    • Locoregional treatment of primary breast cancer. Consensus recommendations from an International Expert Panel [2010]
  • Chinese Clinical Oncology
    • Oncoplastic surgery in the treatment of breast cancer: a review of evolution and surgical training [2025]
  • Chirurgia
    • Quality of Life Evaluation Using Questionnaires in Breast Cancer Patients after Surgery: A Systematic Review [2025]
  • Clinical Oncology
    • International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic [2020]
  • Cochrane Database of Systematic Reviews
    • Implants versus autologous tissue flaps for breast reconstruction following mastectomy [2024]
    • Oncoplastic breast-conserving surgery for women with primary breast cancer [2021]
  • Current Oncology
    • Postmastectomy Breast Reconstruction in Patients with Non-Metastatic Breast Cancer: A Systematic Review [2025]
  • Enhanced Recovery After Surgery
    • Consensus Review of Optimal Perioperative Care in Breast Reconstruction: Enhanced Recovery after Surgery (ERAS) Society Recommendations [2017]
  • European Journal of Cancer
    • Comparison of hypofractionation and conventional fractionation in postmastectomy radiotherapy after immediate breast reconstruction: A systematic review and meta-analysis of complications [2025]
  • Health Expectations
    • Behaviour, barriers and facilitators of shared decision making in breast cancer surgical treatment: A qualitative systematic review using a 'Best Fit' framework approach [2024]
  • Journal of Medical Radiation Sciences
    • Three-Dimensional Printing in Breast Radiation Therapy: A Scoping Review of the Literature [2025]
    • Use of magnetic resonance image-guided radiotherapy for breast cancer: a scoping review [2022]
  • Medicine
    • Exercise-based interventions for postoperative rehabilitation in breast cancer patients: A systematic review and meta-analysis of randomized controlled trials [2025]
  • Radiology and Oncology
    • Neoadjuvant radiotherapy and immediate breast reconstruction: A systematic review of literature of the last decade [2025]
  • Scientific Reports
    • Evaluating oncoplastic breast-conserving surgery: oncological safety, risks, and satisfaction-a systematic review and meta-analysis [2025]
    • A systematic review on the techniques, long-term outcomes, and complications of partial breast irradiation after breast-conserving surgery for early-stage breast cancer [2024]
  • Senologic International Society
    • The Senologic International Society Survey on Ductal Carcinoma In Situ: Present and Future [2022]
  • Surgery
    • The impact of breast reconstruction compared with no reconstruction on breast cancer-related lymphedema: A systematic review and meta-analysis [2025]
• Ireland
  • Ireland's Health Services
    • Treatment of Patients with Breast Cancer: Radiation Oncology National Clinical Guideline [2023]
• Italy
  • Breast
    • Loco-regional adjuvant radiation therapy in breast cancer patients with positive axillary lymph-nodes at diagnosis (CN2) undergoing preoperative chemotherapy and with complete pathological lymph-nodes response. Development of GRADE (Grades of recommendation, assessment, Development and Evaluation) recommendation by the Italian Association of radiation therapy and Clinical Oncology (AIRO) [2021]
  • Journal of Breast Cancer
    • The Italian Association of Radiotherapy and Oncology Recommendation for Breast Tumor Recurrence: Grades of Recommendation, Assessment, Development and Evaluation Criteria [2021]
• Japan
  • Breast
    • Survival of patients with squamous cell carcinoma of the breast compared with invasive ductal carcinoma by biological subtype: A matched analysis of the Japanese national clinical database-breast cancer registry [2025]
  • Breast Cancer
    • Postmastectomy radiation therapy for autologous breast reconstruction: a systematic review and meta-analysis for the 2022 Japanese Breast Cancer Society Clinical Practice Guideline [2026]
    • Timing of postmastectomy radiation therapy in two-stage expander/implant-based breast reconstruction: a systematic review and meta-analysis for the 2022 Japanese breast cancer society clinical practice guideline [2025]
    • Postmastectomy radiation therapy for implant-based breast reconstruction: a systematic review and meta-analysis for the 2022 Japanese Breast Cancer Society Clinical Practice Guideline [2025]
    • The Japanese breast cancer society clinical practice guidelines for radiation treatment of breast cancer, 2022 edition [2024]
    • The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition [2024]
    • Impact of immediate breast reconstruction on perioperative therapy: insights from a Japanese Nationwide Registry [2024]
    • The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition [2020]
    • The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2018 edition [2020]
  • Scientific Reports
    • Impact of coronavirus disease 2019 pandemic on breast cancer surgery using the National Database of Japan [2023]
• Low and middle income countries
  • Journal of Patient-Reported Outcomes
    • Use of patient-reported outcome measures after breast reconstruction in low- and middle-income countries: a scoping review [2024]
• Netherlands
  • BJS
    • Nationwide population-based study of the impact of immediate breast reconstruction after mastectomy on the timing of adjuvant chemotherapy [2019]
  • BJS Open
    • High-impact complications after breast cancer surgery in the Dutch national quality registry: evaluating case-mix adjustment for hospital comparisons [2024]
  • Clinical Breast Cancer
    • National Breast Cancer Surgery Snapshot Study: Breast Cancer Surgery after Neoadjuvant Systemic Therapy in Primary Breast Cancer (MANS Study) [2026]
  • Clinical Oncology
    • Model-Based Selection for Proton Therapy in Breast Cancer: Development of the National Indication Protocol for Proton Therapy and First Clinical Experiences [2022]
  • Radiation Oncology
    • Transparency in quality of radiotherapy for breast cancer in the Netherlands: a national registration of radiotherapy-parameters [2022]
• New Zealand
  • Cancer Epidemiology
    • Trends and disparities in locoregional treatment of programme-detected ductal carcinoma in situ in New Zealand women, 1999-2022 [2025]
  • Ministry of Health New Zealand
    • Breast Reconstruction: National guidelines for best practice [2021]
• Philippines
  • Annals of Surgical Oncology
    • Access to Surgical Treatment for Breast Cancer in the Philippines [2022]
• Republic of Korea
  • BMC Women's Health
    • Impact of diagnosis-to-treatment interval on mortality in patients with early-stage breast cancer: a retrospective nationwide Korean cohort [2025]
  • Breast Cancer Research
    • Cardiovascular disease risk following radiotherapy among breast cancer survivors: a nationwide cohort study in South Korea [2025]
  • British Journal of Cancer
    • A nationwide study of breast reconstruction after mastectomy in patients with breast cancer receiving postmastectomy radiotherapy: comparison of complications according to radiotherapy fractionation and reconstruction procedures [2024]
  • Cancer Research and Treatment
    • Radiation-Associated Heart Disease in Korean Women after Radiotherapy for Breast Cancer: Insights from the National Health Insurance Service Database [2026]
  • Journal of Breast Cancer
    • Patterns of Practice in Radiotherapy for Breast Cancer in Korea [2018]
    • The Practice Patterns and Perceptions of Korean Surgeons Regarding Margin Status after Breast-Conserving Surgery [2017]
  • Journal of Korean Medical Science
    • Changes in Korean National Healthcare Insurance Policy and Breast Cancer Surgery Trend in Korea [2021]
  • Medicine
    • Trends in the Application of Postmastectomy Radiotherapy for Breast Cancer With 1 to 3 Positive Axillary Nodes and Tumors <=5cm in the Modern Treatment Era [2016]
  • PLoS ONE
    • Incidence of hypothyroidism after treatment for breast cancer: A Korean population-based study [2022]
  • Scientific Reports
    • Reduced risk of lymphedema after immediate breast reconstruction in breast cancer: a retrospective nationwide study [2025]
  • World Journal of Surgery
    • Psychological Impact of Type of Breast Cancer Surgery: A National Cohort Study [2022]
• South Africa
  • South African Medical Journal
    • Breast cancer surgical services in South Africa: Availability and barriers to guideline-concordant care [2026]
• South-East Asia
  • Journal of Surgical Oncology
    • Disparities in Breast Reconstruction After Mastectomy in Southeast Asia: A Systematic Review [2025]
• Spain
  • Clinical and Translational Oncology
    • Evidence-based guidelines for hypofractionated radiation in breast cancer: conclusions of the Catalan expert working group [2022]
• Sweden
  • BJS Open
    • Capsular contractures following implant-based breast reconstruction in women undergoing risk-reducing mastectomy: national register-based study [2025]
    • National long-term patient-reported outcomes following mastectomy with or without breast reconstruction: The Swedish Breast Reconstruction Outcome Study Part 2 (SweBRO 2) [2024]
  • British Journal of Surgery
    • Comparing multifocal with unifocal breast cancer and the relationship with survival: national cohort study [2026]
• Taiwan
  • Surgery
    • Comparing irradiated clinical outcomes between modified radical mastectomy and breast-conserving surgery in patients with pathologic stage III breast cancer: A national population-based match cohort study [2025]
• Türkiye
  • JCO Global Oncology
    • Surgical Trends in Breast Cancer in Turkey: An Increase in Breast-Conserving Surgery [2020]
• Uganda
  • PLoS ONE
    • Breast cancer care in Uganda: A multicenter study on the frequency of breast cancer surgery in relation to the incidence of breast cancer [2019]
• United Kingdom
  • Annals of The Royal College of Surgeons of England
    • Guidelines for oncoplastic breast reconstruction [2013]
  • Association of Breast Surgery
    • Contemporary management of phyllodes tumours of the breast: proposal for recommendations from the UK Association of Breast Surgery [2024]
    • Oncoplastic breast surgery: A guide to good practice [2021]
    • Biological and synthetic mesh assisted breast reconstruction procedures: Joint guidelines from the Association of Breast Surgery and the British Association of Plastic, Reconstructive and Aesthetic Surgeons [2021]
  • Breast
    • Expert UK consensus on the definition of high risk of recurrence in HER2-negative early breast cancer: A modified Delphi panel [2023]
  • Breast Cancer Research and Treatment
    • Current use of drains and management of seroma following mastectomy and axillary surgery: results of a United Kingdom national practice survey [2024]
    • Current practice and provision of oncoplastic breast-conserving surgery in the UK: results of the ANTHEM national practice questionnaire [2023]
    • Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis [2023]
  • British Journal of Surgery
    • Ethnicity and the surgical management of early invasive breast cancer in over 164 000 women [2021]
  • European Journal of Surgical Oncology
    • Geographic variation in surgery rates among older patients with early (ER positive HER2 negative) breast cancer: Influence of cardiovascular disease and comorbidities: A national registry dataset analysis [2025]
    • The MARECA (national study of management of breast cancer locoregional recurrence and oncological outcomes) study: National practice questionnaire of United Kingdom multi-disciplinary decision making [2022]
    • A scoring system for 3D surface images of breast reconstruction developed using the Delphi consensus process [2020]
    • Adherence to best practice consensus guidelines for implant-based breast reconstruction: Results from the iBRA national practice questionnaire survey [2018]
  • Health Technology Assessment
    • A novel methodology using direct patient contact and UK national registries to collect long-term data from randomised trials: TARGIT-X - an extended follow-up study of the TARGIT-A trial of targeted intraoperative radiotherapy for breast cancer [2026]
    • One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT [2023]
    • Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCT [2022]
  • National Institute for Health and Care Excellence
    • Intrabeam radiotherapy system for adjuvant treatment of early breast cancer [2018]
    • AlignRT in breast cancer radiotherapy [2018]
    • L-Dex U400 for lymphoedema after breast cancer treatment [2017]
    • Axxent electronic brachytherapy system for early stage breast cancer [2016]
    • Breast reconstruction using lipomodelling after breast cancer treatment [2012]
    • Endoscopic mastectomy and endoscopic wide local excision for breast cancer [2009]
  • NHS England
    • Radiotherapy after primary surgery for breast cancer [2016]
  • Royal College of Radiologists
    • Radiotherapy dose fractionation: fourth edition - Breast cancer [2023]
    • Postoperative radiotherapy for breast cancer: hypofractionation RCR consensus statements [2021]
    • Development of Postoperative Radiotherapy for Breast Cancer: UK Consensus Statements - a Model of Patient, Clinical and Commissioner Engagement? [2018]
    • Postoperative radiotherapy for breast cancer: UK consensus statements [2016]
  • World Journal of Surgical Oncology
    • The Manchester guidelines for contralateral risk-reducing mastectomy [2015]
• United States
  • Advances in Radiation Oncology
    • Master Breast Radiation Planning: Simple Guide for Radiation Oncology Residents [2024]
    • The Association Between Cardiac Mortality and Adjuvant Radiation Therapy Among Older Patients With Stage I Estrogen Positive Breast Cancer: A Surveillance, Epidemiology, and End Results (SEER)–Based Study on Cardiac Mortality and Radiation Therapy [2020]
  • Aesthetic Surgery Journal
    • Influencers of Immediate Postmastectomy Reconstruction: A National Cancer Database Analysis [2022]
  • Agency for Healthcare Research and Quality
    • Partial Breast Irradiation for Breast Cancer [2023]
    • Breast Reconstruction After Mastectomy [2021]
  • American College of Radiology
    • Imaging of Deep Inferior Epigastric Arteries for Surgical Planning (Breast Reconstruction Surgery)
    • Conservative surgery and radiation - stage I and II breast cancer
  • American College of Surgeons
    • Risk of Synchronous Distant Recurrence at Time of Locoregional Recurrence in Patients With Stage II and III Breast Cancer (AFT-01) [2018]
  • American Journal of Surgery
    • Refusal of recommended breast cancer surgery: Trends after the Affordable Care Act and medicaid insurance expansion [2026]
  • American Physical Therapy Association
    • Interventions for Breast Cancer–Related Lymphedema: Clinical Practice Guideline From the Academy of Oncologic Physical Therapy of APTA [2020]
  • American Radium Society
    • Executive Summary of the American Radium Society Appropriate Use Criteria: Regional Nodal Irradiation for Breast Cancer [2025]
  • American Society for Radiation Oncology
    • Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSO Clinical Practice Guideline [2025]
    • Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline [2024]
    • Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline [2018]
    • Radiation Therapy for the Whole Breast: An American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline [2018]
  • American Society of Anesthesiologists
    • 2026 American Society of Anesthesiologists Practice Guideline on Perioperative Pain Management Using Local and Regional Analgesia for Cardiothoracic Surgeries, Mastectomy, and Abdominal Surgeries [2026]
  • American Society of Breast Surgeons
    • Consensus Statement on Venous Thromboembolism (VTE) Prophylaxis for Patients Undergoing Breast Operations [2024]
    • Pain Management in Breast Surgery: Recommendations of a Multidisciplinary Expert Panel—The American Society of Breast Surgeons [2020]
    • Pain Control in Breast Surgery: Survey of Current Practice and Recommendations for Optimizing Management-American Society of Breast Surgeons Opioid/Pain Control Workgroup [2020]
    • Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks [2016]
    • Contralateral Prophylactic Mastectomy Consensus Statement from the American Society of Breast Surgeons: Additional Considerations and a Framework for Shared Decision Making [2016]
    • Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus Conference [2015]
    • Official Statements
  • American Society of Clinical Oncology
    • Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ [2016]
    • Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update [2016]
  • Annals of Surgical Oncology
    • Longitudinal Increases in Time to Surgery for Patients with Breast Cancer: A National Cohort Study [2024]
    • Guideline-Concordant Surgical Care for Lobular Versus Ductal Inflammatory Breast Cancer [2024]
    • Current State of Evidence-Based Long-Term Monitoring Protocols for Breast Plastic Surgery Patients [2024]
    • Breast Surgical Oncology Epidemiologic Research: A Guide and Comparison of Four National Databases [2023]
    • Assessment of Practice Patterns Following Publication of the SSO–ASTRO Consensus Guideline on Margins for Breast-Conserving Therapy in Stage I and II Invasive Breast Cancer [2015]
  • Breast
    • Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability [2021]
  • Breast Cancer Research and Treatment
    • The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database (NCDB) [2024]
    • Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines [2023]
  • Cancer Medicine
    • Rural-urban differences in secular trends of locoregional treatment for ductal carcinoma in situ: A patterns of care analysis [2022]
  • CardioVascular and Interventional Radiology
    • Cryoablation Versus Breast-Conserving Surgery for Early-Stage, Low-Risk Breast Cancer <= 1.5 cm: A Cost-Effectiveness Analysis [2026]
  • Clinical Breast Cancer
    • Invasive Breast Cancer Treatment Patterns in Women Age 80 and Over: A Report from the National Cancer Database [2022]
  • Infection Control & Hospital Epidemiology
    • Postdischarge prophylactic antibiotics following mastectomy with and without breast reconstruction [2022]
  • JAMA
    • Uptake and Costs of Hypofractionated vs Conventional Whole Breast Irradiation After Breast Conserving Surgery in the United States, 2008–2013 [2014]
  • JAMA Oncology
    • Temporal Trends in Post-Mastectomy Radiation Therapy and Breast Reconstruction [2016]
  • JAMA Surgery
    • Analysis of a Trend Reversal in US Lumpectomy Rates From 2005 Through 2017 Using 3 Nationwide Data Sets [2022]
  • JCO Oncology Practice
    • Disparities at the Intersection of Race and Ethnicity: Examining Trends and Outcomes in Hispanic Women With Breast Cancer [2022]
    • Disaggregation of Asian American and Pacific Islander Women With Stage 0-II Breast Cancer Unmasks Disparities in Survival and Surgery-to-Radiation Intervals: A National Cancer Database Analysis From 2004 to 2017 [2022]
    • Advances in Breast Cancer Radiotherapy: Implications for Current and Future Practice [2021]
  • Journal of Plastic Surgery and Hand Surgery
    • Autologous and implant based immediate breast reconstructive trends following unilateral modified radical and radical mastectomy: a SEER database analysis [2025]
  • Journal of Reconstructive Microsurgery
    • Trends in Hospital Billing for Mastectomy and Breast Reconstruction Procedures from 2013 to 2020 [2024]
  • Journal of Surgical Oncology
    • Effects of COVID-19 on mastectomy and breast reconstruction rates: A national surgical sample [2022]
  • M.D. Anderson Cancer Center
    • Evolution in Surgical Management of Breast Cancer-related Lymphedema: The MD Anderson Cancer Center Experience [2020]
    • DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes [2017]
    • Breast reconstruction at the MD Anderson Cancer Center [2016]
  • Medicina
    • Post-Mastectomy Breast Reconstruction Disparities: A Systematic Review of Sociodemographic and Economic Barriers [2024]
  • Medicine
    • Impact of lack of surgery on outcomes in elderly women with nonmetastatic breast cancer-A surveillance, epidemiology, and end results 18 population based study [2020]
  • National Comprehensive Cancer Network
    • NCCN Guidelines Update: Evolving Radiation Therapy Recommendations for Breast Cancer [2017]
    • Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology [2016]
  • npj Breast Cancer
    • Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint [2018]
  • Plastic and Reconstructive Surgery Global Open
    • Breast Reconstruction in Inflammatory Breast Cancer: An Analysis of Predictors, Trends, and Survival from the National Cancer Database [2021]
  • Radiation Research
    • Trends in Dose to the Contralateral Breast from Breast Cancer Radiotherapy in the United States [2025]
• Western countries
  • Microsurgery
    • Postmastectomy Breast Reconstruction Following Massive Weight Loss: An Updated Systematic Review and Identification of Research Gaps [2026]
• {Related topics}
  • Topic
    • Breast plastic surgery
    • Breast cancer treatment

Breast imaging

• Asia
  • Diagnostics
    • Is Ultrasound an Accurate Alternative for Mammography in Breast Cancer Screening in an Asian Population? A Meta-Analysis [2020]
• Australia
  • Journal of Medical Radiation Sciences
    • MRI screening for breast cancer in women at high risk; is the Australian breast MRI screening access program addressing the needs of women at high risk of breast cancer? [2015]
• Australia, New Zealand
  • Australasian Society for Ultrasound in Medicine
    • Guidelines on Breast Ultrasound Examination and Reporting [2018]
• Canada
  • Alberta Health Services
    • Staging Investigations for Patients with Newly Diagnosed Breast Cancer
  • Canadian Association of Radiologists
    • Canadian Association of Radiologists Breast Disease Imaging Referral Guideline [2024]
    • COVID-19: Safe Guidelines for Breast Imaging During the Pandemic [2020]
    • Breast Imaging and Intervention [2016]
  • Canadian Association of Radiologists Journal
    • Medico-Legal Cases in Breast Imaging in Canada: A Trend Analysis [2024]
  • Canadian Society of Breast Imaging
    • The Canadian Society of Breast Imaging Recommendations for the Management of Axillary Adenopathy in Patients with Recent COVID-19 Vaccination - Update [2021]
    • Resources
  • Ontario Health
    • Breast Magnetic Resonance Imaging for Preoperative Evaluation of Breast Cancer: A Systematic Review and Meta-Analysis [2024]
    • Preoperative Breast Magnetic Resonance Imaging [2023]
    • Baseline Staging Imaging for Distant Metastasis in Women with Stage I, II, and III Breast Cancer [2019]
    • The Utility of PET/CT in Breast Cancer (Stages II-IV): An Evidence Summary [2014]
    • Effectiveness of Screening With Annual Magnetic Resonance Imaging and Mammography: Results of the Initial Screen From the Ontario High Risk Breast Screening Program [2014]
• Central and Eastern Europe
  • Pathology & Oncology Research
    • Use of Diagnostic Imaging Modalities in Modern Screening, Diagnostics and Management of Breast Tumours 1st Central-Eastern European Professional Consensus Statement on Breast Cancer [2022]
• Europe
  • European Commission
    • Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC) [2021]
  • European Society of Breast Imaging
    • ESR Essentials: artificial intelligence in breast imaging-practice recommendations by the European Society of Breast Imaging [2026]
    • European Society of Breast Imaging (EUSOBI) guidelines on the management of axillary lymphadenopathy after COVID-19 vaccination: 2023 revision [2023]
    • Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI) [2022]
    • A survey by the European Society of Breast Imaging on the implementation of breast diffusion-weighted imaging in clinical practice [2022]
    • Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging (EUSOBI) [2021]
    • Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group [2020]
    • Breast ultrasound: recommendations for information to women and referring physicians by the European Society of Breast Imaging [2018]
    • A survey by the European Society of Breast Imaging on the utilisation of breast MRI in clinical practice [2017]
    • Breast MRI: EUSOBI recommendations for women’s information [2015]
    • Breast MRI: guidelines from the European Society of Breast Imaging [2008]
• Europe, United States
  • European Association of Nuclear Medicine
    • The EANM-SNMMI guideline on the role of [18F]FDG-PET/CT in breast cancer: Important milestones and perspectives for the future [2024]
    • Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer : (endorsed by the ACR, ESSO, ESTRO, EUSOBI/ESR, and EUSOMA) [2024]
  • European Journal of Nuclear Medicine and Molecular Imaging
    • Joint EANM-SNMMI guidelines on the role of 2-[18F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines [2024]
  • Society of Nuclear Medicine and Molecular Imaging
    • Summary: SNMMI Procedure Standard/EANM Practice Guideline for Estrogen Receptor Imaging of Patients with Breast Cancer Using 16a-[18F]Fluoro-17ß-Estradiol PET [2024]
• Germany
  • Breast Care
    • Consensus Meeting of Breast Imaging: BI-RADS® and Beyond [2019]
  • RöFo
    • Recommendations of the German Radiological Society's breast imaging working group regarding breast MRI [2024]
    • Updated Recommendations for MRI of the Breast [2014]
  • Ultraschall in der Medizin
    • Best Practice Guidelines - DEGUM Recommendations on Breast Ultrasound [2025]
    • Best Practice Guideline – DEGUM Recommendations on Breast Ultrasound – Part I – Examination technique, DEGUM ultrasound criteria, and documentation [2022]
• High-income countries
  • European Journal of Public Health
    • Contrast-associated risks of iodine-based contrast media administration in breast imaging: Tips and overview of existing evidence - A narrative review [2026]
• Hong Kong
  • Hong Kong Medical Journal
    • Use of 18F-fluorodeoxyglucose positron emission tomography coupled with computed tomography in early breast cancer management: consensus-based local recommendations by the Hong Kong Breast Cancer Foundation PET/CT Study Group [2025]
• India
  • Annals of the National Academy of Medical Sciences
    • Best Practice Guidelines for Breast Imaging, Breast Imaging Society, India: Part-2 [2022]
    • Best Practice Guidelines for Breast Imaging, Breast Imaging Society, India: Part-1 [2022]
• International
  • Asian Pacific Journal of Cancer Prevention
    • Radiology Surveillance for Breast Cancer Survivors: A Systematic Review and Meta-Analysis [2026]
  • BMC Cancer
    • Ultrasound for predicting pathological response to neoadjuvant chemotherapy in patients with breast cancer: a systematic review and meta-analysis [2026]
  • BMC Medical Imaging
    • Performance of artificial intelligence-assisted ultrasound elastography in classifying benign and malignant breast tumors: a systematic review and meta-analysis [2025]
  • Breast
    • Supplemental imaging modalities for breast cancer screening in women with dense breasts: A systematic review with economic considerations [2026]
  • Cancer Reports
    • Diagnostic Test Accuracy of Apparent Diffusion Coefficient in Evaluation of Breast Cancer Lymph Node Metastasis: A Systematic Review and Meta-Analysis [2025]
  • Clinical Breast Cancer
    • Performance of Supplemental Imaging Modalities for Breast Cancer in Women With Dense Breasts: Findings From an Umbrella Review and Primary Studies Analysis [2023]
  • European Journal of Surgical Oncology
    • Comparison of contrast-enhanced mammography and breast MRI in tumour extent assessment: A systematic review and meta-analysis [2026]
  • European Radiology
    • Barriers and facilitators of artificial intelligence conception and implementation for breast imaging diagnosis in clinical practice: a scoping review [2024]
  • European Society of Breast Imaging
    • Advanced breast diffusion-weighted imaging: what are the next steps? A proposal from the EUSOBI International Breast Diffusion-weighted Imaging working group [2024]
  • Journal of Applied Clinical Medical Physics
    • MRI-based radiomics models for early predicting pathological response to neoadjuvant chemotherapy in triple-negative breast cancer: A systematic review and meta-analysis [2025]
  • Journal of Translational Medicine
    • Detection of breast cancer lesions using APT weighted MRI: a systematic review [2025]
  • Radiology: Imaging Cancer
    • Performance of Diagnostic Breast Imaging in Symptomatic Pregnant and Lactating Patients: Systematic Review and Meta-Analysis [2025]
  • Tomography
    • A Review of Artificial Intelligence in Breast Imaging [2024]
  • World Federation for Ultrasound in Medicine and Biology
    • WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 2: breast [2015]
• Italy
  • La radiologia medica
    • Breast imaging and cancer diagnosis during the COVID-19 pandemic: recommendations from the Italian College of Breast Radiologists by SIRM [2020]
• Japan
  • Annals of Nuclear Medicine
    • Clinical practice guidelines for high-resolution breast PET, 2019 edition [2021]
    • Clinical practice guideline for dedicated breast PET [2014]
  • Japanese Journal of Radiology
    • Ultrafast MRI and diffusion-weighted imaging: a review of morphological evaluation and image quality in breast MRI [2025]
  • Journal of Medical Ultrasonics
    • The Japan Society of Ultrasonics in Medicine guidelines on non-mass abnormalities of the breast [2023]
• Netherlands
  • JAMA Oncology
    • Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk [2020]
• Republic of Korea
  • Ultrasonography
    • Practice guideline for the performance of breast ultrasound elastography [2014]
• South Africa
  • SA Journal of Radiology
    • Understanding indications and defining guidelines for breast magnetic resonance imaging [2018]
• United Kingdom
  • National Institute for Health and Care Excellence
    • Aixplorer ShearWave Elastography for ultrasound imaging and assessing suspicious breast lesions [2014]
  • NHS England
    • Breast screening: using MRI with higher risk women
    • Breast screening: acquisition and testing of ultrasound scanners
  • Royal College of Radiologists
    • Guidance on screening and symptomatic breast imaging, Fourth edition [2019]
    • Recommendations for cross sectional imaging in cancer management, Second edition: Breast cancer [2014]
• United States
  • American College of Radiology
    • Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer [2010]
    • Supplemental Breast Cancer Screening Based on Breast Density
    • Palpable Breast Masses
    • Mammography and Breast Imaging Resources
    • Imaging of the Axilla
    • Imaging of Invasive Breast Cancer
    • Imaging of Ductal Carcinoma in Situ (DCIS)
    • Imaging After Mastectomy and Breast Reconstruction
    • Imaging After Breast Surgery
    • Evaluation of Nipple Discharge
    • Breast Pain
    • Breast Imaging of Lactating Women
    • Breast Imaging During Pregnancy
    • ACR Practice Parameter for the Performance of Whole-Breast Ultrasound for Screening and Staging
    • ACR Practice Parameter for the Performance of Preoperative Image-Guided Localization in the Breast
    • ACR Practice Parameter for the Performance of Molecular Breast Imaging (MBI) Using a Dedicated Gamma Camera
    • ACR Practice Parameter for the Performance of Contrast-Enhanced Magnetic Resonance Imaging (MRI) of the Breast
  • American Society of Breast Surgeons
    • Consensus Statement on Diagnostic and Screening Magnetic Resonance Imaging of the Breast [2018]
  • Breast Cancer Surveillance Consortium
    • Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium [2021]
    • Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk [2019]
    • Is Breast MRI Better at Finding Second Breast Cancers than Mammograms Alone for Breast Cancer Survivors? [2019]
    • The Role of Preoperative Magnetic Resonance Imaging in the Assessment and Surgical Treatment of Interval and Screen-Detected Breast Cancer in Older Women [2016]
    • Patterns of breast magnetic resonance imaging use in community practice [2014]
  • Breast Journal
    • Screening Magnetic Resonance Imaging Recommendations and Outcomes in Patients at High Risk for Breast Cancer [2015]
  • Cancer
    • Disparities in the Use of Screening Breast MRI in Community Practice by Race, Ethnicity and Socioeconomic Status [2015]
  • Clinical Imaging
    • Recent trends in the utilization of molecular breast imaging in the United States [2026]
  • Journal of Breast Imaging
    • Establishing an Evidence-based Modern Breast MRI Program [2026]
• {Related topics}
  • Topic
    • Breast cancer screening, mammography
    • Breast cancer diagnosis
    • Breast cancer
    • Benign breast diseases

Breast plastic surgery

• Australia
  • Australian Journal of General Practice
    • Breast implants: A guide for general practice [2021]
  • NSW Health
    • Toolkit for the management of breast implants
    • Recommended management of a patient with a breast implant
• Australia, New Zealand
  • Plastic and Reconstructive Surgery Global Open
    • Breast Implant Selection: Consensus Recommendations Using a Modified Delphi Method [2019]
• Canada
  • Alberta Health Services
    • Navigating Breast Implants, Cancer & Illness
  • Canada's Drug Agency
    • Povidone-Iodine for Breast Implant Surgery: A Review of Clinical Effectiveness and Guidelines [2019]
  • Public Health Agency of Canada
    • Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) – Canadian Surveillance 2023 Data
• Denmark
  • Danish Medical Journal
    • Poor adherence to clinical guidelines for women undergoing breast reduction [2016]
• Europe
  • European Association of Plastic Surgeons
    • Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Review of Epidemiology and Prevalence Assessment in Europe [2021]
  • European Commission
    • Guidance on the vigilance system for CE-marked devices - Breast implants [2024]
• Europe, United States
  • Plastic and Reconstructive Surgery Global Open
    • Breast Implant Utilization Trends in USA versus Europe and the Impact of BIA-ALCL Publications [2021]
• Germany
  • Geburtshilfe und Frauenheilkunde
    • Biological Matrices and Synthetic Meshes Used in Implant-based Breast Reconstruction – a Review of Products Available in Germany [2013]
• International
  • Aesthetic Surgery Journal
    • 2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCL [2022]
    • Expert Consensus on the Use of a New Bioengineered, Cell-Friendly, Smooth Surface Breast Implant [2019]
  • BMC Surgery
    • A systematic review and meta-analysis of risks and benefits with breast reduction in the public healthcare system: priorities for further research [2021]
  • European Journal of Breast Health
    • New Data on the Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma [2021]
  • European Journal of Medical Research
    • Risk factors for complications after reduction mammaplasty: a systematic review and meta-analysis [2025]
  • Journal of Plastic, Reconstructive & Aesthetic Surgery
    • Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma - A systematic review of literature [2026]
  • Modern Pathology
    • Breast implant-associated anaplastic large cell lymphoma: a review [2019]
  • Tidsskrift for Den norske legeforening
    • Breast implant-associated anaplastic large cell lymphoma [2024]
• Ireland
  • Ireland's Health Services
    • Breast Implant Associated Anaplastic Large Cell Lymphoma - BIA-ALCL Report [2021]
• Israel
  • Israel Medical Association Journal
    • Breast Implantation Rates in Israel: Is There a Change in Trend? [2021]
• Italy
  • Breast
    • Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL [2022]
  • Medicina
    • BIA-ALCL and BIA-SCC: Updates on Clinical Features and Genetic Mutations for Latest Recommendations [2024]
• Netherlands
  • Aesthetic Plastic Surgery
    • Medical Specialist Care Utilization Prior to the Explantation of Cosmetic Silicone Breast Implants: A Nationwide Retrospective Data Linkage Study [2024]
  • Aesthetic Surgery Journal
    • Breast Implant Prevalence in the Dutch Female Population Assessed by Chest Radiographs [2020]
• Republic of Korea
  • BMC Surgery
    • Litigation meets evidence: a novel approach to understanding preventable complications in breast reconstruction [2025]
  • Medicine
    • Current status of an implant-based augmentation mammaplasty in Korean women: Implications for risk management and social sustainability of breast implant industry in the context of the first Korean case of a medical device fraud [2025]
• Sweden
  • Journal of Plastic Surgery and Hand Surgery
    • Prevalence of women with breast implants in Sweden: a study based on the population-based mammography screening programme [2023]
• United Kingdom
  • Academy of Medical Royal Colleges
    • Breast reduction [2024]
    • Breast prosthesis removal [2024]
  • Association of Breast Surgery
    • UK Guidelines for Lipomodelling of the Breast on behalf of Plastic, Reconstructive and Aesthetic Surgery and Association of Breast Surgery Expert Advisory Group [2022]
  • British Psychological Society
    • Guideline for the role of practitioner psychologists in the assessment and support of women considering risk-reducing breast surgery [2018]
  • Medicines and Healthcare products Regulatory Agency
    • UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG) [2021]
    • Symptoms sometimes referred to as Breast Implant Illness
    • Breast implant associated anaplastic large cell lymphoma (BIA-ALCL)
  • NHS Digital
    • Breast and Cosmetic Implant Registry
  • NHS England
    • Breast screening: imaging women with breast implants
    • Breast screening: breast implant guidelines
  • Women's Health
    • A guide to breast implants for the non-breast specialist [2016]
• United States
  • Aesthetic Surgery Journal
    • Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma in the United States: A Systematic Review [2023]
  • American Association of Plastic Surgeons
    • American Association of Plastic Surgeons Consensus on Breast Implant-Associated Anaplastic Large-Cell Lymphoma [2024]
  • American College of Radiology
    • Breast Implant Evaluation
  • American Family Physician
    • Breast Implants: Common Questions and Answers [2021]
  • Centers for Medicare & Medicaid Services
    • Cosmetic and Reconstructive Surgery
  • Food and Drug Administration
    • Saline, Silicone Gel, and Alternative Breast Implants [2020]
    • Breast Implants
  • Journal of Clinical Oncology
    • Best Practices Guideline for the Pathologic Diagnosis of Breast Implant–Associated Anaplastic Large-Cell Lymphoma [2020]
  • Journal of General Internal Medicine
    • Breast Implant Safety: an Overview of Current Regulations and Screening Guidelines [2022]
  • Maturitas
    • Breast plastic surgery in perimenopausal and postmenopausal women: Menopause-informed counseling on screening, safety, and long-term breast health [2026]
  • Plastic and Reconstructive Surgery
    • Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE): Initial Report of Findings 2012 – 2018 [2019]
  • Plastic Surgery
    • Breast Implant–Associated Anaplastic Large-Cell Lymphoma: Current Understanding and Recommendations for Management [2020]
  • Seminars in Plastic Surgery
    • Finding Consensus After Two Decades of Breast Implant-Associated Anaplastic Large Cell Lymphoma [2019]
  • StatPearls
    • Breast Implants
    • Breast Augmentation
• Western countries
  • Aesthetic Plastic Surgery
    • The Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma; A Systematic Review and Meta-Analysis [2024]
• {Related topics}
  • Topic
    • Breast cancer treatment: surgery, radiotherapy
    • Breast cancer
    • Benign breast diseases

Familial breast cancer, hereditary breast cancer, genetic predisposition

• Africa
  • International Journal of Breast Cancer
    • Breast Cancer in Africa: Limitations and Opportunities for Application of Genomic Medicine [2016]
• Asia
  • Journal of Medical Genetics
    • Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries [2015]
• Brunei Darussalam
  • PLoS ONE
    • Prevalence and spectrum of germline BRCA1 and BRCA2 mutations in multiethnic cohort of breast cancer patients in Brunei Darussalam [2025]
• Canada
  • Canadian Family Physician
    • Identification and management of women with a family history of breast cancer: Practical guide for clinicians [2016]
  • Current Oncology
    • Canadian Recommendations for Germline Genetic Testing of Patients with Breast Cancer: A Call to Action [2025]
• China
  • Chinese Medical Journal
    • Clinical practice guideline of BRCA1/2 testing for patients with breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021 [2021]
  • Frontiers in Oncology
    • Familial Breast Cancer: Disease Related Gene Mutations and Screening Strategies for Chinese Population [2021]
  • Journal of Epidemiology
    • Hereditary Breast Cancer in the Han Chinese Population [2013]
  • PLoS ONE
    • Identification of a Comprehensive Spectrum of Genetic Factors for Hereditary Breast Cancer in a Chinese Population by Next-Generation Sequencing [2015]
• China, United States
  • Scientific Reports
    • Cost-effectiveness of talazoparib for patients with germline BRCA1/2 mutated HER2-negative advanced breast cancer in China and the US [2024]
• Europe
  • European Journal of Cancer
    • Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendations [2019]
  • European Society for Medical Oncology
    • Breast cancer germline multigene panel testing in mainstream oncology based on clinical-public health utility: ESMO Precision Oncology Working Group recommendations [2025]
    • BRCA in breast cancer: ESMO Clinical Practice Guidelines [2011]
  • Journal of Community Genetics
    • Genetic testing for familial/hereditary breast cancer—comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany [2011]
• France
  • Oncologist
    • Factors Influencing Adherence to the Risk Management Program for Women With a Genetic Predisposition to Breast Cancer: Real-World Data from a French Multicenter Program [2024]
• Germany
  • Cancer Medicine
    • Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer [2018]
• High-income countries
  • JAMA Oncology
    • MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations [2024]
• International
  • Breast
    • Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis [2021]
  • Breast Cancer Research
    • Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers [2020]
  • British Journal of Radiology
    • Radiogenomic profiling to determine BRCA alteration status-a systematic review and meta-analysis [2025]
  • Cancer Control
    • Clinical Management in BRCA Carriers with Early Breast Cancer [2025]
  • Cancer Management and Research
    • A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated breast cancer [2019]
  • Cancer Medicine
    • A systematic review of recommendations on screening strategies for breast cancer due to hereditary predisposition: Who, When, and How? [2021]
  • Clinical Epidemiology
    • A systematic review of the international prevalence of BRCA mutation in breast cancer [2019]
  • Journal of Medical Economics
    • Value of germline BRCA testing in patients with breast cancer: critical review of cost-effectiveness analyses using published value frameworks [2025]
  • New England Journal of Medicine
    • Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk [2015]
  • Radiotherapy and Oncology
    • Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study [2026]
• Iran
  • Journal of Research in Medical Sciences
    • BRCA1 and BRCA2 mutations in Iranian breast cancer patients: A systematic review [2015]
• Ireland
  • Health Information and Quality Authority
    • HTA of High Risk Breast Cancer Surveillance [2013]
• Italy
  • Breast
    • PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology [2022]
  • Cancer Treatment Reviews
    • Predictive BRCA Genetic Testing in Italian Patients with Breast Cancer: A Position Paper of Italian Scientific Societies [Italian Association of Medical Oncology (AIOM); Italian Association of Radiotherapy and Clinical Oncology (AIRO); Italian National Association of Breast Surgeons (ANISC); Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP); Italian Society of Surgical Oncology (SICO); Italian Society of Human Genetic (SIGU); Italian Society of General Practice (SIMG); Italian Society of Medical and Interventional Radiology (SIRM)] [2025]
    • Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review [2024]
  • Current Oncology
    • BRCA Testing for Patients Treated in Italy: A National Survey of Breast Centers Associated with Senonetwork [2024]
• Japan
  • Journal of Human Genetics
    • The relationship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database [2021]
• Latin America
  • Revista de Investigación Clínica
    • Genetic Cancer Risk Assessment for Breast Cancer in Latin America [2017]
• Low and middle income countries
  • BMC Cancer
    • Economic evaluation of germline genetic testing for breast cancer in low- and middle-income countries: a systematic review [2024]
• Malaysia
  • Malaysian Journal of Pathology
    • Utilisation of the Malaysian BRCA variants database to construct a target panel for biosensor-based genetic breast cancer screening [2025]
• Netherlands
  • Breast Cancer Research
    • The impact of a mainstream genetic testing pathway and socioeconomic factors on the uptake of germline genetic testing in breast cancer patients: results of the nationwide GENE-SMART study [2025]
  • European Journal of Human Genetics
    • Evaluation of the Dutch BRCA1/2 clinical genetic center referral criteria in an unselected early breast cancer population [2014]
  • Journal of Medical Genetics
    • Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases [2023]
• North Asia
  • Asian Pacific Journal of Cancer Prevention
    • A Systematic Review of the Prevalence of Germline BRCA mutations in North Asia Breast Cancer Patients [2024]
• Norway
  • BMC Cancer
    • Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers [2017]
• Republic of Korea
  • Archives of Plastic Surgery
    • Perceptions of Prophylactic Mastectomy in Korea [2016]
  • Cancer Research and Treatment
    • Short-term Impact of Hormone Replacement Therapy on Risk of Breast Cancer in BRCA Mutation Carriers: A Nationwide Study in South Korea [2024]
    • Implementation of BRCA Test among Young Breast Cancer Patients in South Korea: A Nationwide Cohort Study [2024]
  • International Journal of Environmental Research and Public Health
    • Association of Family History with the Development of Breast Cancer: A Cohort Study of 129,374 Women in KoGES Data [2021]
  • JAMA Network Open
    • Association of Breast Cancer Family History With Breast Density Over Time in Korean Women [2023]
  • Journal of Breast Cancer
    • The Korean Hereditary Breast Cancer Study: Review and Future Perspectives [2013]
• Slovenia
  • European Journal of Surgical Oncology
    • Trends and timing of risk-reducing mastectomy uptake in unaffected BRCA1 and BRCA2 carriers in Slovenia [2021]
• Spain
  • PLoS ONE
    • Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM “El Álamo III” retrospective study [2017]
  • Sociedad Española de Oncología Médica
    • SEOM clinical guideline on heritable TP53-related cancer syndrome (2022) [2023]
• Thailand
  • Frontiers in Public Health
    • A cost-utility analysis of BRCA1 and BRCA2 testing in high-risk breast cancer patients and family members in Thailand: a cost-effective policy in resource-limited settings [2023]
• United Arab Emirates
  • Breast
    • Clinicopathological characteristics of gene-positive breast cancer in the United Arab Emirates [2020]
• United Kingdom
  • Breast Cancer Research and Treatment
    • Family history and risk of breast cancer: an analysis accounting for family structure [2017]
  • British Journal of General Practice
    • Dealing with family history of breast cancer: something new, something old [2014]
  • Journal of Community Genetics
    • Specialist recommendation for chemoprevention medications in patients at familial risk of breast cancer: a cross-sectional survey in England [2021]
  • Journal of Medical Genetics
    • Update: variable implementation of the 2018 UKCGG/UKGTN guidelines for breast cancer gene panel tests offered by UK genetics services [2021]
  • National Institute for Health and Care Excellence
    • Olaparib for treating BRCA mutation-positive HER2-negative advanced breast cancer after chemotherapy [2025]
    • Talazoparib for treating HER2-negative advanced breast cancer with germline BRCA mutations [2024]
    • Olaparib for adjuvant treatment of BRCA mutation-positive HER2-negative high-risk early breast cancer after chemotherapy [2023]
    • Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer [2023]
  • Right Decisions
    • Familial breast cancer
• United States
  • American Journal of Human Genetics
    • Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer [2016]
  • American Society for Radiation Oncology
    • ASTRO Radiation Therapy Summary of the ASCO-ASTRO-SSO Guideline on Management of Hereditary Breast Cancer [2020]
  • American Society of Breast Surgeons
    • Consensus Guidelines on Genetic Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons [2019]
  • American Society of Clinical Oncology
    • Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline Q and A [2024]
    • Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline [2024]
    • Adjuvant PARP Inhibitors in Patients With High-Risk Early-Stage HER2-Negative Breast Cancer and Germline BRCA Mutations: ASCO Hereditary Breast Cancer Guideline Rapid Recommendation Update [2021]
    • Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline [2020]
  • Breast Cancer
    • Do current family history-based genetic testing guidelines contribute to breast cancer health inequities? [2022]
  • Breast Cancer Research and Treatment
    • Adherence to the 2020 American Cancer Society Guideline for Cancer Prevention and risk of breast cancer for women at increased familial and genetic risk in the Breast Cancer Family Registry: an evaluation of the weight, physical activity, and alcohol consumption recommendations [2022]
  • Breast Cancer Surveillance Consortium
    • Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort [2018]
    • Family history of breast cancer, breast density, and breast cancer risk in a U.S. breast cancer screening population [2017]
    • Emerging Trends in Family History of Breast Cancer and Associated Risk [2017]
  • JAMA Network Open
    • Cost-Effectiveness of Adjuvant Olaparib for Patients With Breast Cancer and Germline BRCA1/2 Mutations [2024]
  • Journal of Community Genetics
    • Psychosocial approaches to participation in BRCA1/2 genetic risk assessment among African American women: a systematic review [2014]
• Western countries
  • Journal of Clinical Oncology
    • Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2 [2025]
• {Related topics}
  • Topic
    • Hereditary gynecologic cancer, genetic predisposition
    • Gynecologic oncology
    • Breast cancer risk
    • Breast cancer

Mastitis

• Americas
  • Frontiers in Medicine
    • Non-lactational Infectious Mastitis in the Americas: A Systematic Review [2021]
• Australia
  • BMC Primary Care
    • General practitioners' management of mastitis in breastfeeding women: a mixed method study in Australia [2024]
  • BMJ Open
    • Trends in clinical management of lactational mastitis among women attending Australian general practice: a national longitudinal study using MedicineInsight, 2011-2022 [2024]
• China
  • Chinese Medical Journal
    • Clinical practice guidelines for diagnosis and treatment of patients with non-puerperal mastitis: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021 [2021]
• Eastern and Southern Africa
  • International Breastfeeding Journal
    • Prevalence of and factors associated with lactational mastitis in eastern and southern Africa: an exploratory analysis of community-based household surveys [2022]
• Europe
  • Nutrients
    • Subclinical Mastitis in a European Multicenter Cohort: Prevalence, Impact on Human Milk (HM) Composition, and Association with Infant HM Intake and Growth [2019]
• Germany
  • Geburtshilfe und Frauenheilkunde
    • S3-Guidelines for the Treatment of Inflammatory Breast Disease during the Lactation Period [2013]
• International
  • Breast Journal
    • Factors Affecting Recurrence of Idiopathic Granulomatous Mastitis: A Systematic Review [2023]
  • Cochrane Database of Systematic Reviews
    • Interventions for preventing mastitis after childbirth [2020]
  • European Journal of Medical Research
    • Treatment modalities for granulomatous mastitis, seeking the most appropriate treatment with the least recurrence rate: a systematic review and meta-analysis [2024]
  • Journal of Human Lactation
    • Incidence of and Risk Factors for Lactational Mastitis: A Systematic Review [2020]
  • Military Medical Research
    • Management of granulomatous lobular mastitis: an international multidisciplinary consensus (2021 edition) [2022]
• Iran
  • International Journal of Mycobacteriology
    • Breast Tuberculosis in Iran: A Comprehensive Review [2024]
• Ireland
  • Ireland's Health Services
    • Nipple and breast thrush
    • Lactational Mastitis
• Ireland, United Kingdom
  • British Journal of Surgery
    • Mastitis and Mammary Abscess Management Audit (MAMMA) in the UK and Ireland [2024]
• New Zealand
  • Health New Zealand
    • Breast Feeding – Mastitis and Breast Abscess Treatment and Prevention [2023]
• United Kingdom
  • Right Decisions
    • Mastitis and breast abscess (Guidelines)
• United States
  • Academy of Breastfeeding Medicine
    • Academy of Breastfeeding Medicine Clinical Protocol #36: The Mastitis Spectrum, Revised 2022 [2022]
  • American Society of Breast Surgeons
    • American Society of Breast Surgeons, Society of Breast Imaging, and College of American Pathology 2025 Guidelines for the Management of Infectious and Inflammatory Lesions of the Breast [2026]
    • Presentation and Management of Granulomatous Mastitis in the United States: Results of an American Society of Breast Surgeons Registry Study [2024]
  • Annals of Breast Surgery
    • Abscess/infections/periareolar mastitis [2021]
  • Cleveland Clinic Journal of Medicine
    • Does every patient with lactational mastitis require antibiotic treatment? [2024]
  • StatPearls
    • Acute Mastitis
• WHO
  • World Health Organization
    • Mastitis: causes and management [2000]
• {Related topics}
  • Topic
    • Breastfeeding difficulties
    • Benign breast diseases

Sentinel lymph node biopsy, axillary management

• Austria
  • Wiener klinische Wochenschrift
    • Axillary lymph node status and invasive lobular breast cancer : Analysis of the Clinical Tumor Register of the AGO Austria [2023]
• Canada
  • Canada's Drug Agency
    • Magnetic Localization System for Sentinel Lymph Node Biopsy: A Review of the Diagnostic Accuracy, Cost-Effectiveness, and Guidelines [2020]
    • Sentinel Lymph Node Biopsy for the Management of Breast Cancer: A Review of Guidelines [2019]
• Canada, United States
  • Ontario Health
    • Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline [2021]
• China
  • Chinese Medical Journal
    • Clinical practice guidelines for sentinel lymph node biopsy in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
  • PeerJ
    • The value of nanocarbon contrast methylene blue based on dye-based tracer technology in sentinel lymph node biopsy for breast cancer: a systematic review and meta-analysis [2025]
  • Scientific Reports
    • The feasibility of the ACOSOG Z0011 Criteria to Chinese Breast Cancer Patients: A Multicenter Study [2015]
• Denmark
  • Annals of Surgical Oncology
    • Comparing Methods for Targeted Axillary Dissection in Breast Cancer Patients: A Nationwide, Retrospective Study [2023]
• Germany
  • Archives of Gynecology and Obstetrics
    • Current trends in diagnostic and therapeutic management of the axilla in breast cancer patients receiving neoadjuvant therapy: results of the German-wide NOGGO MONITOR 24 survey [2023]
    • Prognostic value and management of regional lymph nodes in locoregional breast cancer recurrence: a systematic review of the literature [2022]
  • Geburtshilfe und Frauenheilkunde
    • AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update [2021]
• High-income countries
  • BJS Open
    • Sentinel lymph node biopsy in patients with ductal carcinoma in situ: systematic review and meta-analysis [2022]
• International
  • BJS Open
    • Safe and transparent introduction and evaluation of targeted axillary dissection in patients with node-positive breast cancer undergoing primary surgery: international consensus process [2025]
  • Breast
    • Optimizing axillary lymph node management in early-stage HR+/HER2- breast cancer: Practical strategies for enhanced detection rates [2026]
  • Breast Cancer
    • The Feasibility and Reliability of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer Patients With Negative Axillary Lymph Nodes-A Meta-analysis [2024]
  • Cancer Treatment Reviews
    • Uncertainties and controversies in axillary management of patients with breast cancer [2023]
  • Clinical Breast Cancer
    • Impact of Sentinel Lymph Node Biopsy on Management of Older Women With Clinically Node-Negative, Early-Stage, ER+/HER2-, Invasive Breast Cancer: A Systematic Review and Meta-Analysis [2024]
  • Clinics
    • The effectiveness of ultrasound-guided core needle biopsy in detecting lymph node metastases in the axilla in patients with breast cancer: systematic review and meta-analysis [2023]
  • Computational Intelligence and Neuroscience
    • Accuracy and Utility of Preoperative Ultrasound-Guided Axillary Lymph Node Biopsy for Invasive Breast Cancer: A Systematic Review and Meta-Analysis [2022]
  • Current Oncology
    • The Role of Sentinel Lymph Node Biopsy in Breast Cancer Patients Who Become Clinically Node-Negative Following Neo-Adjuvant Chemotherapy: A Literature Review [2023]
  • Frontiers in Oncology
    • Axillary management in patients with clinical node-negative early breast cancer and positive sentinel lymph node: a systematic review and meta-analysis [2024]
  • International Collaboration on Cancer Reporting
    • Reporting of Surgically Removed Lymph Nodes for Breast Tumors: Recommendations From the International Collaboration on Cancer Reporting [2022]
    • Surgically Removed Lymph Nodes for Breast Tumours
  • International Journal of Surgery
    • Performance of sentinel lymph node biopsy after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: systematic review and meta-analysis [2025]
  • Oncologist
    • Can axillary lymph node dissection be omitted in breast cancer patients with 1-2 positive sentinel nodes? A systematic review and meta-analysis [2025]
  • Society of Nuclear Medicine and Molecular Imaging
    • Summary: Appropriate Use Criteria for Lymphoscintigraphy in Sentinel Node Mapping and Lymphedema/Lipedema [2023]
  • Surgery
    • Indocyanine green fluorescence versus blue dye, technetium-99M, and the dual-marker combination of technetium-99M + blue dye for sentinel lymph node detection in early breast cancer-meta-analysis including consistency analysis [2024]
  • Systematic Reviews
    • Prediction of sentinel lymph node status in patients with early breast cancer using breast imaging as an alternative to surgical staging-a systematic review and meta-analysis [2025]
• Italy
  • Current Oncology
    • Axillary Management in Breast Cancer Patients Undergoing Upfront Surgery: Results from a Nationwide Survey on Behalf of the Clinical Oncology Breast Cancer Group (COBCG) and the Breast Cancer Study Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) [2023]
  • European Journal of Surgical Oncology
    • Is routine axillary lymph node dissection needed to tailor systemic treatments for breast cancer patients in the era of molecular oncology? A position paper of the Italian National Association of Breast Surgeons (ANISC) [2024]
• Netherlands
  • Annals of Surgical Oncology
    • What to Do with Non-visualized Sentinel Nodes? A Dutch Nationwide Survey Study [2017]
  • Breast Cancer Research and Treatment
    • Impact of analysis of the sentinel lymph node by one-step nucleic acid amplification (OSNA) compared to conventional histopathology on axillary and systemic treatment: data from the Dutch nationwide cohort of breast cancer patients [2024]
    • Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy [2016]
  • British Journal of Surgery
    • De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1-2 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07) [2024]
• Republic of Korea
  • World Journal of Surgical Oncology
    • Impact of the ACOSOG Z0011 trial on surgical practice in Asian patients: trends in axillary surgery for breast cancer from a Korean Breast Cancer Registry analysis [2022]
• Sweden
  • Breast Cancer Research and Treatment
    • Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer [2017]
• Türkiye
  • Langenbeck's Archives of Surgery
    • Changing practice patterns in axillary management for patients with node-positive breast cancer towards increased use of sentinel lymph node biopsy-alone after neoadjuvant chemotherapy: results of a survey (MF17-01) among Turkish surgeons [2025]
• United Kingdom
  • Breast Cancer Research and Treatment
    • Current axillary management of patients with early breast cancer and low-volume nodal disease undergoing primary surgery: results of a United Kingdom national practice survey [2024]
  • Clinical Oncology
    • Axillary Surgery Following Neoadjuvant Chemotherapy – Multidisciplinary Guidance From the Association of Breast Surgery, Faculty of Clinical Oncology of the Royal College of Radiologists, UK Breast Cancer Group, National Coordinating Committee for Breast Pathology and British Society of Breast Radiology [2019]
  • National Institute for Health and Care Excellence
    • Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancer [2022]
    • Intraoperative tests (RD-100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer [2013]
    • Endoscopic axillary lymph node retrieval for breast cancer [2005]
• United States
  • American Society of Breast Surgeons
    • Consensus Statement on Axillary Management for Patients With In-Situ and Invasive Breast Cancer: A Concise Overview [2022]
    • Resource Guide for Sentinel Lymph Node Biopsy in Breast Cancer Patients [2018]
  • American Society of Clinical Oncology
    • Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update [2025]
    • Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update [2017]
  • Annals of Surgical Oncology
    • Omission of Axillary Lymph Node Dissection in Patients with pT0-2 ER+/HER2- Breast Cancer with 3-5 Positive Lymph Nodes Undergoing Adjuvant Systemic Therapy and Radiation Does Not Impact Overall Survival: A National Cancer Database Analysis [2026]
    • Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery [2026]
    • National Variation in Implementation of Sentinel Lymph Node Biopsy for Clinically Node-Positive Patients Undergoing Neoadjuvant Therapy [2025]
    • Management and Outcomes in Patients with Breast Cancer with 1-of-1 and 2-of-2 Positive Sentinel Nodes [2025]
    • Is Choosing Wisely Wise for Lobular Carcinoma in Patients Over 70 Years of Age? A National Cancer Database Analysis of Sentinel Node Practice Patterns [2023]
    • Do the ACOSOG Z0011 Criteria Affect the Number of Sentinel Lymph Nodes Removed? [2015]
  • BMC Surgery
    • DCIS and axillary nodal evaluation: compliance with national guidelines [2017]
  • Breast Cancer Research and Treatment
    • Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough? [2020]
  • Cancer
    • Cost-effectiveness of Choosing Wisely guidelines for axillary observation in women older than age 70 years with hormone receptor-positive, clinically node-negative, operable breast tumors [2022]
  • Current Oncology
    • Surgical Management of the Axilla in Invasive Lobular Carcinoma in the Z1071 Era: A Propensity-Score Matched Analysis of the National Cancer Database [2022]
  • Current Oncology Reports
    • Axillary Management: How Much Is Too Much? [2024]
  • JAMA Network Open
    • Trends in Sentinel Lymph Node Biopsies in Patients With Inflammatory Breast Cancer in the US [2022]
  • Journal of Surgical Research
    • Disparities of Management of the Axilla in Women With Clinically Node Negative Breast Cancer [2020]
• Venezuela
  • ecancermedicalscience
    • Treatment plan for breast cancer with sentinel node metastasis [2014]
• {Related topics}
  • Topic
    • Breast cancer
    • Breast biopsy, breast pathology

Triple negative breast cancer

• Africa
  • BMJ Open
    • Triple-negative breast cancer prevalence in Africa: a systematic review and meta-analysis [2022]
• Australia
  • Hereditary Cancer in Clinical Practice
    • Assessment of genetic referrals and outcomes for women with triple negative breast cancer in regional cancer centres in Australia [2021]
  • Journal of Cancer Policy
    • The emerging burden of triple-negative breast cancer in Australia: Universal care does not guarantee equitable access [2026]
  • SA Health
    • Capecitabine and Pembrolizumab (Triple Negative Breast Cancer)
• Barbados
  • Cancer
    • High triple-negative breast cancer prevalence and aggressive prognostic factors in Barbadian women with breast cancer [2020]
• Brazil
  • BMC Cancer
    • Management of early-stage triple-negative breast cancer: recommendations of a panel of experts from the Brazilian Society of Mastology [2022]
• Canada
  • Current Oncology
    • Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025 [2026]
    • Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer [2024]
• China
  • Breast
    • Cost-effectiveness of sacituzumab tirumotecan versus chemotherapy for patients with metastatic triple-negative breast cancer in China [2025]
  • Cancer Medicine
    • Cost-effectiveness analysis of tumor-infiltrating lymphocytes biomarkers guiding chemotherapy de-escalation in early triple-negative breast cancer [2023]
  • Frontiers in Public Health
    • Toripalimab plus chemotherapy in the treatment of metastatic triple-negative breast cancer: a cost-effectiveness analysis [2024]
  • PLoS ONE
    • Cost-effectiveness of sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer in China [2026]
• Developed countries
  • PharmacoEconomics
    • Economic and Humanistic Burden of Triple-Negative Breast Cancer: A Systematic Literature Review [2022]
• Egypt
  • Journal of Medical Economics
    • The cost-effectiveness of treatment for high-risk, early-stage, triple-negative breast cancer in Egypt: an analysis of neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant single-agent pembrolizumab [2025]
• Europe
  • European Medicines Agency
    • The European Medicines Agency review of sacituzumab govitecan for the treatment of triple-negative breast cancer [2022]
• Finland
  • Breast Cancer Research and Treatment
    • FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population [2017]
• Germany
  • BMC Cancer
    • Adherence to treatment guidelines and survival in triple-negative breast cancer: a retrospective multi-center cohort study with 9156 patients [2013]
  • Geburtshilfe und Frauenheilkunde
    • Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) – Recommendations for Daily Routine Practice [2019]
• Hong Kong
  • Hong Kong Medical Journal
    • Expert consensus recommendations on the daily clinical use of pembrolizumab for early triple-negative breast cancer [2025]
• India
  • JCO Global Oncology
    • Meta-Analysis of Prevalence of Triple-Negative Breast Cancer and Its Clinical Features at Incidence in Indian Patients With Breast Cancer [2020]
  • South Asian Journal of Cancer
    • Practical consensus recommendations on management of triple-negative metastatic breast cancer [2018]
• International
  • American Society of Clinical Oncology Educational Book
    • Stage I Triple-Negative Breast Cancer: Moving From One-Size-Fits-All to a Personalized Approach [2026]
  • Asian Journal of Surgery
    • Efficacy of breast conservative surgery versus modified radical mastectomy for triple-negative breast cancer: A systematic review and meta-analysis [2022]
  • BJR|Artificial Intelligence
    • Radiologic imaging biomarkers in triple-negative breast cancer: a literature review about the role of artificial intelligence and the way forward [2024]
  • Breast
    • A systematic review and meta-analysis of BRCA1/2 mutation for predicting the effect of platinum-based chemotherapy in triple-negative breast cancer [2022]
  • British Journal of Cancer
    • Reconsidering the definition of triple-negative breast cancer in the immune checkpoint inhibitor era: an optimal cut-off value for hormone receptor percentage of HER2-negative invasive breast cancer [2026]
  • Cancer Treatment Reviews
    • Evolving therapeutics and ensuing cardiotoxicities in triple-negative breast cancer [2024]
  • Cancers
    • Sacituzumab Govitecan in Triple Negative Breast Cancer: A Systematic Review of Clinical Trials [2024]
    • Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer [2021]
  • Cell & Bioscience
    • Classifications of triple-negative breast cancer: insights and current therapeutic approaches [2025]
  • Cochrane Database of Systematic Reviews
    • Platinum-based chemotherapy for early triple-negative breast cancer [2023]
  • Critical Reviews in Oncology/Hematology
    • Benefit of adjuvant chemotherapy in patients with T1a-bN0, triple-negative breast cancer - A systematic review and meta-analysis [2026]
    • Reawakening the master switches in triple-negative breast cancer: A strategic blueprint for confronting metastasis and chemoresistance via microRNA-200/205: A systematic review [2024]
  • European Journal of Nuclear Medicine and Molecular Imaging
    • The impact of PET imaging on triple negative breast cancer: an updated evidence-based perspective [2024]
  • Expert Opinion on Biological Therapy
    • Developing combination therapies with biologics in triple-negative breast cancer [2024]
  • Frontiers in Immunology
    • The efficacy and safety of sacituzumab govitecan in the treatment of breast cancer: a systemic review and meta-analysis of emerging clinical data [2025]
  • Frontiers in Oncology
    • Efficacy and safety of taxanes combined with chemotherapy drugs in advanced triple negative breast cancer: A meta-analysis of 26 randomized controlled trials [2022]
  • Histopathology
    • Real-world prevalence of PD-L1 positivity in early-stage/metastatic triple-negative breast cancer: primary results and pathology insights from the global retrospective observational VANESSA study [2026]
  • ImmunoTargets and Therapy
    • Recent Advances in Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer [2025]
  • International Journal of Molecular Sciences
    • Non-Coding RNA-Based Therapeutic Strategies in Triple-Negative Breast Cancer: A Systematic Review [2026]
    • Triple-Negative Breast Cancer Unveiled: Bridging Science, Treatment Strategy, and Economic Aspects [2025]
  • International Journal of Nanomedicine
    • Extracellular Vesicles as Emerging Drug Delivery Platforms in Triple-Negative Breast Cancer: A Systematic Review [2026]
  • JNCI Cancer Spectrum
    • Treatment strategies for triple-negative primary breast cancer in older women: a systematic review [2025]
  • Journal of Biomedical Science
    • Non-coding RNAs as modulators of radioresponse in triple-negative breast cancer: a systematic review [2024]
  • Journal of Clinical Medicine
    • Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC) [2023]
  • Journal of the National Cancer Institute
    • The unique risk factor profile of triple-negative breast cancer: a comprehensive meta-analysis [2024]
  • Materials Today Bio
    • Research progress of paclitaxel nanodrug delivery system in the treatment of triple-negative breast cancer [2024]
  • Medicine
    • Comparing efficacy of neoadjuvant therapy of triple-negative breast cancer: A Bayesian network meta-regression analysis [2026]
  • Military Medical Research
    • Targeting RTKs/nRTKs as promising therapeutic strategies for the treatment of triple-negative breast cancer: evidence from clinical trials [2024]
  • Technology in Cancer Research & Treatment
    • Targeting Receptor Tyrosine Kinases as a Novel Strategy for the Treatment of Triple-Negative Breast Cancer [2024]
    • Molecular Classification, Treatment, and Genetic Biomarkers in Triple-Negative Breast Cancer: A Review [2023]
  • Translational Breast Cancer Research
    • Advances in antibody-drug conjugates in the treatment of advanced triple-negative breast cancer: a narrative review [2025]
• Italy
  • Cancer Treatment Reviews
    • Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review [2023]
  • Cancers
    • Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM) [2019]
  • Oncologist
    • Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan [2025]
• Japan
  • Breast
    • Comparison of neoadjuvant and adjuvant chemotherapy for operable triple-negative breast cancer before the era of immune checkpoint inhibitors: A retrospective study from the Japanese National Clinical Database-Breast Cancer Registry [2025]
• Mexico
  • Breast Cancer Research and Treatment
    • The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer [2015]
• Netherlands
  • Laboratory Investigation
    • Programmed Death Ligand-1 Testing in Triple-Negative Breast Cancer: National Practice and Interlaboratory Variation in the Netherlands [2026]
• Poland
  • Oncology in Clinical Practice
    • Systemic treatment in triple-negative breast cancer patients — standard and novel approaches [2024]
• Republic of Korea
  • PLoS ONE
    • Prognostic Role of Adjuvant Chemotherapy in Node-Negative (N0), Triple-Negative (TN), Medullary Breast Cancer (MBC) in the Korean Population [2015]
• Spain
  • Targeted Oncology
    • Second-Line Treatment Options for Patients with Metastatic Triple-Negative Breast Cancer: A Review of the Clinical Evidence [2025]
• Sweden
  • Breast Cancer Research and Treatment
    • Worse survival despite indolent features for triple-negative invasive lobular carcinoma: a Swedish nationwide registry-based study [2025]
  • Journal of Geriatric Oncology
    • Age and comorbidity in relation to treatment and survival outcomes in triple-negative breast cancer: A Swedish nationwide registry-based study [2025]
• Thailand
  • PLoS ONE
    • Real-life clinical pattern, management, and survival in Thai patients with early-stage or metastatic triple-negative breast cancer [2018]
• United Kingdom
  • National Institute for Health and Care Excellence
    • Sacituzumab govitecan for treating unresectable triple-negative advanced breast cancer after 2 or more therapies [2022]
    • Pembrolizumab plus chemotherapy for untreated, triple-negative, locally recurrent unresectable or metastatic breast cancer [2022]
    • Pembrolizumab for neoadjuvant and adjuvant treatment of triple-negative early or locally advanced breast cancer [2022]
    • Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancer [2020]
  • Vaccines
    • Manufacturing and Financial Evaluation of Peptide-Based Neoantigen Cancer Vaccines for Triple-Negative Breast Cancer in the United Kingdom: Opportunities and Challenges [2025]
• United States
  • Advances in Therapy
    • Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in the United States [2023]
  • American Cancer Society
    • Treatment of Triple-negative Breast Cancer
  • American Society of Clinical Oncology
    • Use of Immune Checkpoint Inhibitors in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A [2022]
    • Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update [2022]
  • American Society of Clinical Oncology Educational Book
    • Early-Stage Triple-Negative Breast Cancer Journey: Beginning, End, and Everything in Between [2023]
  • Annals of Surgical Oncology
    • Identifying and Treating Those at Risk: Disparities in Rapid Relapse Among TNBC Patients in the National Cancer Database [2024]
  • Breast Cancer Research and Treatment
    • Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing [2014]
  • Cancers
    • Present and Future of Immunotherapy for Triple-Negative Breast Cancer [2024]
  • Frontiers in Oncology
    • Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer [2024]
  • Frontiers in Public Health
    • Racial and regional disparities of triple negative breast cancer incidence rates in the United States: An analysis of 2011-2019 NPCR and SEER incidence data [2022]
  • JAMA Network Open
    • Trends and Disparities in the Use of Immunotherapy for Triple-Negative Breast Cancer in the US [2025]
    • Clinical and Demographic Factors, Treatment Patterns, and Overall Survival Associated With Rare Triple-Negative Breast Carcinomas in the US [2021]
  • JCO Oncology Practice
    • Treatment Patterns, Trends, and Outcomes of Neoadjuvant Chemotherapy Use Among Patients With Early-Stage Invasive Triple-Negative Breast Cancer [2025]
  • JNCCN
    • Integrating Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Practical Evidence-Based Considerations [2022]
  • Journal of Clinical Pathways
    • Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer [2021]
  • Oncologist
    • Clinical perspective on management of key adverse events with sacituzumab govitecan [2025]
    • Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer: Clinical Overview and Management of Potential Toxicities [2021]
  • Pharmaceutics
    • Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook [2023]
• West Africa
  • JCO Global Oncology
    • Prevalence and Mortality of Triple-Negative Breast Cancer in West Africa: Biologic and Sociocultural Factors [2021]
• {Related topics}
  • Topic
    • Breast cancer